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0.2 Abstract 
Organocatalysis has become one of the most popular areas of research within 
organic chemistry over the past 15 years. This is due to the fact that, usually under 
mild conditions, it is possible to access either highly functionalized or previously 
inaccessible structural motifs using this relatively new type of catalysis.  
Firstly, methodology is reported for the synthesis and use of tertiary amine 
organocatalysts based on the now ubiquitous binaphthyl backbone. The tertiary 
amines synthesized were shown to be effective nitrogen transfer reagents in the 
asymmetric aziridination of chalcone substrates, with enantiomeric excesses of up to 
37% seen. The first example of an isolated chiral hydrazinium salt being used as a 
nitrogen transfer reagent for the aziridination of enones is also described. 
Secondly, a range of α-substituted secondary amines based on the binaphthyl 
backbone has been synthesized from easily accessible iminium salts. Preliminary 
catalyst testing showed them to be interesting alternatives to the more commonly 
seen proline-derived catalysts for asymmetric conjugate additions reactions between 
cyclic enones and malonates, with enantiomeric excesses of 24% seen using 
optimized conditions.   
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0.5 Abbreviations 
Ac Acetyl  
AIBN Azobisisobutyronitrile  
atm Atmosphere  
BINAP 2,2'-Bis(diphenylphosphino)-1,1'-binaphthyl  
BINOL 1,1'-Bi-2-naphthol  
Boc tert-butyloxycarbonyl  
Bs p-bromobenzenesulfonyl  
Bz Benzyl  
Cat* Catalyst  
Cbz Benzyloxycarbonyl  
cy Cyclohexyl  
DBSPINOL 4,4’-Dibromo-1,1’-spirobiindane-7,7’-diol  
DCM Dichloromethane  
DCE 1,2-Dichloroethane  
de Diastereoisomeric excess  
DIPEA Diisopropylethylamine  
DMAP N,N’-Dimethylaminopyridine  
DME 1,2-Dimethoxyethane  
DMF N,N’-dimethylformamide  
DMSO Dimethylsulfoxide  
Dpp Diphenylphosphinyl  
Dppp 1,3-Bis(diphenylphosphino)propane  
ee Enantiomeric excess  
Et Ethyl 
HOSA Hydroxylamine O-sulfonic acid  
HPLC High performance liquid chromatography  
iPr Isopropyl 
Me Methyl 
MSH Mesitylsulfonylhydroxylamine  
NBS N-bromosuccinimide  
NHC N-heterocyclic carbene  
NMM N-methylmorpholine  
 vii 
NMR Nuclear magnetic resonance  
NMP N-methylpyrrolidine  
NOESY Nuclear Overhauser effect spectroscopy  
OTf Trifluoromethanesulfonate (triflate)  
Oxone™ Potassium peroxymonosulfate  
Pf Phenylfluoren-9-yl  
ppm Parts per million  
p-TSA p-Toluenesulfonic acid  
py Pyridine  
Red-Al Sodium bis(2-methoxyethoxy)aluminium hydride  
Rf Retention factor  
rt Room temperature  
TASF Tris(dimethylamino)sulfonium difluorotrimethylsilicate  
TBS Tert-butylsilyl  
tBu tert-Butyl 
TEA Triethylamine  
TFA Trifluoroacetic acid  
THF Tetrahydrofuran  
TLC Thin layer chromatography  
Tol Tolyl  
Ts Tosyl  
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1.1 Organocatalysis – An Introduction 
Ever since it was realized that the spatial arrangement of atoms within 
molecules could dramatically affect their properties, there has been an exponential 
increase in the amount of research going into the enantioselective synthesis of 
compounds. The most cost-effective way to synthesize these molecules is to use a 
small amount of an enantiomerically pure catalyst to effect the transformation and it 
is these enantiocatalytic reactions that have had the greatest impact on organic 
chemistry in the last three decades. In 2000, it was estimated that approximately one 
third of all marketed drugs contained at least one centre of chirality.1 Today, it is 
possible to separate the massive array of enantioselective catalysts available into 
three main categories:  
 
• Organometallic complexes, which utilize reactive metal centres and chiral 
organic ligands to effect enantioselective reactions  
• Bioorganic catalysts (e.g. enzymes), which utilize biological macromolecules  
• Organocatalysts, which utilize small enantiopure organic molecules as 
catalysts without the need for metal centres  
 
The earliest examples of highly selective asymmetric catalysis generally 
utilized organometallic complexes due to the fact that their properties could be easily 
tuned by altering either the metal centre or the ligand. However, organometallic 
catalysis does have its problems, normally associated with either the expense of the 
metal concerned or with the toxicity of the metal residues left in the products of these 
reactions. Although enantioselectivity is generally extremely high in these processes, 
it is sometimes the case that cost is prohibitive on a large (industrial) scale due to the 
cost of the catalyst itself or its removal from the waste stream following the 
completion of the reaction. The same thing can be said for enzymatic 
transformations, as isolation of the required enzymes on a large scale can be 
extremely expensive in practice.  
A currently burgeoning area of catalytic organic chemistry is that of 
asymmetric organocatalysis. That is, the use of small organic molecules to effect 
enantioselective reactions. This area of chemistry has exploded onto the scene in 
the past decade with close to 2000 articles published on the subject between the 
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Figure 1 Publications containing the word “organocatalysis” published 
between 2000 & 2007 
coining of the term in 1998 and 2008. These publications have described 
enantioselective variants of over 130 different chemical manipulations.2 
Organocatalysis has many advantages over other forms of catalysis. It is 
often the case that organocatalysts are far more stable than their organometallic 
counterparts, making them generally far more tolerant of air or moisture, negating 
the need for rigorously anhydrous conditions. They are also generally less expensive 
to prepare than other catalysts with many being available directly from the chiral 
pool. Finally, their relative stability allows for facile covalent attachment to solid 
supports and also allows for their possible use (and subsequent reuse) in high 
throughput screening and continuous flow chemistry. These factors have clearly 
contributed to the burgeoning area of organocatalysis as it means that any research 
group can now partake in this area of research without the need for expensive 
equipment or reagents. This is exemplified in figure 1, whereby the number of papers 
containing the word “organocatalysis” published in the years 2000 – 2007 is 
presented.3 
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Scheme 1 The Hajos-Parrish reaction 
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The first examples of what we now know as organocatalysis were seen nearly 
a century ago, when organic chemistry was still in its infancy. Several accounts, 
including those by Bredig,4,5 Ostwald,6 Marckwald,7 and Langenbeck8 exist from the 
first half of the last century. Unfortunately, none of these were particularly selective 
and sustained work in the area was not forthcoming. Even over the second half of 
the century there have only been sporadic publications on organocatalytic 
processes. The discovery of DMAP and related structures as esterification catalysts 
by Steglich was a bright spot.9 However, this was clearly not an enantioselective 
catalyst. The first publications of note on the subject of enantioselective 
organocatalysis were simultaneous papers by Hajos and Parrish,10 and Eder, Sauer, 
and Wiechert11 in 1974, which showed that the asymmetric intermolecular aldol 
reaction between triketone 1 catalysed by (S)-(–)-proline, yielded either the bicyclic 
ketol 2 or the α,β-unsaturated ketone 3 depending on the conditions used (Schemes 
1 & 2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Unfortunately, while this work was well received it did not spur any sustained 
research in the field, possibly due to the fact that it was seen as more of an anomaly 
than as something that could spawn a whole new connected area of homogeneous 
catalysis. A 25-year hiatus unfortunately then occurred, presumably due to the 
impetus put on metal-based catalysts such as those developed by Evans and 
Scheme 2 The Eder-Sauer-Wiechert reaction 
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others.12 This is supported by two facts, one being that not a single review of this 
type of chemistry was published before 1998 and also the fact that the world 
renowned chemist Dieter Seebach published an article in 1990 on the future of 
organic chemistry stating that the discovery of truly new reactions is likely to be 
limited to the realm of transition-metal organic chemistry, which will almost certainly 
provide us with additional miracle reagents in the years to come whilst completely 
failing to mention the concept of organocatalysis at all.13  
It was not until the work of Shi,14 Denmark,15 Yang,16 and Page17 on 
organocatalytic dioxirane and iminium salt mediated epoxidation in the late 1990’s 
that the area of organic catalysis truly took off. While these were clearly important 
steps forward, the problem with these catalysts are that they are single catalysts with 
a single use for one transformation. As such, even though organocatalysis as we 
know it today was discovered many years ago, mainstream research into its use has 
truly exploded in the past decade following the simultaneous discovery of iminium 
and enamine based secondary amine organocatalysis by MacMillan and List in 
2000. The seminal publications in the area were List’s paper on proline-catalysed 
intramolecular aldol reactions18 and MacMillan’s papers on organocatalytic Diels-
Alder and 1,3-dipolar cycloaddition reactions.19 In both cases, many different 
reactions are catalysed by the same simple secondary amines. From these 
beginnings, in subsequent years single catalysts capable of catalysing highly 
enantioselective organocatalytic asymmetric variants of ubiquitous reactions such as 
the Mannich, Michael, aza-Henry, and Baylis-Hillman reactions as well as 
asymmetric oxidations, aminations and other cycloadditions have been discovered.20 
This has led one commentator to state that organocatalysis has truly matured “from 
infancy into adolescence” in recent years.21  
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1.2 Secondary Amine Organocatalysis 
The publications by MacMillan and List discussed above defined two different paths 
that amine organocatalysis can proceed by. Iminium catalysis activates α,β-
unsaturated aldehyde and ketone systems in the same way that Lewis acids do, by 
lowering the LUMO of one reactant in relation to the HOMO of the other, thus 
allowing the reaction to proceed. Enamine catalysis on the other hand is essentially 
a catalytic version of the Stork enamine reaction.22 Whereas enols exist as 
tautomers of ketones and aldehydes, amine organocatalysts allow chiral enamines 
to form far more readily, thus allowing for asymmetric α–functionalization of carbonyl 
substrates. In order for both of these types of transformations to be highly selective, 
different things must be considered when designing the catalysts. These two catalyst 
modes are represented in Scheme 3.23 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3 The two most well-known forms of organocatalytic activation 
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Scheme 4 General synthesis of MacMillan-type imidazolidinone 
organocatalysts 
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1.2.1 Iminium Organocatalysis 
In the case of iminium amine organocatalysts, MacMillan has shown that the 
geometry of the iminium salt itself is one determining factor in the stereochemical 
outcome of the reaction.24 This was the driving force behind the design of 
MacMillan’s organocatalysts of the type 7, which are derived in three steps from 
commercially available starting materials (Scheme 4). 
 
 
 
 
 
 
 
In the example shown in Scheme 5, the iminium intermediate 11 in the Diels-Alder 
reaction between acrolein 8 and 1,3-butadien-2-ylbenzene 9 catalysed by catalyst 10 
will selectively form the (E)-isomer shown in order to avoid high-energy interactions 
between the acrolein moiety and the gem-dimethyl group present. This in turn means 
that any cycloaddition to the activated intermediate would have to be from the 
direction shown. The benzyl group effectively shields one face of the iminium 
intermediate, meaning that one enantiomer should form preferentially over the other. 
This proved to be the case, with good conversions and high ees seen throughout, 
giving compound 12 in 90% yield and 83% ee. 
The diarylprolinol catalysts 17 simultaneously published by Jørgensen25 and 
Hayashi26 are also well-known iminium amine organocatalysts. The bulky TMS ether 
moiety effectively blocks one face of the formed iminium ion, allowing for selective 
reactions to occur. They are synthesized from proline according to a procedure 
published by Kanth and Periasamy (Scheme 6).27 
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Scheme 6 General synthesis of Jørgensen-type diarylprolinol organocatalysts 
Scheme 5 Organocatalysed Diels-Alder reaction 
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This synthesis is highly optimized and avoids drawbacks such as the instability of 
intermediates and the use of toxic reagents such as phosgene, which have been 
used in previous syntheses. A simple silylation yields the desired catalyst. Altering 
the Grignard reagent used can form a wide variety of potential catalysts with varying 
properties.28  
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1.2.2 Examples of Iminium Organocatalysis 
After the initial discovery of iminium catalysis by MacMillan, there have been 
countless examples of reactions of this type published in the literature.29 A vast array 
of conjugate additions have been discovered, including conjugate hydride reductions 
using Hantzsch esters,30 as well as the additions of malonates,31 nitroalkanes,32 and 
heterocycles such as pyrrole (Scheme 7),33 to enals and enones, which form a wide 
range of architectures such as 21. If a specialised type of nucleophile is used, it is 
also possible form epoxides of the type 24 (Scheme 8),34 aziridinations,35 and 
cyclopropanations.36 Finally, there are several examples of 4+2,24 3+2,37 and 4+3 
(Scheme 9)38 type cycloadditions in the literature that are effectively catalysed by 
organocatalysts, giving compounds such as 27. 
Scheme 7 Organocatalytic Friedel-Crafts Alkylation 
Scheme 8 Organocatalytic Epoxidation of Enals 
Scheme 9 Organocatalytic 4+3 cycloaddition  
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Scheme 10 General synthesis of Jørgensen-type diarylprolinol 
organocatalysts 
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Finally, there are limited examples of reactions employing first iminium catalysis and 
subsequently enamine catalysis. Thus, many novel compounds have been 
discovered in this manner. An example, published by Jørgensen, is shown in 
Scheme 10.39 Here, novel aminothiols such as 31 exhibiting leukotriene A4-
hydrolase inhibition were synthesized in a facile, one-pot manner that would not 
have been possible using conventional organic chemistry techniques. 
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Scheme 11 Mechanism of Aldolase I catalysed aldol reactions 
(double-headed arrows represent proton shuttling between Lys201 & Asp102) 
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1.3.1 Enamine Organocatalysis 
 Enamine type catalysts are often compared with type I aldolase enzymes, which are 
found in vitro and are essential cogs in glycolysis pathways, gluconeogenesis, and in 
the Calvin cycle.40 Aldolases react in a similar manner to the previously described 
standard mechanism for enamine-based organocatalysis. This has been elegantly 
proven by Wong, Wilson and co-workers, who managed to obtain X-ray structures of 
proposed covalently bonded intermediates of a biochemical pathway involving an 
aldolase enzyme (Scheme 11).41 
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Figure 2 Hajos’ initial postulation for the mechanism of the proline-catalysed 
asymmetric aldol condensation 
Figure 3 Heterogeneous template model postulated by Swaminathan 
These findings were also backed up by NMR studies of the same reaction pathway. 
It was this type of reactivity that List and Barbas were attempting to mimic in their 
initial publication on the proline-catalysed aldol reaction.18  
The fact that these types of reactions do in fact proceed through an enamine 
intermediate has been the topic of debate over the years. Concerning the Hajos-
Parrish intramolecular aldol reaction, there are several models that have been 
postulated over the years, by Hajos,10 Agami,42 Swaminathan,43 and Houk.44 Hajos 
initially dismissed the possibility of an enamine intermediate and instead proposed 
the formation of an aminocarbinol intermediate (Figure 2) formed by direct 
nucleophilic addition of proline to one of the cyclic ketones in the starting material. 
This would then be attacked by the enol (present in equilibrium with the acyclic 
ketone) in the molecule.  
 
 
 
 
This theory was discredited by List, who showed that 18O was incorporated into the 
product when 18O labelled H2O was added to the reaction mixture after rigorously 
removing other water from the DMSO solvent used. This confirms that an iminium 
ion (and subsequently an enamine) must form that is subsequently hydrolysed by 
water in the reaction mixture once the reaction is complete.45  
Swaminathan proposed that this type of catalysis occurred heterogeneously, with the 
reaction occurring on the surfaces of the insoluble, crystalline proline in the reaction 
mixture, with the enantioselectivity arising from a templating effect (Figure 3). 
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Figure 4 Two-proline model suggested by Agami 
Swaminathan also stated that if a reaction containing solid proline as a catalyst was 
filtered, the reaction ceased to occur, and also quoted a patent by Hajos and co-
workers that described the solventless proline catalysed aldol condensation soon 
after their initial publication.46 This was again discredited by List, who stated simply 
that many aldol condensations catalysed by proline are completely homogeneous. 
Thirdly, Agami has postulated a transition state for this reaction that involves two 
proline molecules taking part at the same time, with one forming the nucleophilic 
enamine and one acting as a proton donor (Figure 4).  
 
 
 
 
 
This process can be compared to the aldolase enzyme-mediated aldol reactions. He 
also stated that non-linear effects are at play in this type of reaction, which confirmed 
in his mind the need for two proline molecules in the transition state. List and co-
workers, upon repeating this work, observed no such non-linear effects. Also, if two 
proline molecules were required for the transition state to form, one would expect a 
diminished rate and enantioselectivity if dilution were increased. Again, List found no 
evidence of this.45  
The most commonly accepted model for this type of reaction is that proposed by List 
and Houk. They propose a transition state containing only a single proline molecule 
with the carboxylate acting as the required proton donor, with a stabilized 6-
membered ring formed. This can be described as a metal-free Zimmerman-Traxler 
model,47 and accurately predicts the enantioselectivity seen in a variety of proline-
catalysed aldol-type reactions. The favoured and disfavoured transition states of the 
reaction between acetone and acetaldehyde are shown in Figure 5.  
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Figure 5 List-Houk model for the proline-catalysed asymmetric aldol reaction 
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Figure 6 Comparison of three different models for the Hajos-Parrish reaction 
 
 
  
 
The favoured model has the methyl group of the acetaldehyde in an equatorial 
position whereas it is axial in the disfavoured orientation. This reduces any steric 
hindrance that could occur. This effect would obviously be more pronounced with a 
larger aldehyde (p-nitrobenzaldehyde is the one most often used for catalyst testing). 
Also, for this 6-membered ring to form the enamine has to be in the anti configuration 
with respect to the carboxylic acid sidechain. Any other conformations result in a 
much higher energy transition state. 
When considering the Hajos-Parrish reaction, this model also explains the selectivity 
seen. When compared to both the initial transition state proposed by Hajos as well 
as the uncatalysed transition state, modelling studies have shown the List-Houk 
intermediate to be lower in energy by upwards of 10 kcal mol-1 (Figure 6).48  
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Scheme 12 Asymmetric proline-catalysed Mannich reaction 
Scheme 13 Asymmetric proline-catalysed aldol reaction 
Scheme 14 Asymmetric proline-catalysed cross aldehyde aldol reaction 
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1.3.2 Examples of Enamine Organocatalysis 
The initial publication by List instigated a rich period of investigation in this area.18 
Within a few years, there were many variations of this aldol reaction published. The 
most important of these were published by List himself as well as MacMillan and co-
workers. By altering the substrates of the reactions, methodologies were discovered 
for the proline-catalysed Mannich reaction to give compounds of the type 4249 
(Scheme 12) and cross aldehyde couplings to give compounds of the type 45 & 47 
(Scheme 13 & 14),50 as well as an aldol reaction between β-hydroxyketones and 
aldehydes that yielded trans-diol products.51 This method is complementary to the 
well-known Sharpless methodology for the asymmetric synthesis of cis-diols52 using 
his version of the Upjohn dihydroxylation.53  
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Scheme 15 Asymmetric proline-catalysed cross aldehyde aldol reaction 
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Another excellent example of enamine activation is the organocatalytic synthesis of 
carbohydrates published by MacMillan. Using a proline-catalysed cross aldol 
reaction between two molecules of TIPS-protected β-hydroxyaldehyde 48, it was 
possible to isolate 49 in high yield and with high selectivity. From there, Mukaiyama 
aldol reactions (under a variety of conditions) were used to access a variety of 
hexoses including mannose 51, glucose 52, and allose 53, which previously would 
have required many more steps to obtain (Scheme 15).54,55 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Further examples include a variety of α-functionalizations such as 
halogenations,56,57,58 aminations,59,60 and oxygenations,61 as well as other carbon-
carbon bond forming reactions including conjugate additions of aldehydes to 
nitroalkanes62 and inter- and intramolecular conjugate additions to enones.63,64,65
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Scheme 16 SOMO organocatalysis 
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1.4.1 SOMO Organocatalysis 
In recent years, a third mode of organocatalysis has been discovered by MacMillan. 
This mode is referred to as singly occupied molecular orbital (SOMO) catalysis, and 
involves the oxidation of a well-known enamine intermediate using a stoichiometric 
single-electron oxidant such as ceric ammonium nitrate (CAN) to form a radical 
anion intermediate that will react with different substrates from the other two modes, 
thus opening up a whole new area of enantioselective organocatalysis.66 The 
proposed intermediate 55 for this type of process is shown in Scheme 16. 
 
 
 
 
 
 
1.4.2 Examples of SOMO Catalysis 
While examples of this type of activation are sparse compared to the more 
ubiquitous enamine and iminium-type processes, there are several important 
transformations that use SOMO catalysis. MacMillan initially developed an 
asymmetric α-allylation of aldehydes to give compounds such as 61 (Scheme 17) as 
well as preliminary work on an asymmetric heteroarylation to give 64 (Scheme 18) 
and an asymmetric cyclization-chlorination cascade to give 66 (Scheme 19), all of 
which demonstrate the broad utility of this type of catalysis. Since then, the α-
allylation has been extended to include ketone substrates,67 and related α-
oxidations68 and α-arylations69 of aldehydes have been published by Sibi and 
Nicolaou respectively. 
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Scheme 17 Asymmetric α-allylation of aldehydes 
Scheme 18 Asymmetric α-heteroarylation of aldehydes 
Scheme 19 Asymmetric cyclization-chlorination cascade 
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2.1 The use of Amine Organocatalysis in Natural Product Synthesis 
A publication by MacMillan in 1997 suggested that the current state of organic 
synthesis was not enabling the pharmaceutical industry to keep up with the need for 
new (or existing) drugs.70 The example he used was Taxol® 67, a potent anti-cancer 
drug that was initially isolated from the bark of the Pacific Yew tree in 1966, but its 
complex structure was not elucidated until 1971.71  
 
 
 
 
Taxol has succumbed to total synthesis on a number of occasions. The earliest 
syntheses were reported by Nicolaou, Horton, Danishefsky, Wender, Mukaiyama, 
and Kuwajima.72 However, as a result of its intricate structure, the number of steps 
required to complete the compound has ranged from 37-51 chemical steps. This 
initially made biological testing incredibly difficult, as the isolation of Taxol from 
natural sources was also prohibitively difficult. From 10 kg of dry bark (corresponding 
to five whole trees), 1 g of Taxol was isolated. Considering that a ton of Taxol was 
required to meet worldwide need every year, MacMillan proposed the wider use of 
cascade synthesis as a means to decrease the number of steps required to 
introduce complexity into compounds. This theory is well-known by examples in 
nature, including the biosynthesis of Taxol by a variety of enzymes from the well-
known terpene precursor geranylgeranyl diphosphate (GGPP) 69 via an intermediate 
known as taxadiene 68 (Scheme 20). MacMillan envisaged that using his newly 
discovered iminium activation chemistry it would be feasible to carry out these 
transformations in the laboratory. 
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Scheme 21 Key organocatalytic asymmetric Diels-Alder reaction in the total 
synthesis of hapalindole Q  
N
Ts
CHO Me
Me
N
N
H
O
Ph
NTs
CHO N
Ts
CHO
.HCl
+
71
3 eq.
+(40 mol%)
DMF/MeOH/H2O
35%
endo:exo 85:15
93% ee70 72 73
10
While organocatalysis has been shown to work in a vast array of model systems, the 
true test of this relatively new system has been the use of these catalysts in the 
synthesis of complex natural products. This “trial by fire” as one commentator put 
it,73 has fortunately led to elegant, streamlined syntheses of highly complex natural 
products that hitherto required lengthy routes or were simply inaccessible using more 
conventional chemistry. Several of these syntheses are highlighted in reviews by 
Christmann.73-74 While it would not be prudent to attempt to describe every example 
in the literature, the syntheses presented in this chapter show the remarkable 
diversity of targets that have succumbed to total synthesis through routes employing 
organocatalysis.  
One of the earliest and yet most elegant syntheses using this new methodology was 
that of hapalindole Q 9 by the group of Kerr.75 An asymmetric Diels-Alder reaction 
between an enal dienophile 70 and 1,3-dimethyl-1,3-cyclohexadiene 71 using 
MacMillan’s imidazolidinone catalyst 10 gave the critical intermediate 72 required in 
low yield but with good endo selectivity and high ee (Scheme 21). Interestingly, and 
gratifyingly for both MacMillan and Kerr, more well-known Lewis acid mediated Diels-
Alder reactions all failed due to polymerisation of the diene in each case.  
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Scheme 22 Total synthesis of Prelactone B 
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Another excellent and somewhat simpler early example of total synthesis using a 
simple L-proline catalyst is that of prelactone B 79 by Pihko and co-workers.76 A 
cross-aldol reaction between isovaleraldehyde 74 and propionaldehyde 75 yielded 
the desired intermediate in high yield along with excellent ee and dr.  Only three 
further steps were required to furnish the natural product 79 in good overall yield 
(Scheme 22). A comparison between this synthesis and the others in the literature 
shows that this was the most economical synthesis published at that time, with 
TBSOTf being the most expensive reagent used throughout. Three more syntheses 
of prelactone B were known at the time. A racemic 6-step synthesis by Kocienski,77 a 
chiral auxiliary based 6-step synthesis by Staunton,78 as well as a comparatively 
long 13-step synthesis by Chakraborty79 all paled into relative insignificance when 
compared to the streamlined synthesis of Pihko. A related synthesis of prelactone C 
by Kobayashi gave a similar natural product, also in 4 steps, but utilized non-
commercially available starting materials as well as a relatively expensive Zr-based 
chiral catalyst.80  
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Scheme 23 Organocatalytic synthesis of a key intermediate in the total 
synthesis of flustramine B 
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MacMillan’s first foray into total synthesis was the use of an asymmetric 1,4-addition 
of a tryptamine analogue to acrolein using one of his imidazolidinone-based 
organocatalysts to form the core structure of several of the pyrroloindoline alkaloids 
with very high selectivity. This is exemplified here by the synthesis of the natural 
product (–)-flustramine B 11, a potassium channel inhibitor that shows muscle 
relaxant properties.81 In this case, the pendant N-Boc protected ethylamine 
intercepts the iminium-type intermediate formed following the initial 1,4-addition to 
acrolein in a favoured 5-exo-heterocyclization. The tricyclic structure so generated is 
the desired pyrroloindoline motif. A few simple functional group transformations gave 
(–)-flustramine B in excellent overall yield (Scheme 23).  
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Scheme 24 Organocatalytic synthesis of advanced intermediate 86 
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Another excellent use of organocatalysis in total synthesis is that which led to the 
first synthesis of littoralisone, again by MacMillan.82 In this case, molecular 
complexity is built up very quickly starting from the aldehyde 83 (itself derived from 
(–)-citronellol 82 in two steps) using a one-pot proline-catalysed aminoxylation and a 
Horner-Wadsworth-Emmons reaction to form 84 in high yield and ee. A standard 
reduction/oxidation protocol gave bis aldehyde 85, which was then subjected to the 
lynchpin reaction of this synthesis, a contra-thermodynamic Michael addition to form 
iridoid 86. By carefully selecting the reaction conditions the desired kinetic product 
was formed as opposed to the monocyclic thermodynamic product 16 (Scheme 24).  
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Scheme 25 Organocatalytic carbohydrate synthesis 
Scheme 26 Completion of the synthesis of littoralisone 
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The previously mentioned paper by MacMillan on carbohydrate synthesis has also 
been used in natural product synthesis.55 Thus, compound 19 was synthesized using 
a 5-step protocol via compound 18 (Scheme 25).  
 
 
 
 
 
 
 
TMSOTf-catalysed coupling of 93 (derived from 86) and 92 gave advanced 
intermediate 94, which was then irradiated to facilitate a 2+2 cycloaddition. Finally, 
hydrogenolysis of the benzyl protecting groups furnished littoralisone 95 in 13% yield 
over 13 steps (Scheme 26).  
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Scheme 27 Total synthesis of (–)-(5R,6S)-6-acetoxyhexadecanolide 
Scheme 28 Total synthesis of (R)-convolutamydine 
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One of the most succinct syntheses using organocatalysis is that of (–)-(5R,6S)-6-
acetoxyhexadecanolide 99, a natural mosquito attractant pheromone, by the group 
of Li.83 A simple, highly selective proline-catalysed asymmetric aldol reaction led to 
the β-hydroxyketone intermediate 98. A simple acetylation and Baeyer-Villiger 
oxidation gave the natural product 99 in an impressive overall yield (Scheme 27).  
 
 
 
 
 
 
 
Several members of the convolutamydine family of natural products have 
succumbed to total synthesis involving organocatalysis, this time at the hands of 
Nakumura and co-workers.84 In this case, the enamine is derived from a variety of 
aldehydes, and the aldol acceptor is brominated isatin derivative 100 (Scheme 28), 
which was shown after much optimization to give the highest selectivity for these 
substrates. Previous attempts to synthesize these compounds were hampered by 
poor selectivity,85 but by using N-(2-thiophenesulfonyl)prolinamide 101 as catalyst, it 
was found that the addition of a second unit with H-bonding ability increased the ee 
of the final product presumably due to a more ordered transition state.  
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Scheme 29 Initial organocatalytic steps in the total synthesis of (+)-conicol 
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Organocatalysis also lends itself well to use in natural product synthesis because the 
operational simplicity and robustness of the catalysts generally mean that cascade 
and one-pot reactions can be designed in order to increase molecular complexity 
quickly and highly efficiently. This is shown exceptionally well in the synthesis of (+)-
conicol by Hong and co-workers.86 Starting from the nitrostyrene 103 and two 
α,β−unsaturated aldehydes (104 and 107) as well as Jørgensen’s diphenylprolinol 
catalyst 105, two cycles and four contiguous stereocentres could be built up in >99% 
ee in a simple one-pot process in reasonable yield (Scheme 29). The initial Henry 
reaction proceeds with complete stereoselectivity, and 106 can be isolated if desired. 
Subsequent addition of a second aldehyde leads to the chromene derivative 108. 
Several more steps were then required to access the natural product. Nonetheless, 
this remains the only synthesis of (+)-conicol, which has potential anti-cancer 
properties against a variety of cell lines.  
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Scheme 30 One-pot organocatalytic reductive cyclization and Tishchenko 
reaction to form the molluscicide ricciocarpin 
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Not only can a single organocatalyst be used in a single pot with multiple substrates, 
it is also the case that they can be used in the same pot as other metal-based 
catalysts and even, in some cases, other organocatalysts with different properties. 
This is exemplified by two recently published total syntheses; ricciocarpin A by List87 
and (–)-aromadendranediol by MacMillan.88  
The synthesis of ricciocarpin involves an innovative one-pot reductive Michael 
cyclization and Tishchenko reaction (Scheme 30). In this case the initially formed cis-
substituted cyclohexane 112 is epimerized by Sm(OiPr)3, which incidentally also acts 
as the catalyst for the second step of the cascade. Thus, the lactone ring forms with 
complete diastereoselectivity, giving the natural product in high yield. This completed 
the shortest recorded synthesis of ricciocarpin 115, which is a potent molluscicidal 
agent that acts against the water snail Biomphalaria glabrata, a vector for the 
parasites known to cause the potentially deadly disease schistomoniasis.  
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Scheme 31 One-pot, three step synthesis of an intermediate in the synthesis 
of (–)-aromadendranediol utilizing three different catalysts 
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In order to show far how this methodology can be pushed, MacMillan and co-workers 
have shown that a cascade involving three separate catalytic cycles in one pot can 
be implemented using three different catalysts. A number of highly functionalized 
motifs can be synthesized depending on the substrates and reagents chosen. For 
example, in the first reported synthesis of the analgesic and sedative natural product 
(–)-aromadendranediol, a ring-closing metathesis, an asymmetric Mukaiyama-
Michael addition, and finally an asymmetric aldol reaction all occur sequentially in 
one pot, forming a complex bicyclic intermediate from the three commercially 
available starting materials shown. Standard cross-metathesis yielded intermediate 
118. Subsequent addition of the silyloxyfuran 119 and the imidazolidinone catalyst 
20 led to intermediate 120, and finally addition of proline led to an intermolecular 
aldol condensation, giving 121. This set four of the five contiguous stereocentres 
seen in the natural product, and a further eight steps led to the completion of 
synthetic (–)-aromadendranediol, which proved to be identical to the natural isolate 
(Scheme 31).  
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Scheme 32 Asymmetric synthesis of demethyl calamenene utilizing SOMO 
catalysis 
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Nicolaou has recently even used the relatively new concept of SOMO catalysis 
(described in detail in section 1.4) in their brief synthesis of the potent cytotoxic 
natural product demethyl calamenene.89 A Friedel-Crafts type α−arylation of 
aldehyde 122 using a combination of MacMillan’s catalyst and CAN yielded bicycle 
123 with high selectivity and in good yield. Compound 123 was then converted into 
the natural product  using standard chemical techniques (Scheme 32).  
 
 
 
 
 
 
This brief review of work in this area shows that there have clearly been massive 
breakthroughs in the use of organocatalysis in natural product synthesis. The use of 
organocatalysts gives a valid alternative to the use of the better-known chiral 
auxiliary based synthetic protocols for introducing chirality into substrates early in 
total syntheses. However, there are still drawbacks in this area. With certain 
exceptions, including some from within the Page group,90 catalyst loadings are still 
generally very high (20-30 %) compared to those generally seen when using 
organometallic catalysts. This is something that needs to be addressed in the future. 
Also, whereas in the case of chiral auxiliary-based chemistry the chromatographic 
separation of diastereoisomers is often facile, the same cannot be said of 
organocatalytic reactions, where the products are usually enantiomeric and thus 
cannot be separated using normal methods. Thus, while all of these elegant 
syntheses do exist, there is still huge room for improvement in this relatively new 
field. 
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3.1 Axial Chirality and the Work of Maruoka 
The phenomenon of atropoisomerism (from the Greek, a = not, tropos = turn) arises 
when there is sufficient hindrance to rotation around a biaryl single bond at a given 
temperature that the two optically pure atropoisomers can be isolated.91 The 
substitution required around a biaryl system for restricted rotation has been studied 
extensively. The general definition of the presence of atropoisomerism in a given 
substrate given by Oki is that, at room temperature, one isomer can be isolated from 
the other and have a half-life of 1000 s (16.7 minutes).92 Generally, the requirement 
for this is a tetra-substituted biaryl, although other substitution patterns have also 
been shown to prevent rapid racemization.93 
While there are many examples of axially chiral natural products (colchicine 12494 
and knipholone 12595 are shown), the most well-known atropoisomeric compounds 
in the literature are biaryl ligands and catalysts exemplified by BINAP 126. This was 
first described as a ligand for the Rh-catalysed asymmetric hydrogenation of α-
(acylamino)acrylic acids by Noyori and co-workers in 1980.96 
 
 
 
 
 
 
Since then, BINAP has been shown to be a highly selective ligand for a variety of 
metals, due in equal parts to the flexibility of the system (allowing chelation of a 
variety of metals) and to its conformational stability (allowing it to form well-defined 
complexes).97 This is exemplified by the fact that the Ru-BINAP complex, also 
described by Noyori, has been shown to catalyse an unprecedented array of 
chemical manipulations, including the highly enantioselective reductions of allylic 
alcohols,98 α-keto acids,99 and β-keto esters100 as well as a variety of kinetic 
resolutions.101,102 
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With these successes in the area of organometallic catalysis, it was only a matter of 
time before axially chiral organocatalysts were seen in the chemical literature. There 
are many examples of this, including prolinamide 127,103 guanidine 128,104 and 
thiourea 129,105 which have been used to catalyse a variety of processes.  
 
 
 
 
These catalysts, while sometimes highly selective, are not particularly well known. 
However, the work of Maruoka, who developed amino acid and amino sulfonamide 
catalysts such as 130, 131 and 132 for enamine type organocatalysis, has received 
more widespread acclaim. These catalysts have proven to be highly stable, highly 
selective catalysts for asymmetric aldol106,107 and Mannich108,109 reactions. 
 
 
 
 
 
These compounds were designed with several ideas in mind. Firstly, this would be 
one of very few organocatalysts associated with enamine activation that is not 
derived from proline. In practice, this led to a difference in syn/anti selectivity in the 
asymmetric Mannich reaction between 3-methylbutanal 133 and the N-PMP imine 
134 derived from ethyl glyoxylate, with excellent anti selectivity seen when using 131 
(Scheme 33). This is the opposite selectivity from that seen when L-proline was used 
as a catalyst for the same reaction.49 Secondly, it was suggested that a lack of an α-
substituent in these catalysts would increase the rate of enamine formation by 
reducing steric constraints in that particular step. Thirdly, these types of amines are 
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Scheme 34 Decarboxylative decomposition of proline 
Scheme 33 Asymmetric Mannich reaction catalysed by 131 
N
H
CO2H
N N
N O
CO2
R R
R R
RCHO
(2 eq.)
-CO2
RCHORCHO -H2O
41 138
137136
O NPMP
CO2Et
+
131 (5 mol%)
dioxane, rt, 0.5 h
93% yield
>20:1 trans:cis
>99% ee
O
CO2Et
NHPMP
133 134 135
associated with low nucleophilicity and low basicity, both traits that are desirable in 
selective organocatalysts.  
 
 
 
 
Finally, it was hypothesized that not having an α-amino acid moiety in the 
organocatalyst would increase its stability. For example, side reactions in 
organocatalytic reactions that utilize proline are prone to catalyst deactivation due to 
decarboxylative azomethine ylide formation (conversion of 136 into 137) under 
standard reaction conditions (Scheme 34). Utilizing a catalyst that does not contain 
an α-amino acid motif would prevent these side reactions from occurring.  
 
 
 
 
 
 
 
 
 The initial publication by Maruoka described the synthesis of amino acid 130. 
It was synthesized in 7 steps from diester 139 (R = neopentyl). Bromination using 
Mg(TMP)2 and molecular bromine afforded monobromide 140. Subsequent LiAlH4 
reduction and bromination yielded tribromide 142, which was then easily converted 
to azepine 143 using standard conditions. A Pd-catalysed carbonylation yielded 
ester 140, which was then deprotected in two steps to give the desired compound 
130 (Scheme 35).106 
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Scheme 35 Synthesis of amino acid 130 
Scheme 36 Aldol reaction catalysed by amino acid 130 
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This type of synthesis was employed for all the catalysts mentioned above. The 
initial catalyst testing was for the asymmetric aldol reaction between p-
nitrobenzaldehyde and acetone  (Scheme 36). 
 
 
 
This reaction proceeded as expected, giving the β-hydroxyketone product in 70% 
yield and 93% ee. In comparison, running the same reaction using L-proline as 
catalyst gave only 18% conversion to the desired product with only 71% ee. The 
decomposition pathway discussed above was seen to occur in this case, with 1,3-
oxazolidine 149 isolated in 48% yield with respect to the 5 mol% of catalyst used.  
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Scheme 37 Aldol reaction catalysed by amino acid 132 
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After optimization, it was found that a wide variety of heteroaromatic, alkenyl and 
electron-deficient aromatic aldehydes could be used along with a variety of acyclic 
and cyclic ketones. In the case of the cyclic ketones, excellent trans/cis selectivity 
(>95:5) was seen in all cases.  
Generally in this initial publication catalyst loadings were quite high (10 mol%). In an 
effort to decrease this loading, catalyst 130 was synthesized.107 It was hoped that the 
electron-donating nature of the biphenyl system would increase the nucleophilicity of 
the amine moiety, thus increasing the rate of formation of a potential enamine 
intermediate. This did prove to be the case, with catalyst loadings as low as 0.1 
mol% able to catalyse the same aldol reaction as before in a selective manner after 
a similar reaction time (Scheme 37). 
 
 
 
 
In an effort to subtly alter the characteristics of this type of catalyst, Maruoka also 
synthesized sulfonamide 131 (see Scheme 33).109 It was hypothesized that this 
alteration would increase the distance between the amine moiety and the required 
acidic proton, thus altering the preference of the orientation of the intermediate 
enamine. This had the effect of changing the diastereoselectivity of the product. 
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Scheme 38 Asymmetric iodination of aldehydes catalysed by 150 
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As well as synthesizing highly selective catalysts 130 – 132, Maruoka has also 
synthesized other catalysts for a variety of α-functionalizations of aldehydes. This 
includes asymmetric metal-free iodinations,110 aminoxylations,111 and 
brominations.112 The properties of these new catalysts 150 and 151 were tailored to 
the different potential reactions they would be utilized for. 
 
 
 
 
 
Organocatalytic asymmetric iodinations are scarcely seen in the chemical literature, 
due in part to the propensity of the products to racemize easily under basic 
conditions.113 Compound 150 (Ar = C6F5) was synthesized as a catalyst for 
asymmetric iodination in the hope that the alcohol moiety would activate the NIS 
iodinating agent and the electron withdrawing pentafluorophenyl groups would 
decrease the nucleophilicity of the amine. This proved to be the case, and α-
iodoaldehydes were formed in high yield and enantiomeric excess (Scheme 38). 
 
 
 
The same catalyst was tested for asymmetric brominations using NBS. 
Unfortunately, the selectivities proved to be lower. Altering the brominating agent 
increased the selectivity, albeit with very low conversions. After NMR experiments, it 
was shown that the tertiary alcohol in 150 was decomposing the brominating agent. 
Thus, silyl ether 151 was synthesized. This gave similar selectivities to 150 whilst 
increasing the conversions seen from <10% to >80%. The selectivity was attributed 
to the steric bulk now present at the 3-positions as opposed to any sort of attractive 
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Scheme 39 Asymmetric bromination of aldehydes catalysed by 53 
Scheme 40 Asymmetric aminoxylation of aldehydes catalysed by 53 
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interaction between the brominating agent and the ether. After optimization, 
selectivities were seen to be universally high when a range of substrates was tested 
(Scheme 39).  
 
 
 
 
The same also proved to be the case for the asymmetric aminoxylation, with 
products isolated in good yield with excellent ee using catalyst 152 (Scheme 40).  
 
.  
 
 
This chapter reports only a small number of the organocatalytic processes that this 
type of catalyst can be used for. They are generally more selective than related 
proline-derived catalysts and are also more easily tuned. There are other related 
reactions that Maruoka has published including conjugate additions of aldehydes to 
methylenemalonates114 and nitroalkanes,115 cross aldol reactions between 
aldehydes and glyoxylic acid derivatives,116 and Mannich reactions between 
aldehydes and ketimines.117 We hoped that similar catalysts formed via a 
methodology based on α-functionalization of binaphthyl-derived iminium salts would 
also prove to be just as selective. Our work to this end is described in the following 
sections.  
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Scheme 41 Ring opening of epoxides by a variety of nucleophiles 
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4.1 Asymmetric Aziridination 
Aziridines are three membered rings containing two carbon atoms and one nitrogen 
atom. They are analogues of epoxides, the well-known three-membered cyclic 
ethers. While not as reactive as epoxides, there is still an appreciable ring strain 
associated with them (approximately 27 kcal mol-1). As a result, they are highly 
susceptible to ring opening by a wide variety of nucleophiles (Scheme 41). There are 
several reviews on aziridine chemistry where these ring openings and other 
reactions are discussed in detail.118,119  
  
 
 
 
 
 
 
 
 
 
The inherent reactivity of aziridines (and epoxides) make them valuable 
intermediates in both the pharmaceutical industry and in bulk industrial processes to 
produce chemicals including epoxy resins, ethylene glycol and polyethylenimine. 
There are also several known examples of natural products containing aziridines that 
show potent antimicrobial and anti-cancer properties. These compounds include the 
mitosanes120 (mitomycin C, 164), which are isolated from Streptomyces verticillatus 
and the azinomycins121 (azinomycin A, 165), which are isolated from Grieseofuscus 
S42227. Both of these families of compounds show potent anti-cancer properties 
due to their ability to alkylate DNA through their aziridine (and epoxide) moieties and 
subsequently initiate apoptosis.  
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Scheme 42 Lewis acid promoted polymerization of aziridines 
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The propensity of aziridines towards ring opening means that there are relatively few 
ways to synthesize them selectively, especially in their N-unprotected form.122 There 
are countless methods for asymmetric epoxidation in the literature for a wide range 
of substrates.123 Conversely, there are often compatibility issues with other functional 
groups when N-unprotected aziridines are formed due to the ability of the aziridine 
nitrogen to act as a nucleophile. This can cause unwanted side reactions, including 
polymerization to give compounds of the type 167 (Scheme 42).124  
 
 
 
 
There are several reviews on asymmetric aziridination in the literature covering early 
chiral auxiliary chemistry125 as well as more up-to-date reviews incorporating 
organometallic and organocatalytic methods.126,127 It is worth pointing out here that 
the vast majority of asymmetric aziridination methodology deals solely with N-
protected aziridines and that a lot of even the most recently published aziridination 
protocols utilize chiral auxiliary chemistry. This highlights how difficult it is to form 
aziridines enantioselectively. There are several methods for the formation of 
aziridines from a variety of substrates, including carbon transfer to imines, reactions 
of azirines, cyclizations, aza-Darzens-type reactions and finally nitrogen transfer to 
alkenes. Some of these methods are discussed in the following sections. 
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Scheme 43 Carbene addition to N-PMP imines 
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4.1.1 Addition to imines 
One of the well-known methods for synthesizing aziridines is through formal addition 
of a carbon atom to an imine. There are three distinct ways this can occur; addition 
of a carbene, addition of a ylide, and using an aza-Darzens reaction. Examples are 
shown below. 
Huang and co-workers showed that reactions between (R)-pantolactone-derived 
diazoacetates 168 and N-aryl imines 169 would form highly functionalized aziridines 
such as 172 with reasonable levels of diastereoselectivity.128 The mechanism is 
proposed to proceed via a metal carbene complex 170 that subsequently 
decomposes to an azomethine ylide 171 before finally forming the aziridine 172 
(Scheme 43). These compounds are valuable intermediates in the preparation of α-
hydroxy-β-amino acids, which have been shown to be precursors for a variety of 
drugs and natural products.129  
 
 
 
 
 
 
 
 
 
Stockman and co-workers have shown that through reaction of an enantiopure N-
sulfinylketimine 173 derived from benzophenone with an ylide formed by 
deprotonation of S-allyltetrahydrothiophenium bromide 174, it was possible to form 
2-vinylaziridines such as 175 in excellent yield and with >19:1 diastereoselectivity 
(Scheme 44).130 
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Scheme 44 Addition of an ylide to enantiopure N-sulfinyl imines 
Scheme 45 Preparation of (+)-isothiocineole 179 
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Scheme 46 Preparation of chiral sulfonium salt 180 
   
 
 
 
A similar application of this work is from the group of Aggarwal.131 By utilizing a chiral 
sulfur ylide derived in two steps from either (+)- or (−)-limonene it was possible to 
form a wide range of both aziridines and epoxides with extremely high enantio- and 
diastereoselectivity. Reaction of either enantiomer of limonene 176 with elemental 
sulphur at elevated temperatures allows for the facile isolation of either (+)- or (−)-
isothiocineole 179 with >98% ee after a simple distillation (Scheme 45).  
 
 
 
 
From there, alkylation with benzyl bromide at room temperature affords the precursor 
to the desired chiral ylide 180 (Scheme 46).  
 
 
 
 
Deprotonation at the benzylic position followed by subsequent reaction of this ylide 
intermediate with either an aldehyde (to form an epoxide) or an imine (to form an 
aziridine) then proceeds smoothly at room temperature (Scheme 47). 
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Scheme 47 Aziridination of N-tosyl imines to give trans-aziridine products 
Scheme 48 Aziridination of N-tosyl imines to give trans-aziridine products 
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When considering this type of imine chemistry, this work represents the highest level 
of diastereoselectivity ever recorded for these types of reactions. However, the 
limited availability of imine precursors and the requirement for a tosyl group in the 
imine substantially limits the potential uses of the products from this methodology. 
Finally, the other method for facilitating the formal addition of a carbon atom to an 
imine is through an aza-Darzens reaction. One of the more well-known examples of 
this was published by Sweeney and co-workers.132 Using an α-bromoacetate derived 
from camphorsultam and an N-diphenylphosphinyl imine in the presence of LiHMDS, 
it was possible to isolate the aziridine shown with high regio- and stereoselectivity 
(Scheme 48).  
 
 
 
 
 
Subsequent hydrolysis of the camphorsultam auxiliary proved to be facile, allowing 
for the isolation of carboxylic acids, which as indicated above are valuable 
intermediates in organic synthesis.  
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Scheme 49 Neber reaction to form azirines from O-tosyl oximes 
Scheme 50 Nucleophilic addition to azirines to form aziridines 
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4.1.2 Reactions of azirines 
Azirines are the smallest unsaturated N-heterocycles. Once formed, they are then 
highly susceptible to nucleophilic attack at the imine carbon, a process that forms 
aziridines. While relatively rare in the literature, azirines are stable enough to have 
been isolated in a number of natural products including azirinomycin 186133 and (S)-
(+)-antazirine 187.134 
 
 
 
Azirines are generally synthesized from O-tosyl oximes under basic conditions. This 
is known as the Neber reaction (Scheme 49).135 From there, aziridines can be 
produced by a subsequent nucleophilic addition reaction. An example where 
nitrogen-containing heterocycles such as 192 were added to chiral azirine-2-
carboxylic esters 191 (Scheme 50) was published by Alves and co-workers.136 
Finally, it is also possible to utilize azirines in aza-Diels-Alder reactions. Under Lewis 
acid catalysis, azirines such as 194 will act as dienophiles with a range of dienes 195 
thus forming highly functionalized fused aziridines 196 with high dr (Scheme 51).137  
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Scheme 51 aza-Diels-Alder reaction of a diene and an azirine 
Scheme 52 Aziridine synthesis using 1,2-amino alcohol as starting material 
Me NH2
OH
N
Me
Ts
TsCl
Pyridine
74%
197 198
N
CO2R*
OMe
N
OMe
CO2R*
+
MgBr2.OEt2
DCM, -100 oC
82% 
dr 94:6194 195 196
 
 
 
 
While currently relatively rare in the literature, recent advances in azirine chemistry 
have been reviewed.138 There has also been a recent publication in this area, with an 
organocatalytic asymmetric synthesis of azirine-2-carboxylates published recently by 
Takemoto and co-workers using a thiourea-catalysed Neber reaction.139 This type of 
process could prove to be fruitful in the future and push forward this little known area 
of small-ring chemistry. 
4.1.3 Intramolecular substitution 
The best-known method for synthesizing aziridines is by intramolecular nucleophilic 
substitution. There are examples in the literature of aziridine formation from 
enantiopure 1,2-amino alcohols, 1,2-azido alcohols and 1,2-amino sulfides. All 
furnish aziridines stereospecifically.  
There are countless examples of aziridine formation from 1,2-amino alcohols. An 
example of this is the synthesis of enantiopure N-tosyl aziridines 198 from amino 
acid derived amino alcohols 197 published by Jabin and co-workers (Scheme 52).140  
 
 
 
 
This method is useful for the synthesis of protected aziridines. A more useful method 
for the synthesis of NH aziridines is through the reduction of a 1,2-azido alcohol and 
subsequent cyclization. Vasella has used this methodology in the synthesis of 
spiroaziridine glycosidase inhibitors such as 200.141 It is notable in this case that 
other methods for the synthesis of these aziridines failed, making this route a 
valuable alternative to more well-known procedures (Scheme 53).  
 43 
Scheme 53 Synthesis of spiroaziridine glycosidase inhibitors  
Scheme 54 Final step in the total synthesis of aziridinomitosane 
Scheme 55 Synthesis of aziridines from 1,2-amino sulfides  
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Miller employed a similar method as the final step in his synthesis of 
aziridinomitosane (Scheme 54).142 
 
 
 
 
Finally, Arroyo has described a method for the synthesis of aziridines from 1,2-amino 
sulphides 203. This first involves formation of a sulfonium cation 204 followed by 
base-induced ring closure to form the protected aziridine 205 in high yields (Scheme 
55).143 This methodology proved to be very robust, with no racemization (via the 
formation of an intermediate benzylic carbocation) occurring. There is also no base-
induced epimerization and no formation of the imine and ylide decomposition 
products sometimes associated with this kind of system.  
 
 
 
 
4.1.4 Addition of nitrenes to alkenes 
The formal addition of a nitrogen atom to an alkene is an attractive method for 
synthesizing aziridines because of the availability of a vast array of alkene 
precursors. One such method, first reported by Mansuy and co-workers,144 uses 
nitrene precursors such as (N-tosylimino)phenyliodinane (PhINTs) 206. 
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Scheme 56 Late stage aziridination in the synthesis of (+)-agelastatin 
Scheme 57 Example of the Gabriel-Cromwell reaction 
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Using non-chiral Cu catalysts, it has been possible to form aziridines from a wide 
range of alkene substrates with these species. For example, Trost reported the 
synthesis of (+)-agelastatin where an aziridine motif was added to an advanced 
intermediate 207 with complete stereocontrol using PhINTs and a Cu catalyst 
(Scheme 56), giving compound 208.145 
 
 
 
 
 
It is also possible to formally add nitrenes to α-haloacrylates in a process known as 
the Gabriel-Cromwell reaction. In this reaction there is an initial aza-Michael addition 
of an amine followed by subsequent protonation and ring closure to form the 
aziridine. This is exemplified by the work of Maycock and co-workers who used this 
methodology in their synthesis of (+)-bromoxone (Scheme 57).146 
 
 
 
 
 
While the reactions described above rely on asymmetric induction from the 
substrates involved, there are countless examples of chiral ligands for asymmetric 
Cu-catalysed aziridinations, exemplified by the bisoxazoline (BOX) type ligands first 
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Scheme 58 Evans asymmetric aziridination  
Scheme 59 Masamune asymmetric aziridination  
Scheme 60 Evans asymmetric aziridination of cinnamate esters 
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discovered by Brunner,147 Nishiyama,148 and Masamune149 in the late 1980’s. It was 
not until 1991 that, independently, Masamune150 and Evans151 published single 
examples of styrene aziridination catalysed by Cu-BOX complexes (Schemes 58 & 
59). 
 
 
 
 
 
 
 
 
 
 
 
 
While these catalysts were not particularly selective, they did instigate more research 
in this area. Evans went on to publish further work on these reactions, this time the 
aziridination of cinnamate esters using a related BOX-type catalyst 215. Selectivities 
were universally higher using this system (Scheme 60).152 
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Scheme 61 The first organocatalytic asymmetric aziridination 
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This work cemented the status of this reaction as a viable means to synthesize 
enantioenriched aziridines. There have been countless examples of similar reactions 
in the literature, which have been reviewed.126 This remained the state of the art for 
this type of reaction until organocatalytic methods were developed over a decade 
later.  
4.1.5 Organocatalysed Aziridinations 
A publication by Córdova in 2007153 describing the first example of an 
organocatalysed asymmetric aziridination of linear enals such as 217 (Scheme 61) 
led to the development of a wide variety of similar reactions on a variety of 
substrates,122 including a publication by the same group on the aziridination of α-
substituted-α,β-unsaturated enals to give 2-alkyl-2-formylaziridines, again in high 
yield and with good selectivity.154  
 
 
 
 
 
Other methods for organocatalytic aziridination include those of Lindsley, who 
showed that an asymmetric α-chlorination of aldehydes to give compounds such as 
221 followed by a reductive amination and subsequent cyclization to give 222 would 
yield terminal aziridines in high yield (Scheme 62).155 While this does involve more 
than a single step, there are no other methods for synthesizing this type of 
compound using organocatalytic activation.  
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Scheme 62 Synthesis of terminal aziridines using organocatalysis 
Scheme 63 Asymmetric aziridination using an organocatalytic Mannich 
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Another interesting application of enamine activation in aziridination chemistry is the 
work of Hayashi and co-workers.156 By using the imine precursor 223, a 
desulfonylation and subsequent asymmetric Mannich reaction yield the intermediate 
225. Subsequent cyclization and reduction of the resulting aldehyde give aziridines 
such as 226 in Scheme 63.  
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Scheme 64 Tertiary amine catalysed asymmetric aziridination 
Scheme 65 Tertiary amine catalysed asymmetric aziridination 
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Finally, there has been some work on the tertiary amine catalysed asymmetric 
synthesis of NH-aziridines from enones such as trans-chalcone. This type of reaction 
is often not possible using metal catalysts due to the chelating nature of the products 
potentially destroying any catalyst used. Using initial work published by Ikeda157 and 
co-workers, Shi158 and Armstrong159 were both independently able to show that a 
catalytic amount of tertiary amine, in the presence of an electrophilic amine source 
such as O-diphenylphosphinyl hydroxylamine (DppONH2)160 or O-mesitylsulfonyl 
hydroxylamine (MSH)161 (see section 5.1 for more details), was able to transfer a 
nitrogen atom to the double bond of the enone, forming NH-aziridines in the process. 
Whereas Shi favoured Tröger’s base 230 (Scheme 64), Armstrong showed that 
quinine 228 behaved in a very similar manner (Scheme 65). Both catalysts gave in 
the region of 57% ee for the aziridination of trans-chalcone. In both cases, only the 
trans-aziridine was observed.  
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Scheme 66 Synthesis of vinylaziridines using tertiary amine mediated 
asymmetric aziridination 
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Armstrong has also continued to work in this area and has shown that it is possible 
to synthesize N-unsubstituted vinylaziridines 233 from α,β,γ,δ-unsaturated enones 
231 (Scheme 66).162 It is interesting to note in this case that the reaction is 
completely regioselective, with none of the other potential aziridine product seen in 
any case. This lends support to the proposed mechanism for the reaction, which is 
discussed in more detail in section 5.1. 
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Scheme 67 Ikeda’s initial work 
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5.1 Asymmetric aziridination 
At the outset of this research, the focus was on the synthesis of new axially chiral 
tertiary amine organocatalysts for asymmetric aziridination, based on the 
methodology first reported by the groups of Ikeda, Hamelin and Bottaro.163,164,165 
Ikeda showed that hydrazinium salts 236 could be formed in situ in a reaction 
between a hydrazine 234 and an epoxide 235 and could subsequently be 
deprotonated at the terminal nitrogen, forming a nitrogen-nitrogen ylide or aminimide. 
The newly formed nitrogen anion is appreciably more nucleophilic than a standard 
nitrogen-centred anion (such as those found in, for example, lithium 
diisopropylamide or lithium hexamethyldisilazide). This is due to the phenomenon of 
the alpha effect, whereby a nucleophile directly bonded to another heteroatom 
exhibits a much higher reactivity than would be expected if the second heteroatom 
were not present. Well-known examples include the hypochlorite anion, peroxide 
anion, hydroxamides and hydrazines. The exact reasoning behind this is not well 
understood, but the several theories proposed have been the topic of an in-depth 
review by Fina and Edwards.166 Subsequent aza-Michael addition of these ylids to 
the substrate followed by reaction of the resultant enolate with the same nitrogen 
atom yields the aziridine product after loss of the parent tertiary amine (Scheme 67). 
 
  
 
 
Subsequent advances in this area of research were sparse until the publications of 
Shi167 and Armstrong168 in 2006 and 2007. By altering the reaction conditions, a 
tertiary amine could be used as the catalyst for the aziridination of enones, which is a 
major advantage as tertiary amines are far more readily available than the 
hydrazines used by Ikeda. The tertiary amine reacts with an electrophilic source of 
nitrogen, of which there are several reported in the literature. These include O-
diphenylphospinylhydroxylamine (DppONH2),169 O-mesitylsulfonylhydroxylamine 
(MSH),170 O-(2,4-dinitrophenyl)hydroxylamine (DnpONH2),171 and O-
benzoylhydroxylamine.172 This forms the desired hydrazinium salt, which can then 
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Figure 9 The proposed catalytic cycle  
react as described below (Figure 9, where N-methyl morpholine represents the 
tertiary amine catalyst). Tröger’s base and quinine were found to give the highest 
enantioselectivities by Shi and Armstrong, respectively. Both were in the region of 
55-56% ee. While the level of selectivity observed was appreciable, it was by no 
means a perfect system.  
 
 
 
 
 
 
 
 
 
 
 
Previous work within the Page group had shown that novel binaphthyl-based axially 
chiral tertiary amines could catalyze the aziridination of chalcone substrates in up to 
38% ee. The synthesis of these dihydroazepines has been utilized extensively within 
the group to access chiral iminium salts, which are used as oxidation catalysts, and 
as such is highly optimized (Scheme 68).173 
The starting material for this work is (S)-BINOL 237 in all cases. Triflation using Tf2O, 
DMAP and 2,6-lutidine gave 238 in near quantitative yield. Subsequent Kumada 
coupling174 using dichloro(1,3-bis(diphenylphosphino)propane)nickel (II) and 
methylmagnesium bromide yielded dimethylbinaphthalene 239, again in high yield. A 
radical bromination using the typical NBS/AIBN mixture yields the dibromide 240 in a 
reasonable 71% yield after a simple filtration. Finally, ring closure through a double 
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Scheme 69 Synthesis of DppONH2 
Scheme 68 General synthesis of binaphthyl azepines 
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nucleophilic substitution occurs using any of a wide number of primary amines in the 
presence of potassium carbonate in acetonitrile, giving products of the type 241. 
Yields are universally high for this step, ranging from 80% to near quantitative using 
only a very small excess of the amine. This late stage variation in the preparation of 
different potential nitrogen transfer reagents allowed for the simple screening of a 
wide variety of tertiary amines.  
 
 
 
 
 
 
 
 
The electrophilic nitrogen source used was O-diphenylphosphinyl hydroxylamine 
(DppONH2) 243.169 It is easily accessed in one step from commercially available 
diphenylphosphinic chloride 242 and hydroxylamine hydrochloride (Scheme 69). 
 
 
 
 
Other known electrophilic sources of nitrogen such as O-
mesitylsulfonylhydroxylamine (MSH) have been shown to be explosive under 
relatively mild conditions and as such were not used in this work.175  
 
 
 53 
Scheme 70 Aziridination of trans-chalcone using previously optimized conditions 
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It was shown previously that N-isopropyl 244 and N-cyclohexyl 245 substituted 
dihydroazepines gave the best compromise between reactivity and selectivity in the 
aziridination of trans-chalcone (the chosen test reaction) (Scheme 70).176  
 
 
 
 
 
 
 
 
Using optimized conditions and after 48 h, the aziridination proceeds in 70% 
conversion and 38% ee when N-cyclohexyl azepine 245 is used as the catalyst. 
Other N-substituents have been tested and have been discussed at length in 
previous work.177  
In all cases, reactions were sluggish. Attempts to increase the rate of reaction 
by increasing the reaction temperature or the number of equivalents of DppONH2 in 
the reaction mixture also failed to help increase the rate of conversion. In the latter 
case, the reduced ketone product 246 was seen in small but isolable quantities.  
 
246 
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Scheme 71 Reduction of chalcone by diimide formed in situ from two equivalents 
of DppONH2 
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This is presumably due to the formation of small quantities of the strong reducing 
agent diazene (or diimide) forming in situ from the condensation of two molecules of 
DppONH2. Presumably, DppONH2 is both electrophilic and nucleophilic enough to 
condense in this manner, with the side reaction presumably proceeding through the 
mechanism shown (Scheme 71).  
 
 
 
 
 
 
These side reactions and long reaction times led us to consider a different approach.  
Previously isolated achiral hydrazinium salts could be used not as catalysts but as 
stoichiometric nitrogen transfer reagents.178 One equivalent of tertiary amine was 
usually required for good conversion to take place in the one-pot procedure anyway, 
suggesting that catalyst turnover was not occurring at a satisfactory rate. It has also 
been shown in previous work that the formation of hydrazinium salts from the parent 
binaphthyl azepines was a very quick reaction as long as the N-substituent was an 
alkyl (Figure 10) rather than an aryl group (Figure 11).  
As can be seen in figure 10, the conversion from 245 to the hydrazinium salt 248 is 
complete within 10 minutes in CD2Cl2 solution at room temperature. Conversely, 
using the electron rich aniline derivative 249 (which contains an N-benzylaniline 
moiety similar to Tröger’s base 230 used by Shi167) required over 4 hours for the 
same reaction to occur, forming 250.  
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In Scheme 72, for the N-cyclohexyl substrate 245, the reaction was monitored using 
1H NMR spectroscopy, recording the advancement of the reaction at regular 
intervals: the disappearance of the pair of doublets at δ = 3.25 and 3.90 ppm and the 
formation of four doublets at δ = 4.12, 4.21, 5.47, and 5.58 ppm, corresponding to 
the four non-equivalent benzylic protons in the hydrazinium salt, can be seen to be 
largely complete within five minutes. In the case of the N-PMP azepine 249 in 
Scheme 73, the corresponding pair of doublets at δ = 3.76 and 4.38 ppm give way to 
doublets at δ = 4.21, 4.52, 4.86, and 5.21 ppm, but the process is incomplete after 
four hours. 
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Scheme 72 Conversion of 245 to 248 using DppONH2 in CD2Cl2 solution 
Figure 11 Monitoring conversion from 249 to 250 using 1H NMR spectroscopy 
 
Figure 10 Monitoring conversion from 245 to 248 using 1H NMR spectroscopy 
Scheme 73 Conversion of 249 to 250 using DppONH2 in CD2Cl2 solution 
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Scheme 74 Aziridination of trans-chalcone using a preformed hydrazinium salt 
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This clean, quantitative process, with no other discernable products detected using 
1H NMR spectroscopy, suggested to us that it would be feasible to isolate these 
hydrazinium salts and then use them in aziridination reactions with only a base 
additive to form the desired aminimide.  
Thus, solid DppONH2 243 (1.1 equivalents) was added to 244 (1 equivalent) in 
dichloromethane (not dried, under air atmosphere). DppONH2 is an incredibly 
insoluble material in the vast majority of organic solvents and as such the only work-
up required to isolate the desired product was a simple filtration through Celite to 
remove the unreacted aminating agent. Analysis of the 1H NMR spectrum of the 
resulting crude product showed completely clean hydrazinium diphenylphosphinate 
251, which was isolated as a yellow hygroscopic foam. This was then tested as a 
nitrogen transfer reagent with trans-chalcone and gratifyingly, the aziridine was 
obtained in 70% yield and 34% ee, results which are almost identical to those 
obtained when the one-pot procedure was used, albeit in a cleaner manner (the 
starting material, the aziridine product and tertiary amine were the only visible spots 
on the TLC plate after the work-up) (Scheme 74).  
 
 
 
 
 
Although this result was promising, the hygroscopicity of the hydrazinium 
diphenylphosphinate salt 70 meant that it was not suitable for storage for any length 
of time and had to be used quickly after its synthesis. As a result, a counterion 
exchange was attempted to replace the diphenylphosphinate anion with the more 
stable, non-nucleophilic tetraphenylborate anion using the method that has been 
used for many years in the Page group for the isolation of iminium salts.179 To our 
delight, the non-hygroscopic hydrazinium tetraphenylborate salt 71 was isolated as a 
colourless powder in 70% yield over two steps. This compound has proven to be 
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Scheme 75 Isolation of highly stable hydrazinium tetraphenylborate salt 253 
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completely bench-stable even over the course of two years while taking no 
precautions to exclude air or moisture (Scheme 75). 
 
 
 
 
 
 
 
  
This salt also proved to be just as reactive as its less stable precursor in the 
aziridination protocol, with a similarly clean reaction taking place under the standard 
reaction conditions. Enantioselectivity was also not affected in this case.  
In conclusion for this chapter, a series of novel axially chiral tertiary amines have 
been shown to be effective nitrogen transfer reagents when used in conjunction with 
DppONH2, an electrophilic nitrogen source. Also, what we believe to be the first 
example of an isolable chiral hydrazinium salt was isolated and fully characterized. It 
acts as an enantioselective nitrogen transfer reagent in itself for the aziridination of 
trans-chalcone, giving NH-aziridine products in good yield and moderate 
enantioselectivity. This is in complete agreement with the work of Ikeda and 
Armstrong, who suggest that the formation of a hydrazinium salt is an integral part of 
the catalytic cycle for the tertiary amine catalyzed synthesis of aziridines from 
chalcone substrates.168  
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6.1 New Axially Chiral Secondary Amines 
At around the time our work on tertiary amine mediated asymmetric aziridination was 
published,176 Cordova reported the asymmetric aziridination of enals using a 
secondary amine diarylprolinol organocatalyst that has been popularized by 
Jørgensen over the past decade.180 Having modified axially chiral tertiary amines in 
a variety of ways in attempts to increase selectivity, the next logical step was to 
synthesize some axially chiral secondary amines and test them as catalysts for a 
variety of standard asymmetric organocatalytic processes.  
While there are some highly selective organocatalytic systems in the literature, there 
are relatively few structural motifs that are regularly seen. L-Proline, which was used 
by Hajos & Parrish,10 Eder, Sauer & Wiechert,181 List,182 and others as well as the 
now ubiquitous MacMillan imidazolidinone catalysts183 and the diarylprolinol catalysts 
first used by Jørgensen184 and Hayashi185 are highly selective in the majority of 
cases but lack much in the way of structural diversity. We envisaged that the highly 
constrained dihydroazepine system in our binaphthyl amines could act as a selective 
organocatalytic system.  
Maruoka has previously shown that similar functionalized systems can be stable, 
highly selective catalysts for enamine-type organocatalytic processes including aldol 
and Mannich reactions that have been discussed above (in section 3.1).106 However, 
the synthesis of the catalysts themselves rely on an early stage Pd-catalyzed 
carbonylation to insert the desired functionality. It was hoped that using a previously 
utilized methodology from within the Page group it would be possible to synthesize a 
large variety of potential organocatalysts from a single late stage precursor.  
A 2012 publication by the Page group showed that addition of nucleophiles to 
iminium salts 254 derived from BINOL occurs completely diastereoselectively, with 
the product always having the newly attached pendant group in a pseudoaxial 
configuration with respect to the 7-membered dihydroazepine ring  (Scheme 76).186  
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Scheme 76 Highly diastereoselective nucleophilic addition to iminium salts 
Scheme 77 Formation of iminium salts from their parent azepines 
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This configuration can easily be determined by analysis of the 1H NMR spectrum of 
the product. If the R’ group is in the expected pseudoaxial orientation, an associated 
pronounced upfield shift of the signal corresponding to the protons located on the 
first carbon of the group will be clearly apparent in the spectrum. This occurs due to 
shielding interactions between the protons of the R group and the ring current that 
flows through the delocalized aromatic system in the naphthyl group in the 
backbone. It is the opposite phenomenon to that of why protons in aromatic 
compounds experience a pronounced downfield shift compared with protons in 
similar, albeit non-aromatic compounds (e.g. benzene appearing at ~7.3 ppm in a 1H 
NMR spectrum and the vinylic proton in cyclohexene appearing at ~5.6 ppm). The 
pseudoaxial orientation of these newly introduced substituents has also been 
unequivocally proven by single crystal X-ray analysis. This will be mentioned below.  
Our hypothesis was that if simple Grignard reagents could be added 
diastereoselectively into iminium salts, it would also be the case that more exotic 
nucleophiles could also be added in the same way. It was envisaged that we would 
be able to synthesize a wide range of potential organocatalysts from the single 
iminium salt of the type 254 that was itself available upon oxidation of N-substituted 
azepines 241 (accessible in four steps as described above in scheme 68) by the 
action of N-bromosuccinimide in dichloromethane (Scheme 77). Generally, a 
counterion exchange to form the iminium tetraphenylborate is then carried out in 
order to stabilize the iminium salt in an identical manner to the isolation of 
hydrazinium salt 253.  
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Scheme 78 Potential synthesis of NBoc derivatives 
6.1.1 Initial Work and Choice of Protecting Group 
The choice of nitrogen protecting group was important considering the wide variety 
of conditions it would be subjected to throughout any potential synthesis. The 
primary amine required for reaction would have to be either commercially available 
or easily made on multi-gram scale, and it would have to be stable to the acidic 
conditions of the crucial oxidation step from amine to iminium salt as well as the 
strongly basic conditions required for addition of Grignard reagents. It must also then 
be easily deprotected in the presence of other functional groups in the molecule. 
This narrowed down our potential choices substantially from the outset.  
The carbamate protecting groups (Boc, Fmoc etc.) are probably the most well known 
group of nitrogen protecting groups. However, protection normally occurs through 
reaction of a primary or secondary amine with the anhydride of the desired protecting 
group (Scheme 78). For this to happen in our synthesis, a cumbersome deprotection 
and reprotection route would have to be devised, thus increasing the number of 
steps required for any potential synthesis. The stability of potential iminium salts 
containing a carbamate was also called into question, and for these reasons, none of 
the carbamate protecting groups were considered further.  
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Scheme 79 Hydrogenolysis of a PMB protecting group in a biphenyl-based 
system 
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Our initial synthetic route to new secondary amine organocatalysts proceeded 
through the N-p-methoxybenzyl protected iminium salt 256.  
 
 
 
 
There was literature precedent from a patent by Maruoka for the removal of a PMB 
group from a related scaffold using a standard hydrogenolysis protocol (Scheme 
79),187 and we hoped that the same would be true in our binaphthyl-based system. 
 
 
 
 
 
 
 
Thus, azepine 259 was synthesized from dibromide 240 and commercially available 
p-methoxybenzylamine. Iminium salt 260 was then isolated in excellent yield after 
oxidation with NBS to the iminium bromide salt and subsequent counterion exchange 
using NaBPh4 (Scheme 80).  
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Scheme 80 Synthesis of iminium salt 260 
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At this point, some test deprotection reactions were also attempted on the parent 
azepine 259 (Table 1).  
 
 
 
Table 1 Attempted hydrogenolysis of 259 
Catalyst Solvent Time (h) Result 
Pd/C MeOH 16 SM 
Pd(OH)2/C MeOH 16 SM 
Pd/C AcOH 16 SM 
Pd/C THF 16 Decomposition 
 
Unfortunately, Maruoka’s method for deprotection was unsuccessful, giving only 
starting material in all cases. Supposedly, the amine is converted to the 
corresponding ammonium salt in acidic media (i.e. AcOH solvent), which should 
facilitate deprotection. This was not the case in our system, and again only starting 
material was isolated. Finally, when tetrahydrofuran was used as the solvent, 
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Scheme 81 Synthesis of amine trifluoroacetate 262 
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complete decomposition of the azepine ring was observed, presumably showing that 
the two other benzylic positions within the molecule were also highly susceptible to 
hydrogenolysis under the right conditions.  
Next, a simple acidic cleavage such as the one employed by MacMillan in his total 
synthesis of minfiensine was attempted.188 Thus, the azepine 259 was stirred in a 
solution of triethylsilane and trifluoroacetic acid in dichloromethane (Scheme 81). In 
our hands, this method merely protonated the amine and the corresponding 
ammonium trifluoroacetate 262 was isolated in quantitative yield.  
 
 
 
 
 
Finally, a variety of oxidative cleavages were tested. This is the standard method for 
removing PMB groups from ethers but is less used when considering PMB protected 
amines (Table 2).  
Table 2 Attempted oxidative deprotections of 259 
Conditions Solvent 
Temperature 
(oC) 
Time (h) Result 
CeCl3/NaI MeCN reflux 24 SM 
DDQ dry DCM rt 3 Decomposition 
FeCl3/cat. DDQ DCM/H2O rt 3 263 (30%) 
SnCl4/PhSH DCM -50 1 SM 
Ph3C+ -BF4 DCM rt 0.1 Decomposition 
CAN MeCN/H2O rt 0.1 Decomposition 
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Unfortunately, all attempts were unsuccessful, with mild oxidants leading to the 
recovery of the starting material and stronger oxidants resulting in decomposition. A 
notable exception was observed when iron trichloride and DDQ were used; the 
bisaldehyde 263 was isolated in low yield after column chromatography. This did 
prove that the naphthyl benzylic positions were definitely susceptible to the types of 
oxidative cleavage that one normally expects to see only in the case of highly 
electron rich aromatic systems such as the PMB group.  
 
 
 
 
The p-methoxyphenyl (PMP) protecting group (compound 249) was also tested, as it 
is also susceptible to this type of oxidative cleavage.189 Unfortunately, this only led to 
the same results as before, with none of the desired secondary amine seen when 
analysing the 1H NMR spectra of any of the crude reaction mixtures.  
The next class of protecting groups that we considered was the sulfonyl-based 
groups, exemplified by the p-toluenesulfonyl or tosyl group. While notoriously difficult 
to remove (dissolving metal reductions or strongly acidic conditions), there are 
several protecting groups in this class that are susceptible to deprotection under a 
wide range of conditions. The one that caught our eye in this case was the little-used 
trimethylsilylethanesulfonyl (SES) group, which can be selectively deprotected in the 
presence of other sensitive functionalities using a source of fluoride.190 This occurs 
via a fragmentation of the protecting group into one equivalent each of trimethylsilyl 
fluoride, as well as gaseous ethylene and sulfur dioxide. After workup, the amine is 
generally isolated cleanly (Scheme 82). 
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Scheme 83 Synthesis of sulfonamide 264 
Scheme 84 Attempted oxidation of 264 to give N-bromo intermediate 265 
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Unfortunately the desired amine is prohibitively expensive and even the related 
chloride is only available on relatively small scale, which would hinder scale up 
attempts.191  
In order to test the compatibility of sulfonyl protecting groups with our synthetic route, 
N-tosylazepine 264 was synthesized from the standard dibromide precursor 240 
using commercially available p-toluenesulfonamide (Scheme 83).  
 
 
 
 
The hope was that the electron-withdrawing sulfonyl group would still allow for NBS 
oxidation to occur to give the N-tosyl iminium salt. Unfortunately, this proved not to 
be the case. Even under forcing conditions with 3 eq. of the NBS oxidant at reflux in 
dichloromethane or 1,2-dichloroethane, the starting material was recovered 
completely in each case. This shows just how stable tertiary sulfonamides are and 
also that their electron-withdrawing nature renders the amine non-nucleophilic to the 
point that the proposed intermediate of the oxidation (the N-bromo intermediate 265) 
cannot form (Scheme 84). Bhandarkar has discussed this mechanism in depth.192 
Unfortunately, as a result of this failure, the search for a protecting group continued.  
 
 
 
 
 
 
 
  
 67 
Scheme 86 Unwanted deprotection of compound 266 
Scheme 85 Synthesis of N-trityl azepine 266 
N
Br
Br K2CO3, MeCN,reflux, 16h
95%
Ph3CNH2
CPh3
240 266
NCPh3 NH
NBS
DCM, rt, 2h
> 50%
266 261
Next on the list of potential protecting groups was the highly labile trityl group.193 The 
stability of the triphenylcarbenium cation is well known and is often exploited when 
using this protecting group. The synthesis of compound 266 proceeded without issue 
(Scheme 85). 
 
 
 
 
 
However, we feared that the trityl group would not survive the mildly acidic conditions 
of the oxidation step (due to residual HBr present in the N-bromosuccinimide). This 
unfortunately proved to be the case, with appreciable amounts of the unwanted 
secondary amine seen after several oxidation attempts using even freshly 
recrystallized NBS (Scheme 86). 
  
 
 
 
 
Our final choice of protecting group was the allyl group, which had been used 
previously in a literature synthesis of related compounds by Hawkins.194 The only 
potential issue we foresaw was whether the alkene part of the protecting group 
would be stable to the NBS oxidation step to form the required iminium salt.  
Due to the low boiling point of allylamine, our general method for dihydroazepine 
synthesis had to be altered slightly. As such, 2.5 equivalents of allylamine were used 
in this case at a lower than standard temperature. Purification of compound 267 was 
found to be facile. A single wash with cold acetone removed any impurities from the 
solid azepine product (Scheme 87).  
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Scheme 88 First synthesis of N-allyl iminium salt 268 
Scheme 89 Synthesis of 268 via bromoaldehyde intermediate 270 
Scheme 87 Synthesis of N-allyl azepine 267 
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Our initial attempts at the oxidation of 267 to iminium salt 268 were unsuccessful, as 
purification of the salt proved to be extremely difficult (Scheme 88). There is 
literature precedent for the dibromination of N-allyl groups by NBS and, although 
nothing was ever isolated from these reaction mixtures, we assumed that this is one 
of several decomposition pathways that could be at play in this case.195  
 
 
 
 
Another potential route to the iminium salt 268 was via bromoaldehyde 270, which 
has been used extensively within the Page group for the synthesis of iminium salts 
(Scheme 89).173  
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Scheme 90 DDQ oxidation to form 268 
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However, this three step protocol (which required two cumbersome chromatography 
steps) was found to give an unacceptably low yield of the desired iminium salt, which 
was difficult to separate from unreacted 270, as well as small but isolable amounts of 
the diethyl acetal byproduct 271, which was seen repeatedly when analyzing 1H 
NMR spectra of crude reaction mixtures.  
 
 
 
 
Attempts to form the desired N-tosyl iminium salt by this method also failed, with a 
complex mixture of products formed. None of them corresponded to the desired 
cyclized iminium salt. 
DDQ-mediated oxidation of azepine 267 was attempted which yielded the iminium 
salt 268 in unacceptably low yields after an extremely drawn out purification to 
remove DDQ by-products (Scheme 90).  
 
 
 
 
Gratifyingly, we eventually found that after optimization of the reaction conditions that 
the N-allyl iminium tetraphenylborate could be isolated in useful quantities using a 
drastically modified procedure compared with that used for the synthesis of PMB 
iminium salt 260. We found that by slowly adding NBS to a dilute solution of 267 in 
dichloromethane and monitoring the reaction closely by TLC, it was possible to form 
the desired iminium bromide cleanly in good yield. However, this compound proved 
to be highly unstable and as such counterion exchange was carried out without 
isolation of the intermediate bromide.  
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Scheme 91 MeMgBr addition to iminium salt 268 to give 272 
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The standard method for purification of iminium tetraphenylborates is to recrystallize 
from hot ethanol. This was not suitable in this case, as it caused appreciable 
decomposition of the desired compound. Instead, it transpired that excess NaBPh4 
could be removed from the mixture due to its insolubility in acetone and that other 
impurities could be largely removed due to their insolubility in chloroform. This gave 
us appreciable quantities of 268, which had been inaccessible to this point, allowing 
us to continue on with our proposed synthetic route. 
 
 
 
 
It was then necessary to prove that our methodology was sound and that the 
diastereoselectivity of nucleophilic addition to our iminium salts was not controlled by 
the chiral N-substituents that were used in our previous work but by the axial chirality 
of the binaphthyl backbone.186 Thus, a simple addition of MeMgBr was attempted 
onto iminium salt 268. As before, a large excess of the Grignard reagent was 
required to afford good conversion to the desired product. Thus, after addition of 10 
equivalents of MeMgBr to the iminium salt in dry THF, the methylated product 272 
was isolated in an excellent 84% yield as a single diastereoisomer after column 
chromatography (Scheme 91).  
 
 
 
 
 
This result shows that our methodology should allow us to synthesize a wide array of 
compounds based upon this structural motif. As discussed above, the orientation of 
the methyl group in compound 272 can be inferred from analysis of its 1H NMR 
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Figure 12 1H NMR spectrum of compound 272 
spectrum (Figure 11). The doublet corresponding to the methyl group appears at δ = 
0.55 ppm, which is much further upfield than one would expect for protons in a 
similar environment. Compared with the terminal protons in α-methylbenzylamine (δ 
= 1.34 ppm), it is clear to see the large effect that the ring current effect of the 
binaphthyl backbone has on these protons. 
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6.1.2 Towards the synthesis of α-amino acid 273 
We had two compounds in mind when it came to designing novel organocatalysts. 
The alpha-amino acid 273 appeared to be an appropriate target due to its similarity 
to the well-known amino acid organocatalyst proline. Tetrazoles have been shown to 
be bioisosteres for carboxylic acids in several drugs.196 Compounds such as 275 
have also previously been shown to act as excellent organocatalysts by Ley and co-
workers so we also deemed compound 274 to be a valuable target.197  
 
 
 
 
Thus, our first potential target compound was α–amino nitrile 276, which we hoped 
would provide access to both of these compounds after further derivatization. 
Hydrolysis could presumably lead to 273, while a 3+2 cycloaddition with sodium 
azide could lead to 274. 
  
 
 
 
6.1.2.1 The α-amino nitrile 
Our initial route to 276 was using conditions generally used in well-known 
asymmetric Strecker reactions. That is, the use of trimethylsilyl cyanide (TMSCN) in 
dichloromethane along with several equivalents of an alcohol (usually MeOH), which 
liberates the cyanide anion and allows it to react with the imine (or in our case, the 
iminium salt).198 This worked well and gave near quantitative formation of the desired 
product (Scheme 92).  
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Scheme 92 Initial synthesis of 276 
Scheme 93 Optimized synthesis of 276 
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However, it also unfortunately led to a product contaminated with several silicon-
containing byproducts (characterized by a large number of peaks at δ = ~0 ppm in 
the 1H NMR spectrum). Attempted column chromatography resulted in considerable 
decomposition of a compound that was unstable to acidic conditions. Instead, it was 
found that a simple biphasic mixture of 268 and NaCN in dichloromethane/water was 
found to give far cleaner 276, meaning the crude product could be taken through to 
the next step without further purification (Scheme 93).  
 
 
 
 
At this point, it was also possible to grow crystals of 276 suitable for X-ray analysis. 
The structure is shown in figure 13, where is it clearly possible to see the 
pseudoaxial orientation of the newly introduced nitrile with respect to the azepine 
ring.  
  
Figure 13 Crystal structure of α-amino nitrile 276 
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There were then several possible reactions we were hoping to perform on compound 
276. As mentioned above, 273 and 274 were our primary targets, but it would also 
be interesting to attempt reductions of 276 to potentially form other compounds that 
could prove useful. Attempts at hydrolysis using both basic and acidic conditions 
unfortunately were generally met with complete failure, with either the starting 
material reisolated or complete decomposition seen in all cases (Table 3).  
 
 
 
 
Table 3 Attempts to hydrolyze 276 
Conditions 
Temperature 
(oC) 
Time (h) Result 
conc. HCl reflux 16 Decomposition 
conc. HCl 0 48 SM 
3M NaOH reflux 16 Decomposition 
80% aq. H2SO4 50 oC 16 Decomposition 
 
Attempts to synthesize tetrazole 274 also met with failure. Either no reaction 
occurred whatsoever, or decomposition of the starting material occurred. These 
results are presented in table 4. 
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Table 4 Attempted synthesis of tetrazole 274 
Solvent 
Temperature 
(oC) 
NaN3 (eq.) Additive Result 
PhMe 100 2 - SM 
PhMe 100 1.5 Et3N.HCl SM 
PhMe 130 5 Et3N.HCl SM 
NMP 200 2 TMSCl decomp. 
DMF 140 1.5 NH4Cl SM 
iPrOH:H2O 100 2 ZnBr2 decomp. 
 
Seeing as cyanide is an excellent leaving group and that iminium salt 268 is more 
stable than other iminium salts due to its cyclic nature, it was not surprising that the 
harsh conditions resulted in decomposition. This was further exemplified by 
attempting to reduce the nitrile, either to the aldehyde or to the primary amine. Use 
of lithium aluminium hydride resulted in decomposition of the compound, whereas 
addition of an excess of the less harsh reducing agent diisobutylaluminium hydride 
(DIBAL) resulted in complete conversion of 276 to the parent azepine 267 (Scheme 
94).  
 
 
  
Scheme 94 Attempted reduction of 276 
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Scheme 95 Formation of 267 by reduction of iminium cyanide 277 
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Even slow addition of a single equivalent of the reducing agent at –30 oC resulted in 
the same reaction occurring, albeit at a much slower rate. This lends further 
evidence to the hypothesis that the facile decomposition of 276 proceeds due to the 
fact that the formation of iminium cyanide 277 and subsequent loss of cyanide is a 
favourable process with loss of gaseuous HCN driving the reaction forward. 
Presumably this newly formed iminium ion is then quickly reduced by the hydride 
source in the reaction mixture to give 267 (Scheme 95). 
 
 
 
 
While there are countless examples of α-amino nitrile hydrolysis in the literature, 
there are also many examples of their use as precursors to iminium ions. A 
publication by Stork on the total synthesis of the alkaloid reserpine illustrates this 
fact.199 The α-amino nitrile, itself formed in a similar method to ours, was refluxed in 
acetonitrile causing loss of cyanide. A subsequent Friedel-Crafts reaction formed the 
desired 6 membered ring of the natural product (Scheme 96).  
 
 
 
Finally, another reaction which suggests that this type of equilibrium occurs in α-
amino nitriles is the little known Bruylants reaction, where an α-amino nitrile reacts 
directly with a Grignard reagent, causing what would appear to be a nucleophilic 
substitution with cyanide acting as a leaving group.200 However, it is far more likely 
that an iminium cyanide is forming in the reaction mixture resulting in direct addition 
Scheme 96 Use of an α-amino nitrile as an iminium salt precursor 
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of the Grignard reagent to the electrophilic iminium portion of the ion pair (Scheme 
97 where 276 is used as an example of an α-amino nitrile).  
 
 
 
6.1.2.2 Dithiane additions 
Our next potential route to the α-amino acid was via the addition of a dithiane 
derivative to iminium salt 268 in a modification of the Corey-Seebach reaction.201 
There are very few examples202 in the literature of this type of addition to iminium 
salts, but it was deemed that the synthesis of compounds such as 282 could 
potentially lead to the desired compound 273 from iminium salt 268. This 
retrosynthesis is shown in scheme 98.  
 
 
While it has been reported that there are several problems associated with dithiane 
deprotection (generally to do with the harsh and/or toxic conditions required),203 this 
approach was still deemed a worthwhile endeavour. Table 5 details our attempts to 
make dithiane 282 using both the literature method reported by Duhamel as well as 
other known methods for the additions of metallated dithianes to various 
electrophiles.  
  
Scheme 97 Use of an α-amino nitrile as an iminium salt precursor in the 
Bruylants reaction 
Scheme 98 Potential retrosynthesis of compound 273 via dithiane 282 
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Table 5 Attempted dithiane additions to iminium salt 268 
R 
Dithiane 
(eq.) 
Base 
(eq.) 
Additive 
(eq.) 
Temperature 
(oC) 
Time (h) Yield (%) 
allyl 1 
n-BuLi 
(1.1) 
- -78 – rt 16 0 
allyl 10 LDA (10) - -78 – rt 16 trace 
allyl 10 LDA (10) 
MgBr2 
(10) 
-78 – rt 16 trace 
PMB 10 LDA (10) 
MgBr2 
(10) 
-78 – rt 16 <20 
 
As can be seen, only a trace amount of the desired product was ever detected when 
using N-allyl iminium salt 268. When the same conditions were used for addition to 
the N-PMB iminium salt 260, a small amount of impure material was isolated after 
extensive column chromatography, albeit in a less than satisfactory yield and in 
small enough quantities that further derivatization was not possible.  
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Scheme 99 Proposed alkyne additions to iminium salts 
Scheme 100 Proposed alkyne additions to iminium salts 
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6.1.2.3 Alkyne additions 
One of the other routes that we proposed for the synthesis of 273 was the addition of 
various alkynes to iminium salt 268, yielding propargylamines of the type 283 
(Scheme 99).  
 
 
 
 
 
From there, there are a variety of literature procedures for the conversion of alkynes 
into carboxylic acids, most notably by ozonolysis to the anhydride and subsequent 
hydrolysis.  
We envisaged the synthesis of terminal alkyne 284 would occur initially through the 
use of ethynylmagnesium bromide. Thus, 268 was subjected to our standard 
Grignard addition protocol using 10 eq. of a commercially available 0.5 M solution of 
ethynylmagnesium bromide in THF. The low concentration compared with other 
available Grignard reagents caused an unavoidable decrease in reaction rate but 
was infinitely preferable to the preparation of the Grignard reagent ourselves using 
acetylene gas. Isolated yields were generally in the region of 50 – 75%, which we 
believe was directly related to the quality of the different batches of the Grignard 
reagent as received from the supplier (Scheme 100). 
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Scheme 101 Proposed alkyne additions using copper catalysis 
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This lack of reproducibility led to us contemplating a different route to compound 284 
through the use of organocopper chemistry. It is well known that copper has an 
affinity for terminal alkynes, forming σ-complexes which are known intermediates in 
the now ubiquitous copper-catalyzed “click” azide-alkyne 3+2 cycloaddition (Huisgen 
cycloaddition) discovered by Sharpless204 and Meldal.205 However, copper acetylides 
are also well-known nucleophiles, and a publication by Schreiber and co-workers on 
their catalytic asymmetric addition of alkynes to isolated iminium salts caught our 
eye.206 Using a chiral ligand it was possible to obtain excellent enantioselectivities 
and high yields of the desired products. Consequently, we believed that using a 
modified procedure (without the chiral ligand) we would be able to add a variety of 
alkyne nucleophiles to our iminium salts cleanly and efficiently to give compounds of 
the type 286 (Scheme 101). Gratifyingly, this proved to be the case. Our results are 
summarized in table 6.  
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Table 6 Alkyne additions to iminium salt of the type 285 
Product R R' Alkyne (eq.) Time (h) Yield (%) 
287 allyl Ph 5 24 74 
288 allyl TMS 5 24 74 
289 allyl CO2Me 1.1 2 88 
290 PMB CO2Me 1.1 2 81 
 
Simple acetylenes (R = TMS and Ph) were added effectively but only when an 
excess of alkyne was used. It was, however, the electron deficient alkyne methyl 
propiolate that was really successful, giving 88% yield of the desired compound 289 
within two hours at room temperature. As can be seen, both allyl and PMB groups 
were tolerated, giving similar results in both cases. One of these compounds, 287, 
gave crystals suitable for X-ray analysis (figure 14).  
 
 
 
 
 
Compound 287 was also easily deprotected, giving a similarly yielding route to 
terminal alkyne 284 but avoiding the variability in yield seen using the Grignard 
addition (Scheme 102).  
  
Figure 14 Crystal structure of compound 287 
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Scheme 102 Deprotection of 287 to give 284 
Scheme 103 Derivatization of 291 via lithiation 
Figure 15 Crystal structure of compound 294 
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A potential way of functionalizing 291 would be to lithiate the terminal alkyne using n-
BuLi (or a similar base) and quench this anion with a variety of electrophiles 
(Scheme 103).  
 
 
 
 
  
This again proved to be fruitful, with both ethyl chloroformate and carbon dioxide gas 
used to isolate compounds 294 and 295 respectively. It was also possible to form 
crystals of 294 by recrystallization from hot ethanol (Figure 15).  
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Scheme 104 Deprotection of 287 to give secondary amine 294 
Scheme 105 Attempted ozonolysis of 284 
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With a variety of these propargylamine derivatives now in hand, their deprotections 
were tested using the standard conditions published by Guibe (Pd(PPh3)4 and N,N’-
dimethylbarbituric acid in refluxing dichloromethane).207 While the unfunctionalized 
compound 287 was deprotected without issue in 92% yield to give 296 (Scheme 
104), the ester 294 failed to be deprotected cleanly, with several spots on TLC 
present after the reaction was worked up. Only one as yet unidentified compound 
was ever isolated, which we believe to be a carbocyclization product arising from 
reaction of the intermediate palladium π-allyl complex and the alkyne.  
 
 
 
 
   
Regardless of this deprotection failure, we moved on with our plan to test the 
ozonolysis of 284 and 296, with the hope being that we could access acid 273. Thus, 
compounds 284 and 296 were submitted to a standard ozonolysis protocol by 
bubbling ozone gas through a solution of the compounds in dichloromethane at low 
temperature. After a standard reductive quench with dimethyl sulfide, NMR 
spectroscopy of the crude reaction mixture unfortunately showed no discernible 
products from the reaction with 284 (Scheme 105) and the only observable product 
of the reaction with 296 was benzoic acid (Scheme 106). 
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Scheme 107 Ozonolysis of naphthalene 
Scheme 108 Attempted oxidation of alkyne 296 
Scheme 106 Attempted ozonolysis of 296 
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This result showed that the desired alkyne fragmentation was occurring but 
unfortunately also that the binaphthyl backbone was not stable to the strongly 
oxidizing conditions of this reaction. Perusal of the literature showed that this is in 
fact a known potential pitfall of naphthalenes in general. Bailey showed that upon 
ozonolysis of naphthalene itself it is in fact possible to isolate peroxides of the type 
300 when using alcoholic solvents for the ozonolysis process (Scheme 107).208 
 
 
 
  
Another possibility that we saw for the functionalization of compound 296 was 
through the use of a Ru-catalysed oxidation reaction, which would again provide 
potential access to compound 273 via an intermediate anhydride. This was shown by 
Yang and co-workers to be a viable route to benzoic acid derivatives from 
diarylacetylenes.209 Using either ruthenium dioxide or TPAP along with Oxone® as 
stoichiometric oxidant, the reactions unfortunately met with the same fate as before, 
with benzoic acid being the only observable compound in the NMR spectrum of the 
crude reaction mixture (Scheme 108). 
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Scheme 109 Synthesis of compound 305 
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We hypothesized at this point that the biphenyl system 305 would hopefully prove to 
be more stable to these oxidative conditions. As such, compound rac-305 was 
obtained in two steps from the novel biphenyl iminium salt 303, itself available in two 
steps from 301 (synthesis shown in scheme 109). There are known methods to 
make these biphenyl systems in an enantiomerically pure manner,210 so this would 
hopefully prove to be a viable route to new axially chiral organocatalysts. 
 
 
 
 
  
 
 
 
 
 
 
After submitting compound 305 to both the ozonolysis and Ru-catalysed hydration 
conditions, the same result was witnessed in both cases, benzoic acid was the only 
observable compound present.  
As a consequence of these failures, we deemed it necessary to alter our choice of 
targets. The α-amino acid has thus far proved impossible to access using the 
methods we have attempted. Our future potential synthetic routes to this compound 
are described in section 7.1.  
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Figure 16 Point-axis stereochemical relay in compounds 306 and 307 
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6.1.3 Axis-Centre Stereochemical Relays Revisited 
As mentioned above, when an R substituent is in a pseudoaxial orientation in a 
system of the type 255, there is an associated upfield shift of the R group in the 1H 
NMR spectrum (Figure 12). It can thus be possible to infer the orientation of any 
substituent by looking at this shift and comparing it to the shift that would normally be 
expected for this type of group in other molecules. 
Wallace has synthesized enantiopure 306 & 307 using a modification of the well-
known Meyers’ lactamization methodology.211 They showed that in this biphenyl 
system where there is a very small energy barrier to rotation around the biaryl axis, 
the orientation of the biaryl backbone is controlled by the orientation of the R group 
relative to the central 7-membered ring. This is itself controlled by the nature of the 
N-substituent. If the amine is unsubstituted, the methyl group in 306 [δH (500 MHz, 
CDCl3) 1.50 (d, 3H, α-Me), 3.64 (q, 1H, α-H)] is found in a pseudoequatorial 
orientation due to the fact that any hindrance between the NH proton and the methyl 
group is presumably outweighed by the pseudo 1,3-allylic strain between the methyl 
group and to closest aromatic proton in the biaryl axis. This is not the case in N-Boc 
derivative 307 [δH (500 MHz, CDCl3) 0.86 (d, 3H, α-Me), 5.13 (q, 1H, α-H)], where 
the opposite is true and the methyl group adopts a pseudoaxial orientation to avoid 
steric clashes with the newly introduced carbamate (Figure 16).  
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In another publication by Wallace, the phenyl substituted azepine 308 [δH (500 MHz, 
CDCl3) 4.87 (s, 1H, α-H)] and its Boc derivative 309 [δH (500 MHz, CDCl3) 6.24 (s, 
1H, α-H)] were synthesized.  
 
 
 
 
It was shown that the much larger phenyl groups were still subject to the same sort 
of stereochemical relay that was previously shown. Addition of the Boc group 
showed that the phenyl group would readily adopt either a pseudoequatorial or a 
pseudoaxial orientation depending on the nature of the N-substituent, documented 
by marked shifts in the both the aromatic protons of the phenyl group as well as the 
proton α- to the amine.  
In previous work within our group, by synthesizing 310 [δH (500 MHz, CDCl3) 1.32 
(d, 3H, α-Me), 3.32 (q, 1H, α-H)] it was possible to show that a smaller N-Me group 
in this system still allowed the α-methyl group to maintain a pseudoequatorial 
orientation as a result of the pseudo 1,3-allylic strain still outweighing any other steric 
interactions. This is inferred due to the fact that there is very little change in the 
chemical shift of the α-proton. 
 
 
 
 
However, in the case of allylated rac-304 [δH (500 MHz, CDCl3) 4.40 (s, 1H, α-H)] 
and deprotected rac-305 [δH (500 MHz, CDCl3) 4.77 (s, 1H, α-H)], which were 
synthesized as part of this project, we made some interesting observations 
pertaining to this sort of axis-centre stereochemical relay. We envisaged that upon 
deallylation of rac-304 we would see a marked shift in the 1H NMR chemical shift of 
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the α-proton in common with these other previously reported cases. This was not the 
case here, with nowhere near the same shift seen compared with the cases 
described above. 
 
 
 
 
Preliminary modeling calculations by Wallace suggested that the lowest energy 
conformation of azepines of this type would be determined by the size of the α-
substituent. It is possible that this larger phenylacetylene substituent is now large 
enough to be permanently locked in a pseudoaxial conformation and at the same 
time lock the axial chirality of the backbone. While the Boc derivative of 305 has not 
been synthesized, it would be an interesting future experiment that would confirm 
this one way or the other. While there is a significant difference in steric burden 
between the allyl group and Boc group, we believed that the N-allyl group should 
have been large enough to have some effect on the orientation of the α-substituent. 
Work continues in this area. 
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Scheme 110 Proposed retrosynthesis of compound 311 
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Scheme 111 Potential decomposition of proline by decarboxylation 
6.2.1 The synthesis of β-amino acid 311 
Given that initial work towards the synthesis of α-amino acid 273 ultimately failed, we 
set our sights on the addition of some different side chains to iminium salt 268. We 
deemed a sensible alternative to 273 would be the β-amino acid 311, which we 
hoped to form through a Reformatsky-type reaction using an organozinc reagent 
derived from tert-butyl bromoacetate (retrosynthesis shown in Scheme 110).  
 
 
 
 
 
β-Amino acids have been shown to be selective organocatalysts for a variety of 
processes, for example in the work by Armstrong and co-workers.212 We also 
envisaged that 311 would be more stable than α-amino acid 273 due to the fact that 
the reported decomposition pathways that are known to affect compounds of this 
type in certain organocatalytic processes (usually aldol reactions, Scheme 111) 
would not occur when a β-amino acid was used. 
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Scheme 113 Synthesis of compound 311 
Scheme 112 Synthesis of intermediate 312 
Figure 17 Crystal structure of β-amino ester 312 
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Fortunately for us, the synthesis of 312 proved to be far more straightforward than 
that of 273. Using t-butyl bromoacetate and zinc powder activated with TMSCl and 
1,2-dibromoethane, the Reformatsky product 312 was isolated in a moderate but 
reproducible 57% yield after column chromatography (Scheme 112).  
 
 
 
 
 
It was possible to obtain crystals of this product suitable for X-ray analysis (Figure 
17).  
 
 
 
 
 
Deallylation using standard conditions and subsequent cleavage of the t-butyl ester 
proceeded without any problems, yielding β–amino acid 311 in respectable overall 
yield (Scheme 113). 
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Scheme 114 Aldol condensation of acetone and p-nitrobenzaldehyde 
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With compound 311 in hand, we set about searching for a reaction that we could use 
to test the efficacy of this new type of catalyst. We hoped for example that it would 
catalyze the asymmetric aldol condensation in a similar fashion to that of L-proline in 
the work of List and co-workers.182 Modeling studies have shown that the carboxylic 
acid present in the enamine formed between acetone and the proline catalyst forms 
a favourable transition state by hydrogen bonding interactions between itself and the 
aldehyde substrate (Figure 18).213  
 
 
 
 
Preliminary reactions using literature procedures for the condensation of acetone 
and p-nitrobenzaldehyde (Scheme 114) were not met with success as no conversion 
to the desired product was seen even after several days at room temperature.  
 
 
 
 
Only after a benzoic acid co-catalyst was added was a small conversion seen, albeit 
at an extremely slow rate compared with other known catalysts such as that of 
Maruoka. His binaphthyl catalyst 130 that is mentioned above contains what 
essentially amounts to a benzoic acid (pKa ~4.2) derivative whereas ours contains 
something more like acetic acid (pKa ~4.76). 
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Scheme 115 Malonate addition to an α,β-unsaturated enone 
Scheme 116 Nitroalkane addition to an α,β-unsaturated enone 
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It may be that the lack of reactivity observed in our case is due to the differences in 
pKa between these two types of carboxylic acid, which is quite large considering the 
logarithmic nature of this scale. 
We next turned our attention to the use of 311 in iminium-based organocatalysis. As 
discussed in the introduction, there are many variants of reactions based on this 
mode of catalytic activation. However, we desired something that utilized cheap, 
readily available and stable starting materials and formed stable products that were 
easily characterized. This led us to selecting two reactions that have been reported 
by numerous groups, the conjugate addition of malonates (Scheme 115) and 
nitroalkanes (Scheme 116) to α,β-unsaturated ketones. 
 
 
 
 
 
 
 
 
There are a wide range of enones, nitroalkanes and malonates that are commercially 
available which meant that a wide range of catalyst tests could be carried out without 
the need to synthesize any of the substrates. Enones are also generally more stable 
compared to the related enals, which would perhaps mean that side reactions would 
be kept to a minimum. The conversion from starting material to product could be 
easily monitored qualitatively by TLC and quantitatively by 1H NMR spectroscopy 
and the enantiomeric excess could easily be calculated using either chiral HPLC or, 
as in our case, by further derivatization of the products.  
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6.2.2 Determination of enantiomeric excess 
From study of the literature, it became apparent that if we were to test a wide variety 
of malonate and nitroalkane additions, we would require a wide range of chiral HPLC 
columns in order to satisfactorily separate the enantiomers of each of the products. 
This led us to search the literature for an alternative to this type of analysis. 
Fortunately, a paper by Wynberg and Hiemstra was found.214 Before the use of chiral 
HPLC columns was widespread, they published an accurate method for determining 
the enantiomeric excess of chiral ketones using 13C NMR spectroscopy. The method 
revolved around acetal formation using an enantiopure 1,2-diol. This would give a 
pair of diastereoisomeric acetals, each one corresponding to one of the two 
enantiomers of the initial product. It was then possible to obtain the ee by integrating 
the peaks of the 13C NMR spectrum of this pair of diastereoisomers. The assumption 
was made initially that no kinetic resolution or racemization occurs when the acetal is 
formed. However, this was shown to be correct by analysing a sample of known 
enantiomeric excess. The data obtained showed the ee to be correct to ± 2% in all 
cases.  
In this initial paper, it was found that using (R)-(–)-2,3-butanediol 319 gave the best 
separation between the diastereoisomeric pairs. Accurate measurements were only 
obtained when the separation between peaks was > 2 ppm, which was the case 
when 319 was used. 
 
 
 
The authors of the original paper also pointed out that it could be argued that 
integrating 13C peaks was not a valid method for obtaining ee because it is known 
that both nOe effects and differences in relaxation times can and do cause changes 
in the peak heights of carbon atoms depending on the environment they are in within 
a molecule. Wynberg argued that this effect was minimized due to the two 
diastereoisomers being so similar to one another. 
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Scheme 117 Synthesis of racemates 
Figure 19 Part of the 13C NMR spectroscopy of acetal 322  
showing its racemic nature 
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To check that our potential products would be amenable to this type of further 
derivatization, we isolated rac-321 and rac-322 using a previously published method 
using catalytic potassium tert-butoxide in THF, which furnished the desired 
compounds in reasonable yield.215 Using the aforementioned method acetals 322 
and 323 were then formed in quantitative yield (Scheme 117).  
 
 
 
 
 
Gratifyingly, 13C NMR spectroscopy of both compounds gave acceptable separation 
of peaks in the two diastereoisomers. A portion of the spectrum of rac-322 is shown 
in figure 19 showing the splitting of the peaks in the two diastereoisomeric acetals. 
By selecting one of the pairs of peaks and integrating them, it is also possible to 
confirm the racemic nature of the compound.  
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Table 7 Initial testing of catalyst 310(a) 
6.2.3 Initial Testing – Malonate Addition 
Our initial testing utilized cyclohexenone and dibenzyl malonate as substrates along 
with a variety of stoichiometric bases that were shown to be necessary in 
publications by Ley197 and Hanessian216 in order to deprotonate the malonate and 
facilitate the conjugate addition process. Hanessian reported the results they 
obtained using chloroform as solvent and L-proline as catalyst along with a wide 
variety of bases. We tested a variety of these bases as part of our own optimization 
using compound 311 as catalyst and chloroform as the solvent (Table 7). 
 
 
  
 
Base Time (h) 
Conversion 
(%) 
ee (%) 
trans-2,5-Dimethylpiperazine 144 0 n/a 
CsF 144 <10 n/d 
LiOH.H2O 48 100 17 
NaOH 16 100 racemic 
KOH 16 100 racemic 
CsOH.H2O 16 100 racemic 
Hünig’s base 96 0 n/a 
DMAP 96 0 n/a 
TMEDA 96 0 n/a 
(a) Reactions were carried out on 0.25 mmol scale with magnetic stirring in Biotage microwave vials (2-5 mL 
size) using undistilled CHCl3 (2 mL). Conversion from starting material to product was calculated via 1H NMR 
using the integrations of diagnostic peaks. Enantiomeric excess was determined by integrating peaks in the 13C 
NMR of the diastereoisomeric acetals formed between the product and (R)-(–)-2,3-butanediol. 
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Table 8 Initial testing of catalyst 310(a) 
Of the bases tested by Ley and Hanessian caesium fluoride and trans-2,5-
dimethylpiperazine were among the most selective. Unfortunately in our hands this 
proved not to be the case, with little to no conversion to the desired product isolated 
in either case. The use of other amine bases (TMEDA, DMAP etc.) also met with 
failure, with no conversion seen in either case. To our delight, however, using alkali 
metal hydroxides as the base under these conditions resulted in clean conversion to 
the desired addition product. Whereas NaOH, KOH and CsOH.H2O yielded only 
racemic product, the use of LiOH.H2O gave a small but encouraging enantiomeric 
excess in the region of 17%. Clearly, further optimization was required. 
The choice of solvent is well known to have a large effect on the selectivity of 
organocatalytic reactions. Thus, using LiOH.H2O as base and 10 mol% 310 we 
tested a number of solvents. Our results are shown in Table 8. 
 
 
 
Solvent Base Time (h) 
Conversion 
(%) 
ee (%) 
Neat None 144 0 n/a 
Et2O LiOH.H2O 168 100 14 
Toluene  LiOH.H2O 16 100 19 
DMF LiOH.H2O 168 0 n/a 
DMSO LiOH.H2O 168 0 n/a 
Benzene LiOH.H2O 48 85 16 
DCM LiOH.H2O 96 100 23 
DCM LiOH 144 100 21 
(a) Reactions were carried out on 0.25 mmol scale with magnetic stirring in Biotage microwave vials (2-5 mL 
size) using undistilled solvents (2 mL). Conversion from starting material to product was calculated via 1H NMR 
using the integrations of diagnostic peaks. Enantiomeric excess was determined by integrating peaks in the 13C 
NMR of the diastereoisomeric acetals formed between the product and (R)-(–)-2,3-butanediol. 
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There are a few interesting results in table 8. Running the reaction with no solvent or 
base resulted in no conversion, which shows that the base is necessary for the 
reaction to proceed. Use of ethereal solvent both increased reaction time and 
decreased selectivity. Use of toluene on the other hand caused a notable increase in 
reaction rate as well as an increase in ee. Polar aprotic solvents (i.e. N,N-
dimethylformamide and dimethyl sulfoxide) killed catalytic activity completely, with no 
conversion seen after a week at room temperature in either case. The most 
promising entry, however, was that of dichloromethane. While the rate of reaction 
was lower (four days at room temperature was required for the reaction to reach 
completion), the ee increased to 23% which was the highest seen thus far. Finally, 
when considering the final two entries in table 8, it can be seen that the reaction 
proceeded at an increased rate using the hydrated base compared with the 
anhydrous one. This increase in rate is presumably due to the equivalent of water 
present in the reaction mixture, which may increase the rate of hydrolysis of the 
iminium intermediate and as a result increase catalyst turnover. A drop in selectivity 
did not accompany this rate increase. This confirmed our hypothesis that anhydrous 
conditions were not required for these catalyst runs and that an equivalent of water 
in the reaction was in fact beneficial.  
Our next task was to test the effect of temperature on this system. Thus, four of the 
test reactions that are mentioned above were repeated, this time at 0 oC (Table 9). 
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O
BnO2C CO2Bn
O
CO2Bn
CO2Bn
+
cat. (10 mol%)
base (1 eq.)
solvent, 0 oC
Table 9 Initial testing of catalyst 310(a) 
 
 
  
Solvent Base Time (h) 
Conversion 
(%) 
ee (%) 
CHCl3 LiOH.H2O 240 100 19 
CHCl3 NaOH 48 100 9 
Toluene LiOH.H2O 48 100 14 
Toluene NaOH 48 100 7 
(a) Reactions were carried out on 0.25 mmol scale with magnetic stirring in Biotage microwave vials (2-5 mL 
size) using undistilled solvents (2 mL). Conversion from starting material to product was calculated via 1H NMR 
using the integrations of diagnostic peaks. Enantiomeric excess was determined by integrating peaks in the 13C 
NMR of the diastereoisomeric acetals formed between the product and (R)-(–)-2,3-butanediol. 
While there was a small increase in selectivity (e.g. 19% ee cf. 17%), this was 
deemed insignificant due to an associated massive increase in reaction times. Ten 
days at 0 oC was required for complete conversion in the first entry using CHCl3 and 
LiOH.H2O. While the same conditions were not tested using dichloromethane as 
solvent, we envisaged that the reaction would take an unacceptable period of time to 
reach completion.  
With these preliminary results now in hand, a selection of different malonates were 
tested in the conjugate addition to cyclohexenone and an acyclic analogue, 
benzylideneacetone. While the addition of dibenzyl malonate to cyclohexenone has 
been shown to be a generally selective reaction compared with other similar 
examples, we believed it necessary to carry out these reactions in the interests of 
completeness. The racemates for these reactions were synthesized as before using 
KOtBu in dry THF (Scheme 118 & 119). These compounds were then converted into 
their respective acetals without issue and all in quantitative yields.  
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O O
+
KOtBu (0.1 eq.)
THF
rt, 16 h
HO OH
(1.05 eq.)
p-TSA.H2O (cat.)
PhH, reflux, 1h
OO
RO2C CO2R CO2R
CO2R
CO2R
CO2R
Scheme 118 Racemic malonate additions to cyclohexenone 
Scheme 119 Racemic malonate additions to benzylideneacetone 
+
KOtBu (0.1 eq.)
THF
rt, 16 h
HO OH
(1.05 eq.)
p-TSA.H2O (cat.)
PhH, reflux, 1h
RO2C CO2R
Ph Me
O
Ph
OMe
RO2C CO2R
Ph
Me
RO2C CO2R
O
O
Table 10 Substrate testing using 310(a) 
 
 
 
  
 
 
 
 
Finally for this chapter, the enantioselective variants of these reactions were carried out 
using our previously optimized conditions. These results are presented in table 10.  
 
Enone R Time (h) 
Conversion 
(%) 
ee (%) 
Benzylideneacetone Me 96 40 8 
Benzylideneacetone Et 96 91 racemic 
Benzylideneacetone iPr 96 78 10 
Benzylideneacetone Bn 96 87 13 
Cyclohexenone Me 48 100 14 
Cyclohexenone Et 48 100 14 
Cyclohexenone iPr 96 100 17 
Cyclohexenone Bn 96 100 23 
(a) Reactions were carried out on 0.25 mmol scale with magnetic stirring in Biotage microwave vials (2-5 mL 
size) using undistilled CHCl3 (2 mL). Conversion from starting material to product was calculated via 1H NMR 
using the integrations of diagnostic peaks. Enantiomeric excess was determined by integrating peaks in the 13C 
NMR of the diastereoisomeric acetals formed between the product and (R)-(–)-2,3-butanediol. 
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Scheme 120 Retrosynthesis of compound 325 
Scheme 121 Synthesis of catalyst 325 
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268 327
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NH
CO2H
N
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+
Br
OtBu
O
325 268 326
Benzylideneacetone is clearly not a good substrate for this type of reaction, with 
uniformly very low enantioselectivity and reactivity seen across the board even in 
comparison to cyclohexenone. Unfortunately, our initial test substrates also 
unsurprisingly gave our best results (perhaps due to the steric bulk of the benzyl 
groups compared with methyl or ethyl).  
Following this initial work, we set about optimizing the structure of our organocatalyst 
310. We envisaged that altering the bromoacetate used in our pivotal Reformatsky 
reaction should impart different properties to our catalysts. While there are very few 
t-butyl bromoacetates commercially available with substituents at the α-position, one 
that is available is t-butyl α-bromoisobutyrate 326. The retrosynthesis of potential 
catalyst 325 is shown in Scheme 120.  
 
 
  
While catalyst 325 would be slightly less acidic than 310 due to the electron donating 
nature of the two methyl groups (similar comparisons can be made between acetic 
acid and pivalic acid), we also envisaged that steric hindrance could play some role 
in organizing the potential transition state in an organocatalytic reaction. In order to 
test this, organocatalyst 325 was synthesized using the route shown in scheme 121.  
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O
BnO2C CO2Bn
O
CO2Bn
CO2Bn
+
cat. (10 mol%)
LiOH.H2O (1.0 eq.)
DCM, rt
While we were able to successfully synthesize 325, the yields were lower across the 
board compared with compound 310. Nevertheless, we were able to access 325 on 
a scale that was more than reasonable for catalyst tests to be run. For a direct 
comparison with compound 310, we used our initial test reaction i.e. the reaction 
between dibenzyl malonate and cyclohexenone. The results are shown in table 11 
(the testing of 310 is repeated here for clarity).  
 
 
 
Table 11 Testing of catalyst 325 
Catalyst Time 
Conversion 
(%) 
ee (%) 
310 96 100 23 
325 36 100 9 
 
As can be seen, 325 is a much more active catalyst than 310. The reaction time was 
reduced by over half from 96 hours to around 36 hours. However, the selectivity also 
decreased, with only 9% ee seen using 325.  
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O O
+
cat. (10 mol%)
base (1 eq.)
CHCl3, rt
MeNO2 NO2
Table 12 Nitromethane addition to cyclohexenone 
6.2.4 – Catalyst Testing – Nitroalkane additions 
The other reaction that we proposed when testing catalyst 325 was the addition of 
nitroalkanes to the same enones as discussed above. Hanessian and co-workers 
have reported this reaction, catalysed by L-proline.216 Due to the electron-
withdrawing nature of the nitro group, nitroalkanes contain highly acidic protons, 
even more so in fact than malonates (nitromethane pKa 10.2 cf. diethyl malonate 
pKa 13.0) so we reasoned that they would be acceptable nucleophiles in this type of 
reaction. This suggested that it would be more easily deprotonated than any of the 
malonates used and should therefore add to our activated enone substrates. Our 
initial studies using nitromethane and 2-nitropropane are shown in tables 12 & 13.  
 
 
 
Base Time (h) 
Conversion 
(%) 
ee (%) 
LiOH.H2O 144 0 - 
CsF 144 0 - 
trans-2,5-dimethylpiperazine 144 0 - 
Reactions were carried out on 0.25 mmol scale with magnetic stirring in Biotage microwave vials (2-5 mL size) 
using undistilled CHCl3 (2 mL). Conversion from starting material to product was calculated via 1H NMR using the 
integrations of diagnostic peaks. 
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O O
+
cat. (10 mol%)
base (1 eq.)
CHCl3, rt NO2NO2
Table 13 2-nitropropane addition to cyclohexenone(a) 
N
H
284
 
 
 
   
Base Time (h) 
Conversion 
(%) 
ee (%) 
LiOH.H2O 144 0 - 
CsF 144 0 - 
trans-2,5-dimethylpiperazine 144 0 - 
(a) Reactions were carried out on 0.25 mmol scale with magnetic stirring in Biotage microwave vials (2-5 mL 
size) using undistilled CHCl3 (2 mL). Conversion from starting material to product was calculated via 1H NMR 
using the integrations of diagnostic peaks. 
Unfortunately, for unknown reasons, no reaction whatsoever took place using any of 
the bases tested.  
6.3.1 – Triazole sidechains 
In our attempts to synthesize α-amino acid 273, we made large quantities of the 
alkyne 284 using methods already previously described. As this route was not 
successful, we were left with a quantity of 284 that we decided to further 
functionalize in a different way.  
 
 
 
The now ubiquitous Cu-catalysed Huisgen [3+2] cycloaddition between an alkyne 
and an azide is an extremely common reaction that has found uses in many different 
aspects of the chemical sciences since its publication by Sharpless. Whereas 
Huisgen required elevated temperatures to obtain the desired triazoles in his seminal 
paper,217 Sharpless and Fokin observed that a source of copper (I) in the reaction 
allowed the reaction to proceed at far lower temperatures and at the same time 
selectively form only the 1,4-triazole regioisomer 331 (Scheme 122).204 This is due to 
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Scheme 122 Uncatalysed and catalysed cycloadditions between alkynes and 
azides 
Scheme 123 Synthesis of benzyl azide 
R
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R
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329 330 331 332
329 330 331
Br N3NaN3+
DMSO, rt, 16 h
333 334 335
the formation of organocopper intermediates that are described in the same 
publication. 
 
 
 
 
  
 
The wide applicability and need for only mild reaction conditions have led this type of 
reaction to be classed by Sharpless as a ‘click’ reaction i.e. a reaction where two 
reagents react rapidly together with near-perfect atom economy.218 We envisioned 
that if this could be applied to our system, it would be possible to obtain a wide 
variety of potential triazole-containing organocatalysts by merely altering the azide in 
the reaction mixture. For our initial purposes, benzyl azide 335 was deemed to be a 
safe, commonly used azide that could be synthesized from commercially available 
starting materials (Scheme 123). It was synthesized according to the procedure of 
Hackenberger using benzyl bromide and sodium azide in DMSO.219 
 
 
 
 
With 284 and 335 in hand, some commonly used ‘click’ reaction conditions were 
tested. These results are shown in table 14.  
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Table 14 Synthesis of triazole 336 
Scheme 124 Deallylation of compound 336 to give 337 
NH
N
N
N
Ph
N
N
N
N
Ph
Pd(PPh3)4 (1 mol%)
NDMBA (3.0 eq.)
DCM, reflux, 3h
95%
336 337
N
H
N
N
N
N
Ph
N3
+
336284 335
 
 
 
 
Solvent  
Cu source 
(eq.)  
Additive 
(eq.) 
Temperature 
(oC) 
Time 
(h) 
Yield (%) 
tBuOH/H2O	   CuSO4	  (0.1)	  
Na	  ascorbate	  
(0.15)	  
rt	   48	   <10	  
MeCN	   CuI	  (0.1)	   None	   rt	   1	   23	  
THF/H2O	   CuSO4	  (0.1)	  
Na	  ascorbate	  
(0.15)	  
50	   3	   83	  
 
The first reaction shown in the table utilized the optimized conditions published by 
Sharpless using a catalyst system comprised of copper (II) sulfate and sodium 
ascorbate in a tBuOH/H2O solvent mixture. The ascorbate in this case acts as a 
reducing agent for the copper (II) and maintains it in the desired oxidation state for 
the duration of the reaction. In our hands, no conversion was seen using this system, 
presumably due to the complete insolubility of 284 in the solvents used. Use of a 
copper (I) salt directly without the ascorbate (entry 2) did lead to the desired 
compound, albeit as the minor product out of two which were isolated. The structure 
of the other compound that was formed was not obvious and has not been 
characterized at this point. Finally, the use of the Sharpless catalyst system in 
THF/H2O proved to be far more fruitful, yielding the desired compound 336 in 83% 
yield. This compound was then deallylated using the standard method described 
above in near quantitative yield to give catalyst 337 (Scheme 124). 
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Table 15 Initial testing of catalyst 337(a) 
O
Nu
O
+
337 (10 mol%)
base (1.0 eq.)
Nu
CHCl3, rt
We then tested compound 337 as a catalyst for the malonate additions that have 
been discussed above. The results are presented in table 15.  
 
 
 
  
Nucleophile Base Time (h) 
Conversion 
(%) 
ee (%) 
dibenzyl malonate CsF 144 0 - 
dibenzyl malonate 
trans-2,5-
dimethylpiperazine 
144 60 racemic 
dibenzyl malonate LiOH.H2O 16 100 racemic 
2-nitropropane CsF 144 0 - 
2-nitropropane 
trans-2,5-
dimethylpiperazine 
144 0 - 
2-nitropropane LiOH.H2O 144 0 - 
(a) Reactions were carried out on 0.25 mmol scale with magnetic stirring in Biotage microwave vials (2-5 mL 
size) using undistilled solvents (2 mL). Conversion from starting material to product was calculated via 1H NMR 
using the integrations of diagnostic peaks. Enantiomeric excess was determined by integrating peaks in the 13C 
NMR of the diastereoisomeric acetals formed between the product and (R)-(–)-2,3-butanediol. 
Unfortunately, while triazole 337 did effectively catalyse the addition of dibenzyl 
malonate to cyclohexenone, it did not give any enantiomeric excess. This is a 
disappointing result, but does show that it is probably necessary for a functionalized 
side chain with H-bonding capabilities like 310 or 325 to be present in the catalyst for 
it to give any enantioselectivity in this type of reaction. Also, no conversion was seen 
under any of the conditions when testing the addition of nitropropane to 
cyclohexenone. This is in keeping with the poor results shown before with catalyst 
310. 
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Scheme 125 α-Arylation of branched aldehydes catalysed by Pd complex 339 
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Me CHO
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339 (R = 2,4-(MeO)2-C6H3)
(10 mol%)
Cs2CO3 (1.2 eq.)
DMF, 110 oC, 24 h
75% yield, 96% ee
340 341
6.3.2 Metal Complexes 
The first time 284 was synthesized, we noticed in the crude 1H NMR spectrum that 
there was a large amount of peak broadening. While this can sometimes be put 
down to impaired rotation due to steric hindrance,220 we hypothesized that the 
broadening in this case was down to the presence of a paramagnetic copper 
complex being present in the crude material. Paramagnetic complexes, due to their 
unpaired electrons, are well known to distort NMR experiments.221 These complexes 
are known to be effectively destroyed by adding other ligands such as EDTA to the 
crude reaction mixture. In our hands, however, we found that adding 1M ammonium 
hydroxide solution effectively removed copper from the reaction, forming water-
soluble copper (II) amine complexes in the process.222  
While compound 337 was shown to be an ineffective organocatalyst, we were also 
interested in its ability to chelate metals and form novel organometallic complexes. 
There are examples of similar ligands being used to chelate palladium in the 
literature, forming complexes such as 338223 and 339.224 
 
 
 
 
Amino phosphine complex 339, based on an extremely similar system to ours 
(containing a dihydrophosphepine motif as opposed to our dihydroazepines), has 
also recently been shown to highly selectively catalyse the intramolecular α-arylation 
of α-branched aldehydes such as 340 (Scheme 125). 
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Scheme 126 Synthesis of Pd complex 342 
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70%
337 342
We envisaged that 337 should effectively chelate palladium and as such we 
subjected it to the same conditions as reported by Sarkar. To our delight, stirring 337 
for one hour with a dichloromethane solution of Pd[COD]Cl2 yielded, after 
precipitation with petroleum ether, the novel complex 342 in a respectable 70% yield 
(Scheme 126).  
 
 
 
 
 
This proposed structure was confirmed by X-ray analysis of crystals grown from a 
dichloromethane/diethyl ether solution of the complex (Figure 20). The square planar 
nature of this complex can be easily seen in this case.  
 
 
 
 
 
 
Repetition of this reaction with 343, which was synthesized using the same method 
as for 336, yielded a similar Pd-complex 344 (Scheme 127). This complex exhibited 
some interesting peaks in the 1H NMR spectrum, with several of the aromatic peaks 
exhibiting a pronounced downfield shift (Figure 21). We believe this could be due to 
a potential interaction between the aromatic protons in the PMB group and the dz2 
orbital of the Pd atom that lies perpendicular to the plane of the square planar 
complex. This is the opposite effect to the one responsible for the upfield shift 
Figure 20 Crystal structures of compound 342 
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Figure 21 1H NMR spectra of (a) ligand 343 in CDCl3 and 
(b) after addition of 1.0 eq. of Pd[COD]Cl2 
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N
N
Ph
N
N
N
N
Ph
Pd
Cl
ClPd[COD]Cl2 (1.0 eq.)
DCM, rt, 1h
62%
OMe
MeO
343 344
experienced by the pseudoaxial α-substituents of the azepines that are discussed at 
length in section 6.1 above.  
 
 
 
  
 
 
 
 
 
 
 
 
   
   
There are few examples of these sorts of Pd (II) complexes being used for catalysis 
due to the need for the presence of Pd(0) in most catalytic cycles. There are, 
however, many examples of Cu diamine complexes being used in asymmetric 
catalysis. This is exemplified by the bisoxazoline (Box) type ligands, which have 
found a multitude of uses in asymmetric catalysis as previously discussed in section 
4.1.4.225 
 
Scheme 127 Synthesis of Pd complex 344 
 
(a) 
 
 
 
(b) 
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 In order to determine if a diamagnetic copper (I) complex containing 337 could be 
synthesized, we ran an NMR experiment. After running a 1H spectrum of 337 in 
CD3CN, we introduced 1.1 equivalents of CuI to the NMR tube, which resulted in an 
instant colour change. Subsequent analysis showed that a new complex had indeed 
formed quantitatively (Figure 22). However, attempts to isolate it were met with 
difficulties due to its unstable nature. This does show, however, that 337 is capable 
of forming diamagnetic complexes with copper. It is our hope that said complexes 
can be potentially used for catalytic processes. Our ideas about this are presented in 
section 3.1.  
 
  
(a) 
 
 
 
 
 
(b) 
Figure 22 1H NMR spectra of (a) ligand 337 in CD3CN and  
(b) ligand 337 after addition of 1.1 eq. CuI 
 111 
Scheme 128 Synthesis of α-amino esters using MAC reagents 
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7.1 Future Work 
This thesis reports a new area of research within the Page group. Preliminary work 
on a range of topics has taken place and as such, there are several routes that this 
project could now take in the future. They are presented in this section.  
First and foremost, the synthesis of α-amino acid 273 is still one of our main targets. 
There are two methods that we believe could still give access to this compound that 
has thus far evaded us. Firstly, Nemoto has published a methodology for the 
synthesis of amino acids directly from unactivated imines using masked acyl cyanide 
(MAC) reagents that were developed in his group.226 By reacting dicyanomethyl 
acetate 346 with imines of the type 345 in the presence of a mild base, it was 
possible to isolate cleanly and effectively products of the type 347 (Scheme 128).  
 
 
  
The reaction is believed to proceed by nucleophilic attack of the deprotonated 
dicyanomethyl acetate followed by acetate migration to the newly formed secondary 
amine. The unstable acyl cyanide formed as a result then reacts with the methanol 
solvent resulting in the formation of methyl ester 347. The loss of two equivalents of 
gaseous hydrogen cyanide drives the reaction forward and also explains the lack of 
side reactions that occur. We believe that methyl ester 348 could be accessed in this 
way from the known compound 349, itself formed by oxidation of secondary amine 
261 (Scheme 129).  
 
 
 
  
Scheme 129 Retrosynthesis of α-amino acid 273 based on Nemoto’s MAC 
methodology 
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Scheme 130 H/D exchange in N-nitroso-N’-methylpiperazine 
Scheme 131 Methylation of nitrosamine 356 
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Secondly, it is possible that lithiation at the α-position of the azepine is possible if the 
correct protecting group is used. For example, nitrosamine 350 was shown by Keefer 
and Fodor to easily undergo ready H/D exchange in basic D2O solution at elevated 
temperatures, suggesting that the α-carbanion 351 is stabilized by tautomers 352 
and 353 (Scheme 130).227  
 
 
 
 
 
 
 
  
Superchi and co-workers have utilized this methodology for the synthesis of 
dimethylated 357 from parent nitrosamine 356.228 Using an excess of KH and MeI in 
refluxing THF, the desired compound was isolated in high yield. This reaction 
proceeds via a dianion and yields the desired compound diastereoselectively, 
showing that the more reactive pseudoaxial proton is removed by the base used 
(Scheme 131).  
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Scheme 132 Carbon dioxide addition to nitrosamine 358 
Scheme 133 Methylation of N-Boc azepine 361 
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Wigfield has even shown that compounds such as acid 359 can be accessed using 
this methodology.229 Deprotonation of 358 and subsequent quenching of the anion 
with dry carbon dioxide gas yielded 359, albeit as a mixture with 360 (Scheme 132). 
It is hoped that this sort of chemistry could be applied to the binaphthyl system 
utilized in our work.  
 
 
 
 
 
N-Boc azepine 361 is also known, and it was shown by Wallace211 that the α-protons 
in that case are also acidic enough to be removed by a strong base such as the 
Schlosser superbase derived from n-butyl lithium and KOtBu.230 Compound 362 was 
accessed in this way in excellent yield (Scheme 133). 
 
 
 
  
This, we believe, is definitely a potential method for the synthesis of α-amino acid 
365 and also for related compounds such as tertiary alcohol 364 (an analogue of the 
popular Jørgensen-type catalyst) that could be accessed merely by altering the 
electrophile used (Scheme 134). This could itself also prove to be an effective 
organocatalyst.  
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Scheme 134 Potential routes to organocatalysts based on lithiation of azepine 
363 
Scheme 135 Potential routes to organocatalysts using functionalized Grignard 
reagents 
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Another potential route to new organocatalysts using our original method of 
nucleophilic addition to iminium salt 268 is the use of functionalized Grignard 
reagents that have been developed by Knochel.231 He has shown that functionalized 
Grignard reagents are accessible using his methodology, and behave in the same 
way as other Grignard reagents. As such, we believe that adding nucleophiles of this 
type to iminium salt 268 could yield compounds such as 366. From there, benzoic 
acid derivative 367 or tetrazole 368 would hopefully be accessible by known 
literature procedures (Scheme 135). 
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Scheme 136 Copper-catalysed aziridination 
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The pKa of this aromatic acid 368 would be lower than for β-amino acids 310 and 
325 that are discussed above. We hope that this increase in acidity could also lead 
to an increase in reactivity, both in enamine and iminium-based organocatalytic 
processes.  
Finally, the work on 337 and its metal complexes needs to be expanded upon. As 
indicated above, there are several asymmetric copper-catalysed reactions that utilize 
ligands similar to those described above. One of the most well-known is the 
asymmetric aziridination of olefin substrates using (N-(p-
toluenesulfonyl)imino)phenyliodinane in conjunction with a copper catalyst.232 This 
forms a copper nitrene in situ, which can then add to the alkene substrate (Scheme 
136). Our new ligand 337 will perhaps perform well in this type of asymmetric 
process.   
 
 
Having shown that compounds such as 337 also form complexes with palladium, it 
would be interesting to see what effect different N-substituents on both the azepine 
and the triazole have on the properties of the metal complexes formed and also to 
see if complexes can be formed which contain other metals. This should be a 
relatively facile process due to the highly modular nature of the synthesis of these 
compounds. Also, it could be possible to oxidize 337 to yield imine 371, which could 
have different properties still as a potential ligand.  
 
 
 
 
In conclusion, there are still many routes that this project could take in the future. 
This thesis has barely scratched the surface in terms of the potential uses of 
compounds derived from these axially chiral amines. It will be interesting to see what 
the future holds for this type of compound within the Page group.  
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8.1 General Experimental 
Unless otherwise stated, all starting materials were bought from commercial 
suppliers and were used without further purification. If necessary, solvents were 
dried in the usual manner; THF and Et2O were distilled from sodium benzophenone 
ketyl radical, and toluene, DCM, MeCN, and DMF were distilled from CaH2. Petrol 
refers to the fraction of petroleum ether boiling in the range 40-60 oC. Commercial 
samples were distilled in the lab prior to use to remove any fractions with a boiling 
point higher than this. Solvents were removed using a Büchi rotary evaporator (water 
bath temperature approx. 40 oC) or a high vacuum pump between room temperature 
and 60 oC. In the case of anhydrous reactions glassware and needles were either 
flame-dried or dried in an oven (150 oC) for at least 2 hours and then allowed to cool 
under a stream of nitrogen immediately prior to use. All reactions were carried out 
under an atmosphere of nitrogen or argon. All liquid reagents and solvents were 
added to reaction vessels by means of syringes through rubber septa.  
TLC analysis was carried out on commercially available Kieselgel aluminium backed 
plates. Visualisation was either by UV fluorescence, basic KMnO4 solution and heat, 
or phosphomolybdic acid and heat. Column chromatography was carried out on 
Davisil® chromatographic silica media LC60Ǻ 40-63 µm using standard methods. 
Melting points were obtained using a Büchi Melting Point B-545 apparatus and are 
uncorrected. Optical rotations were obtained using a Bellingham and Stanley 
ADP440 polarimeter using the solvent described in each case with concentrations 
quoted in grams per 100 mL. IR spectra were recorded in the range 4000-400 cm-1 
on a Perkin-Elmer 1720X FT-IR spectrophotometer as thin films on KBr plates or as 
solid samples on diamond windows. NMR spectra were recorded on a Bruker 500 
MHz Spectrometer. Chemical shifts were recorded in parts per million (ppm) and are 
referenced to either tetramethylsilane or the residual protons of the deuterated 
solvents used. Abbreviations used are as follows: s (singlet), d (doublet), t (triplet), q 
(quartet), sept (septet), m (multiplet) and br (broad). Mass spectra were determined 
at the EPSRC Mass Spectrometry Unit, Swansea. Chiral HPLC was obtained using 
a VWR Hitachi Elite LaChrom HPLC system fitted with a Chiralcel OD column using 
the racemate as a standard.   
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8.2 Experimental data 
(S)-[1,1’]-binaphthalene-2,2’-diol bis-trifluoromethanesulfonate 238233 
 
 
 
 
 
 
(S)-[1,1']-Binaphthalene-2,2'-diol (10.0 g, 34.8 mmol, 1.0 eq) and 4-
dimethylaminopyridine (1.75 g, 14.2 mmol, 0.4 eq) were dissolved in dry 
dichloromethane (240 mL) and cooled to -78 oC. To the resulting yellow solution was 
added 2,6-lutidine (12.2 mL, 104 mmol, 3.0 eq) and triflic anhydride (18.00 mL, 104 
mmol, 3.0 eq). The resulting pink solution was allowed to reach room temperature 
and stirred for 20 hours. Silica gel was added to the reaction mixture and the solvent 
removed in vacuo. The compound adsorbed onto silica was transferred to a glass 
sinter and washed with petroleum ether/EtOAc (99:1) until the title compound had 
eluted. Solvents were removed in vacuo to give the title compound as a colourless 
solid (18.65 g, 33.9 mmol, 97%), m.p. 94-96 oC (lit. 93-95 oC173), [α]20D +148 (c 1.00, 
CHCl3) (lit. +145 (c. 1.00, CHCl3173), νmax(solid) /cm-1 2927, 2363, 1621, 1582, 1508, 
δH (400 MHz; CDCl3) 7.25-7.27 (2H, m), 7.39-7.43 (2H, m), 7.57-7.63 (4H, m), 8.00-
8.02 (2H, m), 8.13-8.15 (2H, m), δC (75 MHz; CDCl3) 53.3, 119.3, 123.5, 126.8, 
127.4, 128.0, 128.4, 132.0, 132.4, 133.2, 145.4.  
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(S)-2,2'-Dimethyl-[1,1']binaphthalene 239233 
 
 
 
 
 
 
(S)-[1,1’]-binaphthalene-2,2’-diol bis-trifluoromethanesulfonate (8.20 g, 14.9 mmol, 
1.0 eq) and 1,3-bis(diphenylphosphino)propane nickel (II) chloride (0.70 g, 1.04 
mmol, 0.07 eq) were dissolved in anhydrous diethyl ether (80 mL). The reaction was 
cooled to -78 oC before methylmagnesium bromide (3M in diethyl ether, 19.9 mL, 
59.52 mmol, 4.0 eq) was added dropwise over 30 minutes. The reaction was allowed 
to warm to room temperature and the reaction mixture stirred for 60 hours. The dark 
brown solution was diluted with diethyl ether (50 mL) and Celite was added. The 
mixture was cooled to 0 oC, and the excess Grignard reagent was gradually 
quenched with water. The reaction mixture was then filtered through a plug of Celite 
(washing the solid residue with diethyl ether) to give a clear orange solution. This 
was transferred to a separating funnel and washed sequentially with concentrated 
aqueous HCl solution, water, and brine. The organic phase was dried (MgSO4), 
filtered, and concentrated in vacuo to give a colourless oil which could be used 
without further purification (3.95 g, 14.0 mmol, 94 %). An analytically pure sample 
could be obtained by recrystallization from MeOH; m.p. 84-85 oC (lit. 72-74 oC173), 
[α]20D + 45.8 (c 1.00, CHCl3) (lit. +38 (c. 1.00, CHCl3173), νmax(solid) /cm-1 3042, 2916, 
1906, 1617, 1593, 1565, 1504, 1443, 1419, 1377, 1351, δH (400 MHz; CDCl3) 2.01 
(6H, s), 7.05 (2H, d, J= 8.5 Hz), 7.13-7.15 (2H, m), 7.32-7.34 (4H, m), 7.46 (2H, d, J= 
8.4 Hz), 7.82-7.86 (4H, m); δC (75 MHz; CDCl3) 19.9, 125.0, 125.7, 126.1, 127.5, 
128.0, 128.8, 132.3, 132.8, 134.4, 135.2.  
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(S)-2,2’-Bis-bromomethyl-[1,1’]binaphthalene 240233 
 
 
 
 
(S)-2,2'-Dimethyl-[1,1']binaphthalene (3.50 g, 12.40 mmol, 1.0 eq) was dissolved in 
cyclohexane (28 mL). N-bromosuccinimide (4.66 g, 24.8 mmol, 2.0 eq) and 
azobisisobutyronitrile (0.21 g, 0.13 mmol, 0.1 eq) were added and the mixture 
refluxed for 3 h (TLC showed disappearance of starting material). Ethyl acetate (10 
mL) and water (50 mL) were added to dissolve byproducts and excess NBS. The 
resulting suspension was stirred for 1 hour resulting in precipitation of the title 
compound as a colourless powder (2.70 g, 6.13 mmol, 49%), m.p. 171-174 oC (lit. 
180-182 oC173), [α]20D -163.7 (c 1.30, CHCl3) (lit. -158 (c. 1.00, CHCl3173), νmax(solid) 
/cm-1, 3044, 2916, 1909, 1722, 1593, 1505, 1432, 1211, 817, 759, δH (400 MHz; 
CDCl3) 4.25 (4H, s), 7.07 (2H, d, J= 8.5 Hz), 7.25-7.29 (2H, m), 7.47-7.51 (2H, m), 
7.75 (2H, d, J= 8.5 Hz), 7.92 (2H, d, J= 8.1 Hz), 8.02 (2H, d, J= 8.6 Hz), δC (75 MHz; 
CDCl3) 32.5, 126.85, 126.87, 126.90, 127.80, 128.1, 129.4, 132.6, 133.3, 134.2, 
134.3. 
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General procedure for the synthesis of binaphthalene-derived azepines from 
(S)-2,2’bis(bromomethyl)-[1,1’]binaphthalene and primary amines233 
 
 
 
The primary amine (1.1 eq.) was added to a nitrogen purged, stirred solution of (S)-
2,2’bis(bromomethyl)-[1,1’]binaphthalene (1.0 eq.) and potassium carbonate (3.0 
eq.) in acetonitrile (10 mL per gram of dibromide) at room temperature. The reaction 
mixture was heated to reflux and stirred overnight or until the disappearance of 
starting material was seen by TLC. The mixture was diluted with dichloromethane 
(40 mL per gram of dibromide) and washed with water (2 x 30 mL per gram of 
dibromide) and brine (2 x 30 mL per gram of dibromide). The organic phase was 
separated, dried (MgSO4) and the solvent removed in vacuo to give the desired 
products. 
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(S)-N-Isopropyl-2,7-dihydro-dinaphtho[2,1-c;1’,2’-e]azepine 244 
 
 
 
 
 
Prepared according to the general procedure using isopropylamine (0.15 g, 2.27 
mmol, 1.1 eq.).  Trituration of the crude product in acetone (5 mL) gave the 
analytically pure title compound 5 as colourless powder (0.65 g, 1.92 mmol, 85%), 
m.p. 159-160 oC, [α]20D +336.4 (c 1.00, acetone), νmax(solid) /cm-1 3044, 2965, 2802, 
1590, 1505, 1459, 1372, 1348, 1238, 1158, δH (400 MHz; CDCl3) 1.15 (3H, d, J = 6 
Hz), 1.29 (3H, d, J = 6 Hz), 2.76 (1H, septet, J = 6 Hz), 3.26 (2H, d, J = 12 Hz), 3.93 
(2H, d, J = 12 Hz), 7.24-7.28 (2H, m), 7.44-7.48 (4H, m), 7.59 (2H, d, J = 8 Hz), 7.94 
(4H, d, J = 8 Hz), δC (75 MHz; CDCl3) 19.4, 20.0, 50.4, 51.0, 123.5, 124.0, 125.7, 
126.2, 126.4, 126.5, 129.6, 131.3, 132.6, 133.2, HRMS (CI+): calc. for C25H23N 
(MH+) 337.1831, found 337.1826. 
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(S)-N-Cyclohexyl-2,7-dihydro-dinaphtho[2,1-c;1’,2’-e]azepine 245 
	  	  	  	  	  
Prepared according to the general procedure from cyclohexylamine (0.29 mL, 2.50 
mmol, 1.1 eq). The title compound 19 was isolated as a colourless foam which 
solidified upon drying (0.81 g, 2.15 mmol, 95%), m.p. 81-82 oC , [α]20D +252 (c 1.00, 
CHCl3), νmax(solid) /cm-1, 3046, 2922, 2850, 1593, 1506, 1447, 1361, 1343, 1236, 
1113, 1092, δH (400 MHz; CDCl3) 1.18-1.40 (5H, m), 1.64 (1H, m), 1.76-1.97 (1H, 
m), 2.22 (1H, d, J = 12.2 Hz), 2.40-2.42 (1H, m), 3.29 (2H, d, J = 13 Hz), 3.97 (2H, d, 
J = 12 Hz), 7.23-7.28 (2H, m), 7.44-7.46 (4H, m), 7.60 (2H, d, J = 8 Hz), 7.94-7.96 
(4H, m), δC (75 MHz; CDCl3) 25.6, 26.0, 30.5, 31.1, 31.6, 51.9, 61.7, 125.3, 125.7, 
127.5, 128.0, 128.3, 128.4, 131.4, 133.1, 134.5, 135.1, HRMS (CI+): calc. for 
C28H27N (MH+) 377.2144, found 377.2138. 
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(S)-N-(4-methoxyphenyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine 249 
 
 
 
 
 
 
Prepared according to the general procedure from p-anisidine (0.15 g, 1.14 mmol). 
The crude product was isolated as a pale yellow foam which was purified by column 
chromatography (1:1 petrol : EtOAc) to give the title compound 22 as yellow powder 
(380 mg, 0.94 mmol, 83%) m.p. 91-92 oC, [α]20D -259.6 (c 1.00, CHCl3), νmax(solid) 
/cm-1 3388, 3049, 2995, 2948, 2907, 2831, 2348, 2047, 1915, 1830, 1734, 1615, 
1594, 1580, δH (300 MHz; CDCl3) 3.76 (s, 3H), 3.78 (d, 2H, J = 12 Hz), 4.32 (d, 2H, J 
= 12 Hz), 6.80-6.92 (m, 4H), 7.24-7.31 (m, 2H), 7.43-7.53 (m, 6H), 7.91 (t, J = 8 Hz), 
δC (75 MHz; CDCl3) 53.7, 55.5, 114.4, 117.9, 125.6, 125.9, 127.5, 127.6, 128.4, 
128.8, 131.4, 133.3, 133.6, 134.8, 144.4, 153.1, HRMS (CI+): calc. for C29H23NO 
(MH+) 402.1844, found 402.1847. 
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(S)-4-(4-methoxybenzyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine 259 
 
 
 
 
Prepared according to the general route from p-methoxybenzylamine (247 mg, 1.80 
mmol, 1.05 eq.). The title compound was isolated as a colourless foam which was 
used without further purification (580 mg, 1.40 mmol, 82 %). An analytically pure 
sample was obtained by column chromatography (5:1 petrol:EtOAc à 2:1); [α]20D 
+135 (c 0.98, CHCl3); νmax(solid) /cm
-1 3420, 3051, 3009, 2934, 2833, 1707, 1611, 
1510, 1441, 1246; δH (500 MHz; CDCl3) 3.19 (d, 2H, J = 12.4 Hz), 3.52 (d, 1H, J = 
12.8 Hz), 3.63 (d, 1H, J = 12.7 Hz), 3.67 (d, 2H, J = 12.4 Hz), 3.83 (s, 3H), 6.91 (d, 
2H, J= 8.7 Hz), 7.25-7.28 (m, 2H), 7.35 (d, 2H, J= 8.6 Hz), 7.45-7.49 (m, 4H), 7.54 
(d, 2H, J= 8.3 Hz), 7.96 (d, 4H, J= 8.2 Hz); δC (125 MHz; CDCl3) 55.06, 55.30, 59.07, 
113.80, 125.39, 125.73, 127.50, 127.89, 128.26, 128.31, 130.41, 131.14, 131.45, 
133.15, 133.15, 133.67, 135.12, 158.81; HRMS (CI+): calc. for C30H26NO (MH+) 
416.2009, found 416.2010  
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(S)-4-(tosyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine 264 
 
 
 
 
Prepared according to the general route using p-toluenesulfonamide (383 mg, 2.45 
mmol, 1.1 eq.). The reaction was complete within 2 hours in refluxing MeCN. After 
work-up, careful column chromatography of the crude material (20:1 petrol:EtOAc) 
gave the title compound as a colourless foam (680 mg, 1.52 mmol, 68%); [α]20D +98 
(c 1.06, CHCl3); νmax(solid) /cm
-1 3052, 2923, 2866, 1919, 1596, 1508, 1493, 1462; 
δH (500 MHz, CDCl3) δ 2.39 (s, 3H), 3.68 (d, J = 13.0 Hz, 2H), 4.75 (d, J = 13.0 Hz, 
2H), 7.22 – 7.27 (m, 4H), 7.34 – 7.38 (m, 3H), 7.47 (ddd, J = 8.1, 6.7, 1.2 Hz, 2H), 
7.71 (d, J = 8.2 Hz, 2H), 7.85 (d, J = 8.3 Hz, 2H), 7.91 (d, J = 8.1 Hz, 2H), δC (125 
MHz; CDCl3) 21.52, 49.24, 126.04, 126.13, 127.25, 127.37, 127.41, 128.34, 129.08, 
129.62, 130.99, 131.20, 133.35, 135.03, 136.77, 143.30; HRMS (CI+): calc. for 
C29H24NO2S (MH+) 450.1522, found 450.1522 
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(S)-4-trityl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine 266 
 
 
 
 
Prepared according to the general route using tritylamine (190 mg, 0.72 mmol). The 
product was isolated as a colourless foam (240 mg, 0.68 mmol,  95%); [α]20D +304 (c 
1.02, CHCl3); νmax(solid) /cm
-1 3046, 2928, 2850, 1678, 1643, 1458, 1465, 1361; 1H 
NMR (500 MHz, CDCl3) δ 3.34 (d, 2H, J = 12.5 Hz), 4.07 (d, 2H, J = 12.5 Hz), 7.00 – 
7.18 (m, 13H), 7.23 – 7.32 (m, 4H), 7.46 (d, 6H, J = 7.4 Hz), 7.59 (d, 2H, J = 8.6 Hz), 
7.72 (d, 2H, J = 8.1 Hz); δC (125 MHz; CDCl3) 50.8, 78.1, 125.2, 125.4, 126.1, 127.6, 
127.8, 128.0, 128.1, 128.2, 129.8, 131.2, 132.7, 134.7, 135.0, 144.7); HRMS (CI+): 
calc. for C41H31N (MH+) 537.2456, found 537.2452 
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(S)-4-allyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine 267 
 
 
 
 
(S)-2,2’bis(bromomethyl)-[1,1’]binaphthalene (5.0 g, 11.26 mmol, 1.0 eq.), allylamine 
(1.26 mL, 16.89 mmol, 1.5 eq.) and Et3N (4.70 mL, 33.8 mmol, 3.0 eq.) were  
dissolved in MeCN (50 mL) and stirred at 50 oC for 4 h (TLC indicated 
disappearance of starting material). The solvent was removed in vacuo, leaving a 
pale yellow solid residue. DCM and water were added and the organic phase was 
separated, washed with water (2 x 50 mL) and brine (50 mL), dried (MgSO4) then 
concentrated in vacuo to give a brown solid. This mixture was triturated with cold 
acetone resulting in the precipitation of the title compound as a colourless solid 
(3.201 g, 9.46 mmol, 84 %); m.p. 175 – 178 oC; [α]20D +361 (c 1.01, CHCl3); 
νmax(solid) /cm
-1 3048, 2935, 2801, 2363, 1593, 1507, 1461, 1367, 1335; δH (400 
MHz; CDCl3) 3.07-3.13 (m, 2H, -NCH2CH=CH2), 3.16 (d, 2H, J= 16 Hz, ArCH2N), 
3.75 (d, 2H, J= 16 Hz, ArCH2N), 5.22-5.31 (m, 2H, NCH2CH=CH2), 5.94-6.06 (m, 1H, 
-NCH2CH=CH2), 7.26-7.29 (m, 2H, 2 x CH arom.), 7.46-7.49 (m, 4H, 4 x CH arom.), 
7.55 (d, 2H, J= 12 Hz, 2 x CH arom.), 7.95 (d, 4H, J= 12 Hz, 4 x CH arom.); δC (75 
MHz; CDCl3) 54.78, 58.47, 118.04, 125.49, 125.83, 127.55, 127.55, 127.88, 128.39, 
131.50, 133.21.133.53, 135.14, 136.42. 
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(11bS)-4-amino-4-isopropyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-
ium tetraphenylborate 253234 
 
 
 
 
(S)-N-Isopropyl-2,7-dihydro-dinaphtho[2,1-c;1’,2’-e]azepine (1.0 g, 2.96 mmol) was 
dissolved in DCM (30 mL). DppONH2 (758 mg, 3.25 mmol) was added as a solid in a 
single portion and the resulting white slurry was stirred overnight at room 
temperature (TLC indicated complete consumption of the starting material). The 
mixture was filtered through a pad of Celite and concentrated in vacuo to give the 
hydrazinium diphenylphosphinate as a hygroscopic yellow foam. The crude 
compound was redissolved in a minimum amount of DCM and a saturated solution 
of sodium tetraphenylborate (1.11 g, 3.25 mmol) in MeCN was added. Copious 
precipitation of a colourless solid ensued. The title compound was isolated via 
filtration as a colourless powder (1.53g, 2.28 mmol, 77%), [α]20D +160.8 (c 0.99, 
CHCl3), m.p. 217-219 oC (decomp.); νmax (DCM) /cm-1 3326, 3255, 3054, 3000, 2984, 
1595, 1579, 1478, 1427, 1265; δH (500 MHz; CD2Cl2) 1.09 (d, 3H, J = 6 Hz), 1.24 (d, 
3H, J = 6 Hz), 2.98 (br s, 2H), 3.18 (d, 1H, J = 13 Hz), 3.30 (septet, 1H, J = 6 Hz), 
3.56 (d, 1H, J = 12 Hz), 3.72 (d, 1H, J = 12 Hz), 4.05 (d, 1H, J = 13 Hz), 6.79 (t, 4H, 
J = 7 Hz), 6.93 (t, 8H, J = 7 Hz), 7.28-7.38 (m, 9H), 7.39-7.53 (m, 5H), 7.61-7.72 (m, 
2H), 8.02-8.20 (m, 4H); δC (125 MHz; CD2Cl2) 16.6, 16.8, 65.3, 65.6, 66.5, 122.1 
(4C, para in -BPh4), 125.3, 125.9 (8C, m, meta in -BPh4), 126.2, 126.4, 127.38, 
127.41, 127.5, 127.7, 127.8, 127.9, 128.0, 128.0, 128.6, 128.8, 130.4, 130.7, 131.3, 
131.4, 134.6, 134.8, 134.8, 136.0 (8C, s, ortho in -BPh4), 136.3, 138.6, 163.9 (q, 4C, 
J = 49 Hz, ipso in -BPh4), HRMS (CI+): calc. for C25H25N2+ 353.2012, found 
353.2014. 
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(S)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine hydrochloride 261.HCl 
 
 
 
To a flame-dried 50 mL flask was added (S)-N-allyl-2,7-dihydro-dinaphtho[2,1-c;1’,2’-
e]azepine (1.00 g, 2.99 mmol, 1.0 eq.) and dry DCM (30 mL). N,N’-dimethylbarbituric 
acid (702 mg, 4.5 mmol, 1.5 eq.), Pd(OAc)2 (14 mg, 0.06 mmol, 0.02 eq.) and PPh3 
(79 mg, 0.3 mmol, 0.1 eq.) were added in that order and the resulting yellow solution 
was heated to reflux overnight. The reaction mixture was cooled to room 
temperature and filtered through Celite before being washed sequentially with 1M 
NaOH, water and brine. Concentrated HCl (0.1 mL) was added and the solvent was 
then removed in vacuo to give an amorphous solid that was redissolved in hot 
CHCl3. After 5 minutes, copious precipitation of the title compound ensued. The solid 
was filtered and isolated as a colourless powder (846 mg, 2.54 mmol, 85%); m.p. 
217 – 220 oC; [α]20D +329 (c 0.98, MeOH); νmax(solid) /cm
-1 3415, 2933, 2737, 2588, 
1677, 1592, 1507, 1446, 1364, 1336; 1H NMR (500 MHz, CD3OD) δ 3.72 (d, J = 13.0 
Hz, 2H), 4.38 (d, J = 13.1 Hz, 2H), 7.42 – 7.25 (m, 4H), 7.42 – 7.25 (m, 4H), 7.42 – 
7.25 (m, 4H), 7.66 – 7.48 (m, 2H), 7.76 (d, J = 8.4 Hz, 2H), 7.90 (s, 1H), 8.07 (d, J = 
8.3 Hz, 2H), 8.17 (d, J = 8.4 Hz, 2H); δC (125 MHz; CD3OD) 47.1, 127.9, 128.1, 
128.2, 128.3, 129.3, 129.8, 131.2, 132.6, 135.7, 135.8. 
The amine hydrochloride was easily converted to the secondary amine by 
stirring a DCM solution of the amine hydrochloride with saturated aqueous NaHCO3 
solution for 30 minutes. Separation of the organic layer, drying and removing the 
solvent in vacuo gave the secondary amine as a yellow foam in quantitative yield. 
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(S)-4-(4-methoxybenzyl)-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium 
tetraphenylborate 260 
 
 
 
 
To a stirred solution of (S)-N-(4-methoxybenzyl)-2,7-dihydro-dinaphtho[2,1-c;1’,2’-
e]azepine (3.301 g, 7.95 mmol, 1.0 eq.) in DCM (50 mL) was added N-
bromosuccinimide (1.485 g, 8.34 mmol, 1.05 eq.). The bright yellow solution was 
stirred for 1 h at room temperature and 30 minutes at reflux (TLC indicated complete 
consumption of starting material. Water (30 mL) was added and the organic layer 
was separated then washed sequentially with water (2 x 30 mL) and brine (30 mL). 
Drying (MgSO4) and concentration in vacuo yielded the crude iminium bromide as a 
yellow foam. This was dissolved in the minimum amount of EtOH before NaBPh4 
(2.852 g, 8.34 mmol, 1.05 eq.) dissolved in a minimum amount of MeCN was added 
via pipette. After stirring for 5 minutes, the solvent was removed in vacuo and the 
crude solid was triturated in hot EtOH to give the title compound as a bright yellow 
solid which was dried in vacuo at 60 oC for 12 h to remove residual EtOH (5.341 g, 
7.28 mmol, 92%); m.p. 111 – 113 oC (decomp.); [α]20D +350 (c 1.08, CHCl3); 
νmax(solid) /cm
-1 3449, 3054, 2999, 1639, 1610, 1548, 1513; 1H NMR (500 MHz, 
acetone-d6) δ 3.88 (s, 3H), 4.85 (dd, J = 13.5, 1.5 Hz, 1H), 5.27 (dd, J = 13.5, 1.5 Hz, 
1H), 5.53 (d, J = 13.8 Hz, 1H), 5.56 (d, J = 13.8 Hz, 1H), 6.79 (t, J = 7.2 Hz, 4H), 
6.94 (t, J = 7.4 Hz, 8H), 7.00 (d, J = 8.8 Hz, 2H), 7.09 (dd, J = 8.6, 0.7 Hz, 1H), 7.29-
7.35 (m, 2H), 7.35-7.42 (m, 8H), 7.47-7.56 (m, 4H), 7.59 (ddd, J = 8.1, 6.8, 1.1 Hz, 
1H), 7.84 (ddd, J = 8.1, 6.3, 1.7 Hz, 1H), 8.08 (d, J = 8.4 Hz, 2H), 8.15 (d, J = 8.6 Hz, 
1H), 8.27 (d, J = 8.3 Hz, 1H), 8.39 (d, J = 8.6 Hz, 1H), 9.75 (s, 1H); 13C NMR (125 
MHz, acetone-d6) δ 55.0, 56.1, 65.1, 114.6, 121.6, 123.1, 125.4 (q, J = 2.7 Hz), 
125.51, 126.01, 126.8, 126.9, 127.0, 127.1, 127.7, 128.7, 129.40, 129.43, 130.3, 
130.96, 131.03, 131.65, 131.71, 131.74, 133.2, 135.4, 136.25, 136.7 (d, J = 1.8 Hz), 
141.6, 161.0, 164.1 (q, J = 49.4 Hz), 168.4, 205.6; HRMS (CI+): calc. for C30H24NO 
(MH+) 414.1852, found 414.1853. 
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(3S,11cS)-3-ethynyl-4-(4-methoxybenzyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-
e]azepine 291 
 
 
 
 
In a flame dried 100 mL round-bottomed flask, the iminium salt (1.0 g, 1.36 mmol, 
1.0 eq.) was dissolved in dry THF (20 mL). The yellow solution was cooled to -78 oC 
before ethynylmagnesium bromide (27.2 mL of a 0.5 M solution in THF, 13.6 mmol, 
10 eq.) was added in three portions over 5 minutes. The orange solution was 
allowed to reach room temperature and stirred overnight. Celite and MgSO4 were 
added to the reaction mixture and water was cautiously added over 20 minutes to 
quench any excess Grignard reagent. The mixture was then filtered through a pad of 
Celite and concentrated in vacuo. The residue was redissolved in CHCl3 resulting in 
precipitation of a solid that was removed by a 2nd filtration through Celite. Column 
chromatography of the resulting residue (DCM elution) gave the title compound as a 
yellow foam (449 mg, 1.02 mmol, 75%), [α]20D +102 (c 1.21, CHCl3); νmax(solid) /cm
-1 
3289, 3053, 2933, 2835, 1776, 1682, 1602, 1510; δH (400 MHz; CDCl3) 1.25 (d, J= 
2.6 Hz, 1H), 3.28 (d, J= 12.2 Hz, 1H), 3.67 (d, J= 13.2 Hz, 1H), 3.70 (d, J= 12.3 Hz, 
1H), 3.79 (d, J= 13.1 Hz, 1H), 3.82 (s, 3H), 4.74 (d, J= 2.6 Hz, 1H), 6.91 (d, J = 8.7 
Hz, 2H), 7.23 (ddd, J = 8.1, 6.8, 1.1 Hz, 1H), 7.29 (ddd, J = 8.1, 6.8, 1.1 Hz, 1H), 
7.36-7.45 (m, 4H), 7.48-7.51 (ddd, J = 8.1, 6.8, 1.1 Hz, 1H), 7.57 (d, J= 8.2 Hz, 1H), 
7.58 (d, J= 8.5 Hz, 1H), 7.92 (d, J= 8.5 Hz, 1H), 7.94 – 7.97 (m, 3H); HRMS (CI+): 
calc. for C32H26NO (MH+) 440.2009, found 440.2008 
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General procedure for functionalization of the terminal alkyne 
 
 
 
 
The terminal alkyne (1.0 eq.) was dissolved in dry THF (20 mL per gram of alkyne) 
and cooled to -78 oC. n-BuLi (1.5 eq. of a 2.5 M solution in hexane) was then added 
causing a colour change from yellow to dark blue. After stirring at -78 oC for 1 hour, 
the required electrophile (1.5 eq.) was added in a single portion and the cooling bath 
was removed. The reaction mixture was then stirred until complete consumption of 
the starting material was seen by TLC (typically 1-2 hours). Et2O and saturated 
NH4Cl solution were added to quench the reaction. The organic phase was then 
separated and washed sequentially with water and brine. The solution was then 
dried (MgSO4) and concentrated in vacuo to give the crude compound.  
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3-((3S,11cS)-4-(4-methoxybenzyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-
e]azepin-3-yl)propiolic acid 295 
 
 
 
 
The terminal alkyne (400 mg, 0.82 mmol, 1.0 eq.) was dissolved in dry THF (12 mL) 
and cooled to -78 oC. n-BuLi (496 µL of a 2.5 M solution in hexane, 1.24 mmol, 1.5 
eq.) was then added causing a colour change from yellow to dark blue. The solution 
was allowed to reach room temperature for 1 hour. After cooling again to -78 oC, the 
cooling bath was removed and CO2 gas was bubbled through the solution for 1h. 
Et2O and saturated NH4Cl solution were added to quench the reaction. The organic 
phase was then separated and washed sequentially with water and brine. The 
solution was then dried (MgSO4) and concentrated in vacuo to give the crude 
compound. Recrystallization from hot EtOH gave the title compound as a pale brown 
powder (308 mg, 0.64 mmol, 70 %); νmax(KBr) /cm
-1 3054, 2987, 2685, 2411, 2305, 
1655, 1512, 1441, 1422, 1264; δH (400 MHz; DMSO-d6) 2.98 (d, J = 12.0 Hz, 1H), 
3.62 (d, J = 13.2 Hz, 1H), 3.68 (d, J = 13.2 Hz, 1H), 3.69 (d, J = 11.8 Hz, 1H), 3.74 
(s, 3H), 4.97 (s, 1H), 6.92 (d, J = 8.5 Hz, 2H), 7.15 – 7.28 (m, 2H), 7.32 – 7.35 (m, 
3H), 7.38 – 7.43 (m, 2H), 7.52 – 7.59 (m, 3H), 7.95 (d, J = 8.2 Hz, 1H), 8.00 (d, J = 
8.2 Hz, 1H), 8.07 (d, J = 8.2 Hz, 1H), 8.10 (d, J = 8.2 Hz, 1H), 12.28 (br s, 1H); δC 
(125 MHz; CDCl3) 54.5, 55.4, 55.5, 57.9, 114.3, 125.9, 126.4, 126.7, 126.9, 127.1, 
127.8, 128.2, 128.7, 128.9, 129.2, 129.6, 130.6, 130.7, 131.5, 131.9, 132.7, 133.4, 
133.5, 134.7, 134.8, 135.0, 158.9; HRMS (CI+): calc. for C33H24NO3 (MH+) 
482.1762, found 482.1767. 
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Ethyl 3-((3S,11cS)-4-(4-methoxybenzyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-
e]azepin-3-yl)propiolate 294 
 
 
 
 
Prepared according to the general route for functionalization of the terminal alkyne. 
The lithiated species was quenched with ethyl chloroformate (138 µL, 1.38 mmol, 1.5 
eq.) and stirred overnight. After normal work-up the crude material was purified by 
column chromatography (DCM eluent) to give the title compound as a yellow oil (392 
mg, 0.16 mmol, 69 %); [α]20D +65 (c 0.92, CHCl3); νmax(solid) /cm
-1 3051, 2981, 2957, 
2935, 2834, 2231, 1704; δH (500 MHz; CDCl3) 0.95 (t, J = 7.1 Hz, 3H), 3.30 (d, J = 
12.3 Hz, 1H), 3.62 – 3.70 (m, 2H), 3.70 (d, J = 13.7 Hz, 1H), 3.72 (d, J = 12.4 Hz, 
1H), 3.81 (d, J = 13.3 Hz, 1H), 3.82 (d, J = 12.4 Hz, 1H), 3.83 (s, 3H), 4.77 (s, 1H), 
6.91 (d, J = 8.7 Hz, 2H), 7.26 (ddd, J = 8.1, 6.7, 1.1 Hz, 1H), 7.31 (ddd, J = 8.1, 6.7, 
1.1 Hz, 1H), 7.37-7.45 (m, 5H), 7.51 (ddd, J = 8.1, 6.7, 1.1 Hz, 1H), 7.61 (t, J = 8.3 
Hz, 2H), 7.61 (t, J = 8.8 Hz, 2H), 7.91 (d, J = 7.6 Hz, 1H), 7.96 (d, J = 8.3 Hz, 2H), 
7.96 (d, J = 8.2 Hz, 1H); δC (125 MHz; CDCl3) 13.79, 54.98, 55.31, 55.36, 57.82, 
60.97, 75.03, 77.60, 86.37, 113.97, 125.44, 125.93, 126.14, 127.13, 127.32, 127.55, 
127.79, 128.12, 128.25, 128.70, 129.35, 130.29, 130.39, 131.76, 132.15, 132.39, 
133.43, 133.59, 134.57, 135.20, 135.33, 152.80, 159.01; HRMS (CI+): calc. for 
C35H30NO3 (MH+) 512.2220, found 512.2217. 
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(S)-4-allyl-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium tetraphenylborate 268  
 
 
 
To a solution of 4-allyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine (1.77 g, 5.28 
mmol, 1.0 eq.) in DCM (200 mL) was added solid NBS (1.034 g, 5.81 mmol, 1.1 eq.)  
portionwise over 5 minutes so as not to increase the reaction temperature. After 2 h 
at room temperature (TLC indicated complete consumption of starting material) 
water (100 mL) was added. The organic phase was separated and washed with 
water (2 x 50 mL) and brine (50 mL) then dried (MgSO4) and concentrated in vacuo 
to give the title compound as a bright yellow foam (2.051 g, 4.95 mmol, 94%); 
νmax(solid) /cm
-1 3404, 3053, 2955, 2734, 2544, 2406, 1932, 1708, 1687, 1650, 1614, 
1595, δH (500 MHz; CDCl3) 4.55 (dd, 1H, J = 13.2, 1.3 Hz, ArCH2N), 4.96 (dd, 1H, J 
= 13.3, 0.7 Hz), 5.22 (dd, 1H, J = 14.2, 7.4 Hz), 5.35 (dd, 1H, J = 14.3, 5.3 Hz), 5.59 
(d, 1H, J = 10.4 Hz), 5.70 (d, 1H, J = 16.4 Hz), 5.90 – 5.93 (m, 1H), 7.06 (d, 1H, J = 
10.0 Hz), 7.26 (ddd, 1H, J = 8.4, 6.8, 1.3 Hz), 7.37 (ddd, 1H, J = 8.5, 6.8, 1.3 Hz), 
7.50 (d, 1H, J = 9.2 Hz), 7.53 (ddd, 1H, J = 8.0, 6.8, 1.0 Hz), 7.58 (d, 1H, J = 8.4 Hz), 
7.71 (ddd, 1H, J = 8.1, 6.8, 1.1 Hz), 7.96 (d, 1H, J = 8.2 Hz), 8.06 (d, 1H, J = 8.4 Hz), 
8.10 (d, 1H, J = 8.4 Hz), 8.16 (d, 1H, J = 8.5 Hz), 8.52 (d, 1H, J = 8.6 Hz), 10.90 (s, 
1H),  
The iminium bromide could be easily converted to the iminium tetraphenylborate by 
addition of a solution of sodium tetraphenylborate (1.1 eq.) in a minimum amount of 
acetonitrile to a stirred DCM solution of the iminium bromide. After 5 minutes, the 
reaction mixture was concentrated in vacuo and redissolved in chloroform. Insoluble 
impurities were removed by filtration through Celite. The filtrate was concentrated in 
vacuo, redissolved in acetone and once more filtered through Celite to remove 
residual sodium tetraphenylborate. The clear filtrate was concentrated in vacuo a 
final time and dried under high vacuum for several hours giving the title compound 
as a yellow foam (2.413 g, 3.696 mmol, 70 %).  
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δH (500 MHz; acetone-d6) 4.87 (d, 1H, J = 13.5 Hz), 5.02 (d, 2H, J = 6.2 Hz), 5.29 (d, 
1H, J = 13.5 Hz), 5.63 (d, 1H, J = 10.1 Hz), 5.76 (d, 1H, J = 17.1 Hz), 6.03 – 6.09 (m, 
1H), 6.74 (t, 4H, J = 7.2 Hz), 6.91 (t, 8H, J = 7.4 Hz), 7.08 (d, 1H, J = 8.7 Hz), 7.30 
(ddd, 1H, J = 8.3, 6.8, 1.3 Hz), 7.31 (m, 8H), 7.50 (ddd, 1H, J = 7.9, 6.6, 1.0 Hz), 
7.55 (d, 1H, J = 8.4 Hz), 7.58 (ddd, 1H, J = 8.0, 6.9, 1.1 Hz), 7.82 (ddd, 1H, J = 8.1, 
6.7, 1.2 Hz), 7.88 (d, 1H, J = 8.4 Hz), 8.07 (d, 1H, J = 8.8 Hz), 8.10 (d, 1H, J = 8.2 
Hz), 8.24 (d, 1H, J = 8.2 Hz), 8.27 (d, 1H, J = 8.5 Hz), 8.36 (d, 1H, J = 8.6 Hz), 9.47 
(s, 1H). 
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tert-butyl 2-((3S,11cS)-4-allyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-
yl)acetate 312 
 
 
 
Zn powder (276 mg, 4.32 mmol, 6.0 eq.) was suspended in dry THF (20 mL) in a 
flame-dried 100 mL 3-necked round-bottomed flask. 1,2-Dibromoethane (60 µL, 0.72 
mmol, 1.0 eq.) and chlorotrimethylsilane (91 µL, 0.72 mmol, 1.0 eq.) were then 
added and the reaction mixture was heated to reflux for 1 h. Whilst maintaining 
reflux, t-butyl bromoacetate (529 µL, 3.60 mmol, 5.0 eq.) was then added in portions 
over 5 minutes. Reflux was maintained for a further hour, giving rise to a pale yellow 
solution. In a separate dry flask, (S)-4-allyl-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium 
tetraphenylborate (0.72 mmol) was suspended in dry toluene (20 mL) and cooled to -
78 oC. The Reformatsky reagent was cooled to room temperature and then added to 
the iminium salt solution in a single portion via syringe. The mixture was allowed to 
reach room temperature and stirred overnight before being quenched with water. 
DCM (50 mL) was added. The organic phase was separated and washed with water 
(2 x 50 mL) and brine (50 mL) then dried (MgSO4) and concentrated in vacuo to give 
a pale yellow oil. Column chromatography (9:1 petrol : EtOAc) yielded the title 
compound as a colourless foam (183 mg, 0.41 mmol, 57%); [α]20D +188 (c 0.85, 
CHCl3); νmax(solid) /cm
-1 3051, 3005, 2977, 2933, 2807, 1724; δH (500 MHz; CDCl3) 
1.16 (s, 9H, tBu), 1.51 (dd, 1H, J = 15.1, 7.1 Hz), 1.73 (dd, 1H, J = 15.1, 7.1 Hz), 
3.09 (d, 1H, J = 11 Hz), 3.24 – 3.33 (m, 2H), 3.71 (d, 1H, J = 11 Hz), 4.42 (t, 1H, J = 
8.0 Hz), 5.19 (dd, 1H, J = 10.0, 1.5 Hz), 5.25 (dd, 1H, J = 10.0, 1.5 Hz), 5.93 – 5.99 
(m, 1H), 7.24 – 7.27 (m, 2H), 7.37 (d, 1H, J = 8.5 Hz), 7.43 – 7.48 (m, 4H), 7.63 (d, 
1H, J = 8.5 Hz), 7.93 – 7.97 (m, 4H); δC (125 MHz; CDCl3) 28.0, 42.6, 56.1, 61.4, 
64.11, 79.8, 117.8, 125.5, 125.6, 125.7, 125.8, 127.4, 127.6, 128.0, 128.1, 128.2, 
128.3, 129.0, 129.9, 131.8, 131.9, 133.0, 133.2, 133.5, 135.1, 135.2, 135.4, 136.2, 
171.3; HRMS (CI+): calc. for C31H31NO2 (MH+) 450.2428, found 450.2424. 
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tert-butyl 2-((3S,11cS)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-
yl)acetate 313 
 
 
 
tert-Butyl 2-((3S,11cS)-4-allyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-
yl)acetate (178 mg, 0.40 mmol, 1.0 eq.) and N,N’-dimethylbarbituric acid (187 mg, 
1.2 mmol, 3.0 eq.) were dissolved in dry DCM (10 mL) and stirred under N2. 
Pd(PPh3)4 (9.2 mg, 0.008 mmol, 0.02 eq.) was added as a solid and the resulting 
orange mixture was stirred at 35 oC for 16 h. Further Pd(PPh3)4 (9.2 mg, 0.008 
mmol, 0.02 eq.) was added and the reaction was heated for a further 1 h (50 oC 
external temperature). TLC indicated complete consumption of starting material at 
this point. The reaction mixture was extracted with saturated NaHCO3 solution (3 x 
10 mL) and the combined aqueous phases were re-extracted with DCM (3 x 10 mL). 
The combined organic phases were washed with brine (50 mL), dried (MgSO4), 
filtered and concentrated in vacuo to give a yellow oil. Column chromatography 
(EtOAc eluent) removed a strongly coloured impurity and yielded the title compound 
as a pale brown foam (154 mg, 0.38 mmol, 95%); [α]20D +299 (c 1.27, CHCl3); 
νmax(solid) /cm
-1 3337, 3050, 3004, 2977, 2930, 1912, 1720; δH (500 MHz; CDCl3) 
1.18 (s, 9H), 1.73 (qd, 2H, J = 15.8, 7.6 Hz), 2.35 (br s, 1H), 3.71 (d, 1H, J = 12.1 
Hz), 3,79 (d, 1H, J = 12.1 Hz), 4.62 (t, 1H, J = 7.6 Hz), 7.23 (ddd, 1H, J = 8.0, 6.7, 
1.3 Hz), 7.24 – 7.26 (m, 1H), 7.34 (d, 1H, J = 8.2 Hz), 7.40 (d, 1H, J = 8.4 Hz), 7.44 – 
7.48 (m, 2H), 7.52 (d, J = 8.4 Hz), 7.58 (d, J = 8.2 Hz), 7.94 (t, 3H, J = 7.2 Hz), 7.97 
(d, 1H, J = 8.3 Hz); δC (125 MHz; CDCl3) 28.0, 43.0, 48.8, 59.1, 80.2, 125.5, 125.6, 
125.7, 125.9, 127.0, 127.4, 127.5, 128.1, 128.3, 128.8, 129.1, 129.3, 132.1, 133.1, 
133.2, 133.8, 135.0, 136.7, 137.4, 171.4; HRMS (CI+): calc. for C28H27NO2 (MH+) 
410.2115, found 410.2114. 
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2-((3S,11cS)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl)acetic acid 311 
 
 
 
tert-Butyl 2-((3S,11cS)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl)acetate 
(150 mg, 0.37 mmol, 1.0 eq.) was dissolved in DCM (10 mL) and stirred under N2 
atmosphere. Et3SiH (177 µL, 1.11 mmol, 3.0 eq.) and TFA (1 mL) were added via 
syringe and the clear solution was stirred overnight. The mixture was filtered through 
Celite and concentrated in vacuo. The reaction mixture was azeotroped with CHCl3 
(3 x 10 mL) and toluene (3 x 10 mL) to remove volatile impurities. The colourless oil 
was dissolved in a minimum amount of DCM and petrol was added resulting in 
precipitation of the title compound as a colourless solid. Repetition of this step 
resulted in a second crop of similar purity (total 108 mg, 0.31 mmol, 83%); m.p. 228 
– 230 °C (dec.); [α]20D +211 (c 0.91, CHCl3); νmax(solid) /cm
-1 3399, 3053, 2961, 
2628, 1596; δH (500 MHz; CDCl3) 1.63 (dd, 1H, J = 16.7, 12.5 Hz), 2.10 (dd, 1H, J = 
16.8, 2.7 Hz), 3.85 (d, 1H, J = 12.9 Hz), 4.28 (d, 1H, J = 12.9 Hz), 5.33 (d, 1H, J = 
11.4 Hz), 7.22 (ddd, 1H, J = 8.0, 6.7, 1.0 Hz), 7.26 – 7.33 (m, 3H), 7.40 (d, 1H, J = 
8.4 Hz), 7.46 (ddd, 1H, J = 7.7, 6.6, 0.8 Hz), 7.53 (t, 1H, J = 7.4 Hz), 7.72 (d, 1H, J = 
8.3 Hz), 7.79 (d, 1H, J = 8.4 Hz), 7.90 (d, 1H, J = 8.3 Hz), 7.95 (d, 1H, J = 8.3 Hz), 
8.02 (d, 1H, J = 8.2 Hz); δC (125 MHz; DMSO-d6) 38.2, 46.8, 57.1, 126.5, 126.6, 
126.8, 126.88, 126.91, 128.0, 128.8, 129.1, 129.3, 129.6, 129.7, 131.7, 131.8, 133.2, 
133.3, 133.4, 134.3, 135.2, 136.5, 173.1; HRMS (CI+): calc. for C24H20NO2 (MH+) 
354.1489, found 354.1487. 
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(3S,11cS)-4-allyl-3-ethynyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine 284 
 
 
 
A stirred solution of (S)-4-allyl-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium 
tetraphenylborate (1.00 g, 2.41 mmol, 1.0 eq.) in dry THF (20 mL) was cooled to -78 
oC. Ethynylmagnesium bromide (0.5 M in THF, 48.2 mL, 24.1 mmol, 10 eq.) was 
then added over 10 minutes. The cooling bath was removed and the reaction was 
stirred at room temperature overnight. Saturated aqueous NH4Cl solution was 
added. The quenched reaction mixture was extracted repeatedly with DCM. The 
combined organic phases were combined, washed with brine, dried (MgSO4), 
filtered and concentrated in vacuo to give the crude product as a brown foam. 
Column chromatography of the residue (6:1 petrol:EtOAc) yielded the title compound 
as a yellow foam (648 mg, 1.81 mmol, 75%); [α]20D +252 (c 0.98, CHCl3); νmax(solid) 
/cm-1 3297, 3050, 2962, 2932, 2875, 2816, 2303, 2114, 1910, 1843, 1675; δH (500 
MHz; CDCl3) 1.27 (d, 1H, J = 2.6 Hz), 3.18 (d, 1H, J = 12.0 Hz), 3.20 (dd, 1H, J = 
14.0, 7.2 Hz), 3.31 (dd, 1H, J = 14.0, 7.2 Hz), 3.76 (d, 1H, J = 12.0 Hz), 4.86 (d, 1H, 
J = 2.5 Hz), 5.27 (d, 1H, J = 10.2 Hz), 5.35 (dd, 1H, J = 16.5, 0.7 Hz), 6.00 – 6.08 
(m, 1H), 7.25 (ddd, 1H, J = 8.2, 6.6, 1.4 Hz), 7.30 (ddd, 1H, J = 8.3, 6.8, 1.3 Hz), 
7.41 – 7.45 (m, 3H), 7.50 (ddd, 1H, J = 8.0, 6.8, 1.1 Hz), 7.58 (d, 1H, J = 8.6 Hz), 
7.59 (d, 1H, J = 8.3 Hz), 7.92 (d, 1H, J = 8.2 Hz), 7.96 (t, 2H, J = 7.9 Hz), 7.97 (d, 
1H, J = 8.3 Hz); δC (125 MHz; CDCl3) 55.0, 55.4, 58.1, 70.5, 81.9, 118.8, 125.3, 
125.8, 125.98, 126.02, 127.4, 127.47, 127.53, 127.8, 128.2, 128.2, 128.6, 128.8, 
131.8, 132.3, 132.7, 133.29, 133.33, 134.6, 134.8, 135.7, 135.9; HRMS (CI+): calc. 
for C27H22N (MH+) 360.1747, found 360.1750. 
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(3R,11cS)-4-allyl-3-(1-benzyl-1H-1,2,3-triazol-4-yl)-4,5-dihydro-3H-
dinaphtho[2,1-c:1',2'-e]azepine 336 
 
 
 
 
(3S,11cS)-4-allyl-3-ethynyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine (860 mg, 
1.96 mmol, 1.0 eq.) and benzyl azide (384 mg, 2.35 mmol, 1.2 eq.) were dissolved in 
THF (10 mL). With stirring, a solution of sodium ascorbate (40 mg, 0.4 mmol, 0.2 
eq.) in distilled water (5 mL) was added followed by a solution of CuSO4.5H2O (50 
mg, 0.2 mmol, 0.1 eq.) in distilled water (5 mL). The reaction mixture was warmed to 
50 oC and stirred for 3 h (TLC showed complete consumption of starting material). 
DCM (50 mL) was added and 1M NH4OH (10 mL) was added to destroy any 
residual Cu complexes present in the reaction mixture. The yellow organic phase 
was separated, washed with water and brine, dried (MgSO4), filtered and 
concentrated in vacuo. The crude product was purified by column chromatography 
(2:1:0.02 petrol:EtOAc:Et3N) which gave the title compound as a colourless foam 
(782 mg, 1.59 mmol, 81%); [α]20D +84 (c 1.06, CHCl3); νmax(KBr) /cm
-1 3152, 3050, 
2935, 2810, 1771, 1720, 1668; δH (500 MHz; CDCl3) 3.13 (d, 1H, J = 10.9 Hz), 3.24 
(dd, 1H, J = 13.9, 7.7 Hz), 3.37 (dd, 1H, J = 13.9, 5.1 Hz), 3.76 (d, 1H, J = 10.9 Hz), 
4.66 (d, 2H, J = 2.5 Hz), 5.21 (d, 1H, J = 9.7 Hz), 5.28 (s, 1H), 5.34 (dq, 1H, J = 17.1, 
1.5 Hz), 5.94 – 6.02 (m, 1H), 6.19 (s, 1H), 6.78 – 6.80 (m, 2H), 7.14 – 7.17 (m, 1H), 
7.20 – 7.24 (m, 2H), 7.28 – 7.32 (m, 3H), 7.35 – 7.39 (m, 2H), 7.44 (d, 1H, J = 8.3 
Hz), 7.46 (ddd, 1H, J = 8.0, 6.7, 1.1 Hz), 7.60 (d, 1H, J = 8.3 Hz), 7.65 (d, 1H, J = 8.3 
Hz), 7.74 (d, 1H, J = 8.2 Hz), 7.97 (d, 1H, J = 8.2 Hz), 8.03 (d, 1H, J = 8.2 Hz), δC 
(125 MHz; CDCl3) 53.1, 56.5, 60.1, 62.2, 118.3, 120.1, 125.5, 125.7, 125.78, 125.80, 
127.1, 127.46, 127.48, 127.6, 128.17, 128.23, 128.3, 128.7, 128.8, 129.2, 131.4, 
132.0, 132.5, 133.3, 134.0, 134.3, 134.7, 134.9, 135.8, 136.1, 152.2; HRMS (CI+): 
calc. for C34H29N4 (MH+) 493.2387, found 493.2374 
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(3R,11cS)-3-(1-benzyl-1H-1,2,3-triazol-4-yl)-4,5-dihydro-3H-dinaphtho[2,1-
c:1',2'-e]azepine 337 
 
 
 
 
(3R,11cS)-4-allyl-3-(1-benzyl-1H-1,2,3-triazol-4-yl)-4,5-dihydro-3H-dinaphtho[2,1-
c:1',2'-e]azepine (665 mg, 1.35 mmol, 1.0 eq) was dissolved in dry DCM (10 mL) and 
stirred under N2. NDMBA (631 mg, 4.05 mmol, 3.0 eq.) and Pd(PPh3)4 (31 mg, 0.027 
mmol, 0.02 eq.) were then added sequentially. The resulting orange solution was 
heated to reflux for 3 h (TLC indicated complete consumption of starting material). 
The reaction mixture was cooled then washed with 1M NaOH, water and brine 
before being dried (MgSO4), filtered and concentrated in vacuo to give an orange oil. 
Column chromatography of the crude product (EtOAc) yielded the title compound as 
a colourless foam (579 mg, 1.28 mmol, 95%); δH (500 MHz; CDCl3) 2.74 (br s, 1H, 
NH), 3.74 (d, 1H, J = 12.6 Hz, Ar-CH2-N), 3.87 (d, 1H, J = 12.6 Hz, Ar-CH2-N), 4.39 
(d, 1H, J = 14.7 Hz, N-CH2-Ph), 4.70 (d, 1H, J = 14.7 Hz, N-CH2-Ph), 5.47 (s, 1H, Ar-
CH-triazole), 6.06 (s, 1H (triazole CH), 6.76 (dd, 2H, J = 1.4, 7.9 Hz, ArH), 7.15 (d, 
1H, J = 8.0 Hz, ArH), 7.18 (dd, 1H, J = 1.2, 6.5 Hz, ArH), 7.20 – 7.25 (m, 4H, ArH), 
7.36 (d, 1H, J = 8.5 Hz, ArH), 7.38 (ddd, 1H, J = 1.4, 6.4, 8.0 Hz, ArH), 7.46 (d, 1H, J 
= 8.4 Hz, ArH), 7.47 (ddd, 1H, J = 1.1, 6.7, 8.0 Hz, ArH), 7.70 (d, 1H, J = 8.3 Hz, 
ArH), 7.74 (d, 1H, J = 8.3 Hz, ArH), 7.80 (d, 1H, J = 8.2 Hz, ArH), 7.96 (d, 1H, J = 8.2 
Hz, ArH), 8.02 (d, 1H, J = 8.2 Hz, ArH); δC (125 MHz; CDCl3) 48.6, 53.1, 57.7, 119.1, 
125.2, 125.8, 125.9, 126.9, 127.1, 128.1, 128.2, 128.4, 128.6, 128.8, 129.2, 131.5, 
132.1, 133.4, 134.1, 134.6, 134.8, 136.7, 136.8, 136.9, 151.8; HRMS (CI+): calc. for 
C31H25N4 (MH+) 453.2074, found 453.2081. 
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Palladium Complex 342 
 
 
 
 
(3R,11cS)-3-(1-benzyl-1H-1,2,3-triazol-4-yl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-
e]azepine (250 mg, 0.55 mmol, 1.0 eq.) was dissolved in dry DCM (5 mL) and stirred 
under nitrogen. Dichloro(1,5-cyclooctadiene)palladium(II) (158 mg, 0.55 mmol, 1.0 
eq.) was then added as a solid in a single portion and the resulting solution was 
stirred at room temperature for 1 hour. Most of the DCM was removed in vacuo, 
petroleum ether was added and the title compound precipitated as a pale yellow 
powder (242 mg, 0.385 mmol, 70%); δH (500 MHz; CDCl3) 3.56 (dd, 1H, J = 12.7, 4.1 
Hz), 4.12 (d, 1H, J = 14.7 Hz), 4.64 (d, 1H, J = 12.4 Hz), 4.96 (d, 1H, J = 14.7 Hz), 
6.13 (d, 1H, J = 0.8 Hz), 6.69 – 6.71 (m, 2H), 6.85 (d, 1H, J = 6.5 Hz), 7.17 (d, 1H, J 
= 8.8 Hz), 7.19 – 7.22 (m, 2H), 7.25 – 7.29 (m, 2H), 7.37 (d, 1H, J = 9.2 Hz), 7.49 – 
7.54 (m, 2H), 7.60 (br t, 1H, J = 4.9 Hz), 7.89 (d, 1H, J = 8.1 Hz), 7.97 (d, 1H, J = 8.2 
Hz), 8.06 (d, 2H, J = 8.3 Hz), 8.15 (d, 1H, J = 8.5 Hz), 8.58 (d, 1H, J = 8.3 Hz). 
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(S)-3,5-dihydrodinaphtho[2,1-c:1',2'-e]oxepine 269233  
 
 
 
(S)-2,2’-Bis(bromomethyl)-1,1’-binaphthalene (2.20 g, 5.0 mmol, 1.0 eq.) was 
dissolved in 1,4-dioxane (60 mL) and saturated Na2CO3 solution (60 mL) was added. 
The mixture was heated to reflux for 24 hours (TLC indicated consumption of starting 
material). The reaction mixture was extracted with diethyl ether (3 x 50 mL) and the 
combined organic extracts were washed with brine (50 mL) then dried (MgSO4), 
filtered and concentrated in vacuo to give a yellow oil. Column chromatography (50:1 
petrol:EtOAc) yielded the title compound as a colourless solid (947 mg, 3.2 mmol, 
64%); m.p 184-186 oC (lit. 184-186 oC173); [α]20D +571 (c 1.00, CHCl3) (lit. +571 (c 
1.00, CHCl3173); νmax(solid) /cm
-1 3049, 2959, 2923, 1594, 1507, 1463, 1367, 1237, 
1195, 1057, 909, 828; δH (500 MHz; CDCl3) 4.20 (d, 2H, J = 11.3 Hz, ArCH2O), 4.64 
(d, 2H, J = 11.3 Hz, ArCH2O), 7.29 (t, 2H, J = 7.7 Hz, ArH), 7.50 (t, 2H, J = 7.5 Hz, 
ArH), 7.53 (d, 2H, J = 8.6 Hz, ArH), 7.62 (d, 2H, J = 8.2 Hz, ArH), 7.97 (d, 2H, J = 8.2 
Hz, ArH), 8.00 (d, 2H, J = 8.2 Hz, ArH); δC (125 MHz; CDCl3) 67.5, 125.95, 125.98, 
127.4, 127.6, 128.4, 129.2, 131.2, 133.56, 133.64, 135.5. 
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(S)-2'-(bromomethyl)-[1,1'-binaphthalene]-2-carbaldehyde 270233 
 
 
 
(S)-3,5-dihydrodinaphtho[2,1-c:1',2'-e]oxepine (800 mg, 2.70 mmol, 1.0 eq.) was 
dissolved in warm cyclohexane (30 mL). Bromine (1.1 eq.) dissolved in cyclohexane 
(10 mL) was then added slowly. The reaction mixture was heated to reflux until the 
colour of the bromine had dissipated (approximately 1 h). The solvent was removed 
in vacuo and the residue was redissolved in diethyl ether (20 mL) which was 
subsequently washed with saturated aqueous sodium bicarbonate, water and brine. 
The combined organic phases were dried (MgSO4), filtered and concentrated in 
vacuo to give the crude product as a yellow oil. Column chromatography (99:1 
petrol:EtOAc) yielded the title compound as a colourless solid (531 mg, 1.42 mmol, 
53%); m.p 152-154 oC (lit. 150-152 oC173) ; [α]20D -143 (c 1.00, CHCl3) (lit. -143 (c 
1.00, CHCl3173); νmax(solid) /cm
-1 3057, 2845, 2357, 1688, 1616, 1593, 1509, 1429, 
1324, 1240, 1223, 1027, 909, 870, 821, 750, 730; δH (500 MHz; CDCl3) 4.09 (dd, 1H, 
J = 10.1, 1.0 Hz), 4.34 (dd, 1H, J = 10.1, 1.0 Hz), 7.02 (d, 1H, J = 8.5 Hz, ArH), 7.24 
(d, 1H, J = 8.5 Hz, ArH), 7.29 (ddt, 1H, J = 8.2, 6.8, 1.3 Hz, ArH), 7.35 (ddt, 1H, J = 
8.2, 6.8, 1.3 Hz, ArH), 7.51 (ddt, 1H, J = 8.2, 6.8, 1.3 Hz, ArH), 7.63 (ddt, 1H, J = 8.2, 
6.8, 1.3 Hz, ArH), 7.73 (dd, 1H, J = 8.5, 1.0 Hz, ArH), 7.95 (d, 1H, J = 1H, J = 8.2 Hz, 
ArH), 7.99 (d, 1H, J = 8.6 Hz, ArH), 8.05 (d, 1H, J = 8.6 Hz, ArH), 8.09 (d, 1H, J = 8.7 
Hz, ArH), 8.22 (dd, 1H, J = 8.7, 1.2 Hz, ArH), 9.56 (s, 1H, ArCHO), δC (125 MHz; 
CDCl3) 32.0, 122.4, 126.6, 127.0, 127.1, 127.42, 127.43, 127.44, 128.2, 128.5, 
129.3, 129.4, 129.9, 132.40, 132.42, 132.5, 133.0, 133.6, 134.6, 134.6, 134.6, 136.3, 
141.7, 191.9. 
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rac-6-allyl-5-(phenylethynyl)-6,7-dihydro-5H-dibenzo[c,e]azepine 304 
 
 
 
 
To a stirred solution of 6-allyl-5H-dibenzo[c,e]azepin-6-ium tetraphenylborate (250 
mg, 0.45 mmol, 1.0 eq.) in MeCN (10 mL) was added CuI (8.5 mg, 0.045 mmol, 0.1 
eq.), phenylacetylene (148 µL, 1.35 mmol, 3.0 eq.) and Hünig’s base (126 µL, 0.675 
mmol, 1.5 eq.). The cloudy yellow reaction mixture was stirred for 16 h at room 
temperature (TLC indicated consumption of starting material). The MeCN was 
removed in vacuo and the resulting residue was partitioned between DCM and 
water. The organic phase was separated then washed sequentially with water and 
brine before being dried (MgSO4), filtered and concentrated in vacuo to give the 
crude product as an orange oil. Column chromatography (25:1 petrol:EtOAc) yielded 
the title compound as a pale yellow oil (120 mg, 0.36 mmol, 80%); νmax(KBr) /cm
-1 
3054, 2986, 2685, 2410, 2305, 1598, 1442, 1421, 1265; δH (500 MHz; CDCl3) 3.35 
(d, 1H, J = 13.0 Hz), 3.41 (dd, 1H, J = 13.4, 7.7 Hz), 3.61 (dd, 1H, J = 13.3, 5.7 Hz), 
3.71 (d, 1H, J = 13.0 Hz), 4.40 (s, 1H), 5.28 (d, 1H, J = 10.2 Hz), 5.35 (dd, 1H, J = 
17.0, 1.4 Hz), 6.04 – 6.12 (m, 1H), 7.28-7.29 (m, 3H), 7.33 (d, 1H, J = 7.4 Hz), 7.37-
7.42 (m, 3H), 7.44-7.49 (m, 4H), 7.55 (dd, 1H, J = 7.4, 1.1 Hz), 7.93 (d, 1H, J = 7.0 
Hz); δC (125 MHz; CDCl3) 52.6, 56.0, 56.3, 87.7, 118.4, 123.0, 127.6, 127.9, 128.0, 
128.17, 128.19, 128.3, 128.5, 128.6, 129.6, 129.8, 131.8, 133.4, 134.6, 136.4, 140.4, 
140.7; HRMS (CI+): calc. for C25H22N (MH+) 336.1747, found 336.1749. 
 147 
N
BPh4
N
CO2Me
rac-Methyl 3-(6-allyl-6,7-dihydro-5H-dibenzo[c,e]azepin-5-yl)propiolate 
 
 
 
 
To a stirred solution of 6-allyl-5H-dibenzo[c,e]azepin-6-ium tetraphenylborate (250 
mg, 0.45 mmol, 1.0 eq.) in MeCN (10 mL) was added CuI (8.5 mg, 0.045 mmol, 0.1 
eq.), methyl propiolate (48 µL, 0.54 mmol, 1.2 eq.) and Hünig’s base (126 µL, 0.675 
mmol, 1.5 eq.). The orange reaction mixture was stirred for 16 h at room temperature 
(TLC indicated consumption of starting material). The MeCN was removed in vacuo 
and the resulting residue was partitioned between DCM and water. The organic 
phase was separated then washed sequentially with water and brine before being 
dried (MgSO4), filtered and concentrated in vacuo to give the crude product as an 
orange oil. Column chromatography (25:1 petrol:EtOAc à 15:1) yielded the title 
compound as a pale yellow oil (112 mg, 0.353 mmol, 79%); νmax(KBr) /cm
-1 3054, 
2986, 2955, 2305, 2239, 1714, 1451, 1435, 1435, 1265; δH (500 MHz; CDCl3) 3.30 
(dd, 1H, J = 13.3, 6.0 Hz), 3.34 (d, 1H, J = 13.0 Hz), 3.46 (dd, 1H, J = 13.5, 5.8 Hz), 
3.60 (d, 1H, J = 13.7 Hz), 3.72 (s, 3H), 4.33 (s, 1H), 5.28 (dd, 1H, J = 9.9, 1.4 Hz), 
5.35 (dq, 1H, J = 17.1, 1.7 Hz), 5.96-6.04 (m, 1H), 7.30 (d, 1H, J = 7.4 Hz), 7.39 (dt, 
1H, J = 7.4, 1.5 Hz), 7.42 – 7.48 (m, 4H), 7.50 (dt, 1H, J = 8.1, 1.3 Hz), 7.70 (d, 1H, J 
= 8.0 Hz); δC (125 MHz; CDCl3) 52.6, 52.7, 55.8, 56.2, 86.5, 118.7, 127.7, 128.0, 
128.17, 128.21, 128.49, 128.53, 129.0, 129.8, 132.8, 133.3, 135.8, 140.3, 153.8; 
HRMS (CI+): calc. for C21H20NO2 (MH+) 318.1489, found 318.1491.  
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rac-5-(phenylethynyl)-6,7-dihydro-5H-dibenzo[c,e]azepine 305 
 
 
 
To a stirred solution of rac-6-allyl-5-(phenylethynyl)-6,7-dihydro-5H-
dibenzo[c,e]azepine (100 mg, 0.30 mmol, 1.0 eq.) in dry DCM (10 mL) was added 
NDMBA (140 mg, 0.90 mmol, 3.0 eq.) and Pd(PPh3)4 (7 mg, 0.006 mmol, 0.02 eq.). 
The orange reaction mixture was heated to reflux for 2 hours (TLC indicated 
complete consumption of starting material). The reaction mixture was transferred to 
a separatory funnel and exctracted sequentially with 1M NaOH, water, and brine. 
The organic phase was dried (MgSO4), filtered and concentrated in vacuo to give the 
crude product as a dark orange oil. Column chromatography (3:1 petrol:EtOAc à 
1:1) yielded the title compound as an orange oil (72 mg, 0.244 mmol, 81%); δH (500 
MHz; CDCl3) 3.50 (br s, 1H), 3.57 (d, 1H, J = 12.7 Hz), 3.80 (d, 1H, J = 12.7 Hz), 
4.77 (s, 1H), 7.29-7.31 (m, 3H), 7.38-7.42 (m, 4H), 7.45-7.51 (m, 5H), 7.92-7.94 (m, 
1H); HRMS (CI+): calc. for C22H16N (MH+) 296.1434, found 296.1436 
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(3S,11cS)-4-allyl-3-(phenylethynyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-
e]azepine 287 
 
 
 
 
To a stirred solution of (S)-4-allyl-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium 
tetraphenylborate (1.0 g, 1.53 mmol, 1.0 eq.) in MeCN (20 mL) was added CuI (29 
mg, 0.15 mmol, 0.1 eq.), phenylacetylene (503 µL, 4.59 mmol, 3.0 eq.) and Hünig’s 
base (860 µL, 4.59 mmol, 3.0 eq.). The cloudy reaction mixture was stirred overnight 
at room temperature (TLC indicated complete consumption of starting material). The 
reaction was concentrated in vacuo and the residue was dissolved in DCM. The 
organic phase was washed sequentially with water and brine before being dried 
(MgSO4), filtered and concentrated in vacuo to give the crude product as an orange 
oil. Column chromatography (8:1 petrol:EtOAc) gave the title compound as a pale 
brown foam (492 mg, 1.13 mmol, 74%); [α]20D +126 (c 1.11, CHCl3); νmax(solid) /cm
-1 
3055, 3010, 2927, 1686, 1594; ; δH (500 MHz; CDCl3) 3.26 (dd, 1H, J = 13.5, 7.8 
Hz), 3.27 (d, 1H, J = 12.0 Hz), 3.39 (ddt, 1H, J = 13.4, 5.5, 1.4 Hz), 3.80 (d, 1H, J = 
12.0 Hz), 5.09 (s, 1H), 5.30 (d, 1H, J = 9.8 Hz), 5.38 (dq, 1H, J = 17.1, 1.5 Hz), 6.03 
– 6.05 (m, 2H), 6.06 – 6.14 (m, 1H), 6.83 – 6.86 (m, 2H), 6.97 (ddt, 1H, J = 8.7, 7.0, 
1.3 Hz), 7.27 (ddd, 1H, J = 8.2, 6.8, 1.3 Hz), 7.45 (ddd, 1H, J = 8.3, 6.8, 1.3 Hz), 7.48 
– 7.52 (m, 3H), 7.61 (d, 1H, J = 8.3 Hz), 7.62 (d, 1H, J = 8.5 Hz), 7.89 (d, 2H, J = 8.2 
Hz), 7.98 (t, 2H, J = 8.0 Hz); δC (125 MHz; CDCl3) 55.1, 56.3, 58.1, 83.2, 118.8, 
122.8, 125.4, 125.9, 125.93, 126.0, 127.0, 127.5, 127.6, 127.7, 127.9, 128.3, 128.4, 
128.7, 128.9, 129.6, 131.3, 131.9, 132.4, 133.3, 133.6, 133.7, 134.6, 134.7, 134.8, 
135.7, 136.1; HRMS (CI+): calc. for C33H26N (MH+) 436.2060, found 436.2061. 
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(3S,11cS)-3-(phenylethynyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine 296 
 
 
 
 
To a stirred solution of (3S,11cS)-4-allyl-3-(phenylethynyl)-4,5-dihydro-3H-
dinaphtho[2,1-c:1',2'-e]azepine (164 mg, 0.37 mmol, 1.0 eq.) in dry DCM was added 
NDMBA (173 mg, 1.11 mmol, 3.0 eq.) and Pd(PPh3)4 (8.5 mg, 0.007 mmol, 0.02 
eq.). The orange solution was refluxed for 3 hours (TLC indicated complete 
consumption of starting material). The reaction mixture was transferred to a 
separatory funnel and exctracted sequentially with 1M NaOH, water, and brine. The 
organic phase was dried (MgSO4), filtered and concentrated in vacuo to give the 
crude product as a dark orange oil. Column chromatography (3:1 petrol:EtOAc à 
0:1) yielded the title compound as an orange oil (134 mg, 0.34 mmol, 92%); [α]20D 
+204 (c 1.00, CHCl3); νmax(solid) /cm
-1 3054, 2925, 2851, 1686, 1594; δH (500 MHz; 
CDCl3) 3.69 (d, 1H, J = 13.0 Hz), 3.87 (d, 1H, J = 13.0 Hz), 5.24 (s, 1H), 6.03 – 6.05 
(m, 2H), 6.84 – 6.87 (m, 2H), 6.98 (ddt, 1H, J = 8.8, 7.1, 1.3 Hz), 7.26 (ddd, 1H, J = 
8.3, 6.7, 1.3 Hz), 7.30 (ddd, 1H, J = 8.3, 6.7, 1.3 Hz), 7.44 – 7.51 (m, 3H), 7.54 – 
7.58 (m, 3H), 7.91 (t, 2H, J = 7.8 Hz), 7.96 (d, 1H, J = 8.2 Hz), 7.99 (d, 1H, J = 8.3 
Hz), δC (125 MHz; CDCl3) 48.4, 51.8, 82.5, 90.1, 122.6, 125.4, 126.0, 126.1, 127.0, 
127.19, 127.22, 127.4, 127.5, 127.6, 128.29, 128.33, 129.2, 129.3, 131.2, 132.0, 
132.6, 133.4, 133.5, 134.9, 135.0, 135.2, 136.3; HRMS (CI+): calc. for C30H22N 
(MH+) 396.1747, found 396.1747.  
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(3R,11cS)-4-allyl-3-((trimethylsilyl)ethynyl)-4,5-dihydro-3H-dinaphtho[2,1-
c:1',2'-e]azepine 288 
 
 
 
To a stirred solution of (S)-4-allyl-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium 
tetraphenylborate (1.0 g, 1.531 mmol, 1.0 eq.) and CuI (29 mg, 0.153 mmol, 0.1 eq.) 
in MeCN (20 mL) was added trimethylsilylacetylene (1.087 mL, 7.66 mmol, 5.0 eq.) 
and Hünig’s base (1.33 mL, 7.66 mmol, 5.0 eq.). The reaction was stirred for 16 
hours (TLC showed complete consumption of starting material) then concentrated in 
vacuo. The residue was redissolved in DCM then washed sequentially with water 
and brine. The organic phase was dried (MgSO4), filtered and concentrated in vacuo 
to give a crude orange oil. Column chromatography (20:1 petrol:EtOAc) yielded the 
title compound containing a small amount of an unidentified impurity. Crystallization 
of this product yielded colourless needles of the title compound (485 mg, 1.13 mmol, 
74%); [α]20D +202 (c 1.17, CHCl3); νmax(solid) /cm
-1 3414, 3050, 3008, 2956, 2897, 
2812, 2162, 1641, 1507; δH (500 MHz; CDCl3) -0.55 (s, 9H), 3.15 (d, 1H, J = 12.0 
Hz), 3.17 (dd, 1H, J = 13.6, 7.8 Hz), 3.32 (dt, 1H, J = 13.3, 5.3, 1.3 Hz), 3.74 (d, 1H, 
J = 12.0 Hz), 4.90 (s, 1H), 5.27 (d, 1H, J = 10.2 Hz), 5.34 (dq, 1H, J = 17.2, 1.6 Hz), 
6.02 – 6.09 (m, 1H), 7.23 – 7.27 (m, 1H), 7.28 (ddd, 1H, J = 8.3, 6.7, 1.3 Hz), 7.42 – 
7.45 (m, 3H), 7.48 (ddd, 1H, J = 8.0, 6.7, 1.1 Hz), 7.54 (d, 1H, J = 8.6 Hz), 7.58 (d, 
1H, J = 8.3 Hz), 7.91 – 7.97 (m, 4H); δC (125 MHz; CDCl3) -0.6, 55.4, 56.3, 58.3, 
87.2, 103.7, 118.8, 125.5, 125.8, 125.95, 125.98, 127.7, 127.8, 127.9, 128.3, 128.5, 
128.6, 128.8, 132.0, 132.5, 133.41, 133.42, 133.6, 134.77, 134.81, 135.8, 136.3; 
HRMS (CI+): calc. for C30H30NSi (MH+) 432.2142, found 432.2150. 
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Methyl 3-((3S,11cS)-4-allyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-
yl)propiolate 289 
 
 
 
To a stirred solution of (S)-4-allyl-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium 
tetraphenylborate (1.0 g, 1.531 mmol, 1.0 eq.) and CuI (29 mg, 0.153 mmol, 0.1 eq.) 
in MeCN (20 mL) was added methyl propiolate (142 mg, 1.68 mmol, 1.1 eq.) and 
Hünig’s base (1.33 mL, 7.66 mmol, 5.0 eq.). The reaction was stirred for 2 hours 
(TLC showed complete consumption of starting material) then concentrated in 
vacuo. The residue was redissolved in DCM then washed sequentially with water 
and brine. The organic phase was dried (MgSO4), filtered and concentrated in vacuo 
to give a crude orange oil. Column chromatography (20:1 petrol:EtOAc) yielded the 
title compound as a colourless foam (555 mg, 1.33 mmol, 87%) [α]20D +71 (c 1.18, 
CHCl3); νmax(solid) /cm
-1 3049, 2977, 2934, 2833, 2230, 1704, 1510; δH (500 MHz; 
CDCl3) 3.19 (s, 3H), 3.21 – 3.25 (m, 2H), 3.31 (ddt, 1H, J = 13.5, 5.5, 1.4 Hz), 3.74 
(d, 1H, J = 12.2 Hz), 4.90 (s, 1H), 5.27 – 5.29 (m, 1H), 5.36 (dq, 1H, J = 17.0, 1.3 
Hz), 5.95 – 6.03 (m, 1H), 7.26 (ddd, 1H, J = 8.6, 6.7, 1.3 Hz), 7.33 (ddd, 1H, J = 8.6, 
6.7, 1.3 Hz), 7.41 – 7.46 (m, 3H), 7.52 (ddd, 1H, J = 8.0, 6.8, 1.1 Hz), 7.58 (d, 1H, J 
= 8.3 Hz), 7.62 (d, 1H, J = 8.6 Hz), 7.90 – 7.92 (m, 1H), 7.96 – 7.98 (m, 3H); δC (125 
MHz; CDCl3) 31.0, 51.8, 54.6, 55.5, 57.6, 74.6, 86.7, 119.0, 125.5, 126.0, 126.2, 
127.1, 127.3, 127.5, 127.7, 128.1, 128.3, 128.8, 129.4, 131.76, 131.81, 132.3, 133.5, 
133.7, 134.3, 135.2, 135.3, 135.6, 153.1;  
 
 153 
N
BPh4
N
CO2tBu
tert-Butyl 2-((3S,11cS)-4-allyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-
yl)-2-methylpropanoate 327 
 
 
 
Zn dust (3.978 g, 61.2 mmol, 10 eq.) was suspended in dry THF (50 mL) in a dry 3-
necked round-bottomed flask. Under a flow of nitrogen, 1,2-dibromoethane (524 µL, 
6.12 mmol, 1.0 eq.) and TMSCl (772 µL, 6.12 mmol, 1.0 eq.) were added. The 
resulting suspension was heated to reflux for 1 h. While maintaining reflux, tert-butyl 
α–bromoisobutyrate (11.41 mL, 61.2 mmol, 10 eq.) was added dropwise via syringe 
at such a rate as to maintain steady reflux. The mixture was heated until no zinc dust 
remained then cooled to room temperature. This solution was then added to a pre-
cooled (-78 oC) solution of (S)-4-allyl-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium 
tetraphenylborate (4.0 g, 6.12 mmol, 1.0 eq.) in dry THF (50 mL).  The resulting 
mixture was allowed to reach room temperature and stirred for 16 h (TLC indicated 
complete consumption of starting material) before being quenched with water. DCM 
(50 mL) was added. The organic phase was separated and washed with water (2 x 
50 mL) and brine (50 mL) then dried (MgSO4), fltered, and concentrated in vacuo to 
give a pale yellow oil. Column chromatography (99:1 petrol : EtOAc) yielded the title 
compound as a colourless oil (1.245 g, 2.61 mmol, 42%); [α]20D +191 (c 0.92, 
CHCl3); νmax(solid) /cm
-1 3050, 2976, 2934, 2808, 1764, 1718, 1597; δH (500 MHz; 
CDCl3) 0.29 (s, 3H), 0.42 (s, 3H), 1.29 (s, 9H), 3.41 (d, 1H,  J = 11.4 Hz), 3.47 – 3.49 
(m, 2H), 3.65 (d, 1H, J = 11.4 Hz), 4.54 (s, 1H), 5.12 – 5.14 (m, 1H), 5.23 (dq, 1H, J 
= 17.1, 1.6 Hz), 5.89 – 5.97 (m, 1H), 7.18 (ddd, 1H, J = 8.5, 6.9, 1.5 Hz), 7.21 (ddd, 
1H, J = 8.4, 6.9, 1.4 Hz), 7.31 (d, 1H, J = 8.2 Hz), 7.37 (d, 1H, J = 8.6 Hz), 7.40 – 
7.45 (m, 3H), 7.55 (d, 1H, J = 8.3 Hz), 7.87 – 7.90 (m, 4H); δC (125 MHz; CDCl3) 
22.4, 22.6, 28.0, 51.0, 55.1, 64.6, 77.0, 79.8, 117.2, 125.2, 125.3, 125.6, 125.8, 
127.6, 127.7, 128.0, 128.20, 128.24, 128.3, 128.7, 132.2, 132.8, 132.9, 133.0, 134.2, 
135.8, 136.0, 136.1, 136.5, 176.9; HRMS (CI+): calc. for C33H36NO2 (MH+) 478.2741, 
found 478.2735. 
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tert-Butyl 2-((3S,11cS)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl)-2-
methylpropanoate 328 
 
 
 
To a solution of tert-Butyl 2-((3S,11cS)-4-allyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-
e]azepin-3-yl)-2-methylpropanoate (1.05 g, 2.20 mmol, 1.0 eq.) in degassed DCM 
(20 mL) was added NDMBA (1.029 g, 6.60 mmol, 3.0 eq.) and Pd(PPh3)4 (25 mg, 
0.022 mmol, 0.01 eq.). The resulting orange reaction mixture was heated to reflux for 
2 h (TLC indicated complete consumption of starting material). The organic phase 
was washed sequentially with 1M NaOH, water, and brine then dried (MgSO4), 
fltered, and concentrated in vacuo to give an orange oil. Column chromatography 
(5:1 petrol : EtOAc) yielded the title compound as a colourless foam (654 mg, 1.49 
mmol, 68%); [α]20D +287 (c 0.99, CHCl3); νmax(solid) /cm
-1  3343, 3050, 3009, 2976, 
2929, 1720; δH (500 MHz; CDCl3) 0.25 (s, 3H), 0.75 (s, 3H), 1.39 (s, 9H), 2.30 (br s, 
1H), 3.74 (d, 1H, J = 12.7 Hz), 3.96 (d, 1H, J = 12.7 Hz), 4.90 (s, 1H), 7.15 (ddd, 1H, 
J = 8.3, 7.1, 1.6 Hz), 7.21 (ddd, 1H, J = 8.0, 6.6, 1.2 Hz), 7.26 – 7.28 (m, 1H), 7.39 – 
7.44 (m, 2H), 7.46 (d, 1H, J = 8.6 Hz), 7.51 (d, 1H, J = 8.3 Hz), 7.88 – 7.91 (m, 4H); 
δC (125 MHz; CDCl3) 19.6, 23.7, 28.0, 49.4, 50.8, 70.4, 80.1, 125.0, 125.4, 125.7, 
125.8, 126.7, 127.5, 127.7, 127.9, 128.1, 128.4, 128.8, 132.4, 132.8, 132.9, 133.4, 
134.7, 134.8, 136.1, 139.1, 176.8; HRMS (CI+): calc. for C30H32NO2 (MH+) 438.2428, 
found 438.2424. 
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2-((3S,11cS)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl)-2-
methylpropanoic acid 325 
 
 
 
To a solution of tert-Butyl 2-((3S,11cS)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-
e]azepin-3-yl)-2-methylpropanoate (520 mg, 1.19 mmol, 1.0 eq.) in DCM (10 mL) 
was added triethylsilane (568µL, 3.57 mmol, 3.0 eq.) and trifluoroacetic acid (5 mL). 
The green reaction mixture was stirred overnight at room temperature and then 
concentrated in vacuo. The reaction mixture was dissolved in toluene and again 
concentrated in vacuo in order to remove volatile impurities. Column 
chromatography (EtOAc à 4:1 EtOAc:MeOH) of the residue gave the title compound 
as a colourless powder (322 mg, 0.85 mmol, 71%); [α]20D +132 (c 0.91, CHCl3); 
νmax(solid) /cm
-1 3383, 3053, 2966, 2715, 1688, 1598, 1578; δH (500 MHz; CDCl3) -
0.01 (s, 3H), 1.15 (s, 3H), 4.04 (d, 1H, J = 13.1 Hz), 4.44 (d, 1H, J = 13.1 Hz), 5.30 
(s, 1H), 7.18 – 7.24 (m, 2H), 7.30 – 7.32 (m, 2H), 7.48 – 7.53 (m, 2H), 7.61 – 7.63 
(m, 2H), 7.79 (d, 1H, J = 8.3 Hz), 7.90 – 8.01 (m, 3H); δC (125 MHz; CDCl3) 20.0, 
26.4, 46.9, 48.1, 68.0, 126.1, 126.3, 126.6, 126.7, 127.2, 127.6, 127.98, 128.04, 
128.6, 129.1, 129.5, 130.3, 131.7, 132.0, 132.4, 133.0, 133.5, 133.8, 133.9, 136.1, 
181.8; HRMS (CI+): calc. for C26H24NO2 (MH+) 382.1802, found 382.1803. 
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rac-Dibenzyl 2-(3-oxocyclohexyl)malonate 
 
 
 
Cyclohexenone (250 µL, 2.6 mmol, 1.0 eq.) and dibenzyl malonate (650 µL, 2.60 
mmol, 1.0 eq.) were dissolved in EtOH and stirred at room temperature. DBU (97 µL, 
0.65 mmol, 0.25 eq.) was slowly added via microsyringe and the colourless solution 
quickly became yellow. The mixture was stirred for 1 hour then the solvent was 
removed in vacuo. The residue was dissolved in DCM and sequentially washed with 
water and brine then dried (MgSO4), filtered and concentrated in vacuo. Column 
chromatography (20:1 petrol:acetone à 10:1) gave the title compound as a 
colourless solid (243 mg, 0.64 mmol, 25%); δH (500 MHz; CDCl3) 1.43 – 1.51 (m, 
1H), 1.59 – 1.68 (m, 1H), 1.89 – 1.92 (m, 1H), 1.99 – 2.05 (m, 1H), 2.17 – 2.27 (m, 
2H), 2.35 – 2.39 (m, 1H), 2.42 – 2.46 (m, 1H), 2.52 – 2.60 (m, 1H), 3.41 (d, 1H, J = 
7.7 Hz), 5.14 (s, 2H), 5.15 (s, 2H), 7.27 – 7.29 (m, 4H), 7.32 – 7.35 (m, 6H); δC (125 
MHz; CDCl3) 24.5, 28.7, 38.1, 40.1, 45.1, 56.8, 67.29, 67.31, 128.3, 128.5, 128.6, 
135.12, 135.14, 167.5, 167.6, 209.4 
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Dibenzyl 2-((2R,3R)-2,3-dimethyl-1,4-dioxaspiro[4.5]decan-7-yl)malonate 
 
 
 
 
rac-Dibenzyl 2-(3-oxocyclohexyl)malonate (187 mg, 0.49 mmol, 1.0 eq.) and p-
toluenesulfonic acid monohydrate (10 mg, 0.05 mmol, 0.1 eq.) were dissolved in 
benzene. To the clear solution was then added (R)-(–)-2,3-butanediol (90 µL, 0.98 
mmol, 2.0 eq.). The reaction mixture was heated to reflux for 3 h (TLC indicated 
complete consumption of starting material). The solvent was removed in vacuo and 
the residue was redissolved in DCM. It was then washed sequentially with water and 
brine then dried (MgSO4), filtered and concentrated in vacuo to give the title 
compound as a colourless oil (221 mg, 0.49 mmol, quant.); δH (500 MHz; CDCl3, 
mixture of two diastereoisomers) 1.01 – 1.07 (m, 1H), 1.15 – 1.20 (m, 6H), 1.26 – 
1.45 (m, 3H), 1.52 – 1.78 (m, 5H), 2.45 – 2.50 (m, 1H), 3.35 (t, 1H, J = 16.3 Hz), 
3.43 – 3.58 (m, 2H), 5.08 – 5.20 (m, 4H), 7.28 – 7.34 (m, 10H); δC (125 MHz; CDCl3, 
mixture of two diastereoisomers) 16.8, 16.9, 17.0, 17.1, 22.4, 22.6, 29.1, 29.2, 35.3, 
35.7, 35.8, 36.7, 39.9, 40.8, 57.4, 66.9, 67.0, 77.8, 78.0, 78.1, 78.2, 107.60, 107.63, 
128.21, 128.24, 128.30, 128.33, 128.5, 135.4, 135.5, 168.1, 168.1, 168.24, 168.25 
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rac-Diethyl 2-(3-oxocyclohexyl)malonate 
 
 
 
Cyclohexenone (250 µL, 2.6 mmol, 1.0 eq.) and diethyl malonate (396 µL, 2.60 
mmol, 1.0 eq.) were dissolved in EtOH (5 mL) and stirred at room temperature. DBU 
(97 µL, 0.65 mmol, 0.25 eq.) was slowly added via microsyringe and the colourless 
solution quickly became yellow. The mixture was stirred for 16 h then the solvent 
was removed in vacuo. The residue was dissolved in DCM and sequentially washed 
with water and brine then dried (MgSO4), filtered and concentrated in vacuo. The 
crude brown oil was filtered through a plug of silica (DCM elution) to remove 
coloured impurities. After concentration in vacuo, the title compound was isolated as 
a colourless oil (624 mg, 2.44 mmol, 94%); δH (500 MHz; CDCl3) 1.26 – 1.29 (m, 
6H), 1.49 – 1.55 (m, 1H), 1.64 – 1.70 (m, 2H), 1.94 – 1.97 (m, 1H), 2.04 – 2.09 (m, 
1H), 2.22 – 2.30 (m, 2H), 2.39 – 2.46 (m, 2H), 2.52 – 2.55 (m, 1H), 3.29 (d, 1H, J = 
8.0 Hz), 4.18 – 4.23 (m, 4H); δC (125 MHz; CDCl3) 14.11, 14.12, 24.6, 28.8, 38.1, 
41.1, 45.1, 56.9, 61.6, 167.8, 167.9, 209.7 
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Diethyl 2-((2R,3R)-2,3-dimethyl-1,4-dioxaspiro[4.5]decan-7-yl)malonate 
 
 
 
 
rac-Diethyl 2-(3-oxocyclohexyl)malonate (100 mg, 0.39 mmol, 1.0 eq.) and p-
toluenesulfonic acid monohydrate (10 mg, 0.05 mmol, 0.1 eq.) were dissolved in 
benzene. To the clear solution was then added (R)-(–)-2,3-butanediol (72 µL, 0.78 
mmol, 2.0 eq.). The reaction mixture was heated to reflux for 1 h (TLC indicated 
complete consumption of starting material). The solvent was removed in vacuo and 
the residue was redissolved in DCM. It was then washed sequentially with water and 
brine then dried (MgSO4), filtered and concentrated in vacuo to give the title 
compound as a colourless oil (128 mg, 0.39 mmol, quant.); δH (500 MHz; CDCl3, 
mixture of two diastereoisomers) 1.04 – 1.07 (m, 2H), 1.20 – 1.27 (m, 12H), 1.31 – 
1.34 (m, 1H), 1.36 – 1.38 (m, 1H), 1.43 – 1.82 (m, 5H), 2.39 – 2.46 (m, 1H), 3.21 (d, 
1H, J = 8.5 Hz), 3.58 – 3.64 (m, 2H), 4.15 – 4.19 (m, 4H); δC (125 MHz; CDCl3, 
mixture of two diastereoisomers) 14.2, 16.8, 17.0, 17.11, 17.13, 22.4, 22.7, 29.07, 
29.13, 35.2, 25.6, 25.9, 36.8, 40.0, 40.1, 57.4, 57.5, 61.2, 77.9, 78.1, 78.3, 107.7, 
107.8, 168.4, 168.5, 168.57, 168.60 
 160 
O
CO2Me
CO2Me
O
rac-Dimethyl 2-(3-oxocyclohexyl)malonate 
 
 
 
Cyclohexenone (250 µL, 2.6 mmol, 1.0 eq.) and dimethyl malonate (297 µL, 2.60 
mmol, 1.0 eq.) were dissolved in EtOH (5 mL) and stirred at room temperature. DBU 
(97 µL, 0.65 mmol, 0.25 eq.) was slowly added via microsyringe and the colourless 
solution quickly became yellow. The mixture was stirred for 16 h then the solvent 
was removed in vacuo. The residue was dissolved in DCM and sequentially washed 
with water and brine then dried (MgSO4), filtered and concentrated in vacuo. The 
crude brown oil was filtered through a plug of silica (DCM elution) to remove 
coloured impurities. After concentration in vacuo, the title compound was isolated as 
a colourless oil (512 mg, 2.24 mmol, 86%); δH (500 MHz; CDCl3) 1.45 – 1.53 (m, 
1H), 1.63 – 1.72 (m, 2H), 1.92 – 1.95 (m, 1H), 2.05 – 2.09 (m, 1H), 2.22 – 2.29 (m, 
2H), 2.38 – 2.44 (m, 2H), 2.49 – 2.56 (m, 1H), 3.34 (d, 1H, J = 8.0 Hz), 3.74 – 3.75 
(m, 6H); δC (125 MHz; CDCl3) 24.5, 28.8, 38.1, 41.0, 45.1, 52.7, 56.6, 168.2, 168.3, 
209.6. 
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Dimethyl 2-((2R,3R)-2,3-dimethyl-1,4-dioxaspiro[4.5]decan-7-yl)malonate 
 
 
 
 
rac-Dimethyl 2-(3-oxocyclohexyl)malonate (70 mg, 0.30 mmol, 1.0 eq.) and p-
toluenesulfonic acid monohydrate (6 mg, 0.03 mmol, 0.1 eq.) were dissolved in 
benzene. To the clear solution was then added (R)-(–)-2,3-butanediol (54 µL, 0.60 
mmol, 2.0 eq.). The reaction mixture was heated to reflux for 1 h (TLC indicated 
complete consumption of starting material). The solvent was removed in vacuo and 
the residue was redissolved in DCM. It was then washed sequentially with water and 
brine then dried (MgSO4), filtered and concentrated in vacuo to give the title 
compound as a colourless oil (90 mg, 0.30 mmol, quant.); δH (500 MHz; CDCl3, 
mixture of two diastereoisomers) 0.99 – 1.04 (m, 2H), 1.14 – 1.22 (m, 12H), 1.30 – 
1.37 (m, 2H), 1.40 – 1.49 (m, 2H), 1.53 – 1.69 (m, 10H), 2.39 – 2.45 (m, 2H), 3.26 (d, 
2H, J = 8.5 Hz), 3.53 – 3.64 (m, 2H), 3.71 (s, 12H); δC (125 MHz; CDCl3, mixture of 
two diastereoisomers) 16.8, 17.0, 17.06, 17.12, 22.4, 22.7, 29.1, 35.3, 35.7, 35.8, 
36.7, 40.0, 40.1, 52.3, 52.4, 57.0, 57.1, 77.9, 78.1, 78.3, 107.6, 107.7, 168.8, 168.9, 
168.95, 168.98. 
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Diisopropyl 2-(3-oxocyclohexyl)malonate 
 
 
 
To a stirred solution of diisopropyl malonate (493 µL, 2.6 mmol, 1.0 eq.) in dry THF 
(10 mL) was added potassium tert-butoxide (60 mg, 0.26 mmol, 0.1 eq.). After 
stirring for 5 minutes, cyclohexenone (250 µL, 2.6 mmol, 1.0 eq.) was added 
dropwise over 5 minutes at room temperature. The resulting reaction mixture was 
stirred overnight at room temperature (TLC indicated complete consumption of 
starting material). The reaction mixture was diluted with DCM then washed 
sequentially with water and brine before being dried (MgSO4), filtered and 
concentrated in vacuo to give the crude product as an orange oil. Column 
chromatography (6:1 petrol:EtOAc) yielded the title compound as a colourless oil 
(439 mg, 1.54 mmol, 59%); δH (500 MHz; CDCl3) 1.25 – 1.26 (m, 12 H), 1.49 – 1.55 
(m, 1H), 1.66 – 1.70 (m, 1H), 1.95 – 1.98 (m, 1H), 2.04 – 2.09 (m, 1H), 2.22 – 2.30 
(m, 2H), 2.38 – 2.53 (m, 3H), 3.22 (d, 1H, J = 7.8 Hz), 5.03 – 5.09 (m, 2H); δC (125 
MHz; CDCl3) 21.6, 21.71, 21.72, 24.6, 28.8, 37.9, 41.1, 45.2, 57.2, 69.16, 69.18, 
167.4, 167.5, 209.9.  
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Diisopropyl 2-((2R,3R)-2,3-dimethyl-1,4-dioxaspiro[4.5]decan-7-yl)malonate 
 
 
 
 
rac-Diisopropyl 2-(3-oxocyclohexyl)malonate (158 mg, 0.55 mmol, 1.0 eq.) and p-
toluenesulfonic acid monohydrate (10.5 mg, 0.055 mmol, 0.1 eq.) were dissolved in 
benzene. To the clear solution was then added (R)-(–)-2,3-butanediol (98 µL, 1.10 
mmol, 2.0 eq.). The reaction mixture was heated to reflux for 1 h (TLC indicated 
complete consumption of starting material). The solvent was removed in vacuo and 
the residue was redissolved in DCM. It was then washed sequentially with water and 
brine then dried (MgSO4), filtered and concentrated in vacuo to give the title 
compound as a colourless oil (195 mg, 0.55 mmol, quant.); δH (500 MHz; CDCl3, 
mixture of two diastereoisomers) 1.02 – 1.07 (m, 2H), 1.18 – 1.22 (m, 36H), 1.33 (q, 
2H, J = 12.3 Hz), 1.37 – 1.46 (m, 2H), 1.54 – 1.58 (m, 2H), 1.65 – 1.73 (m, 6H), 1.79 
– 1.82 (m, 2H), 2.37 – 2.40 (m, 2H), 3.11 (dd, 2H, J = 8.7, 1.1 Hz), 3.54 – 3.61 (m, 
4H), 4.99 – 5.05 (m, 4H); δC (125 MHz; CDCl3, mixture of two diastereoisomers) 
16.8, 16.9, 17.1, 17.2, 21.61, 21.63, 21.71, 22.5, 22.8, 29.0, 29.1, 35.0, 35.4, 35.9, 
36.8, 40.0, 40.1, 57.8, 57.9, 68.55, 68.57, 68.59, 68.61, 77.8, 78.0, 78.2, 107.77, 
107.79, 167.9, 168.0, 168.07, 168.10. 
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rac-Dibenzyl 2-(3-oxo-1-phenylbutyl)malonate 
 
 
 
To a stirred solution of dibenzyl malonate (655 µL, 2.6 mmol, 1.0 eq.) and potassium 
tert-butoxide (29 mg, 0.26 mmol, 0.1 eq.) in dry THF (5 mL) was added 
benzylideneacetone (379 mg, 2.6 mmol, 1.0 eq.) as a solution in dry THF (5 mL). 
The orange reaction mixture was stirred at room temperature overnight then 
quenched with water. The organic phase was separated and washed sequentially 
with water and brine before being dried (MgSO4), filtered and concentrated in vacuo 
to give the crude product as an orange oil. Column chromatography of the residue 
(10:1 petrol:EtOAc) yielded the title compound as a pale yellow oil which solidified on 
standing (941 mg, 2.19 mmol, 86%); δH (500 MHz; CDCl3) 1.95 (s, 3H), 2.88 (d, 2H, 
J = 6.9 Hz), 3.82 (d, 1H, J = 9.9 Hz), 3.97 – 4.02 (m, 1H), 4.89 (s, 2H), 5.13 – 5.14 
(m, 2H), 7.05 – 7.06 (m, 2H), 7.18 – 7.33 (m, 13H); δC (125 MHz; CDCl3) 30.3, 40.5, 
47.1, 57.4, 67.2, 67.3, 127.3, 128.1, 128.2, 128.27, 128.31, 128.4, 128.5, 128.57, 
128.59, 135.0, 135.2, 140.2, 167.4, 167.9, 206.0. 
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Dibenzyl 2-(1-phenyl-2-((4R,5R)-2,4,5-trimethyl-1,3-dioxolan-2-yl)ethyl) 
malonate 
 
 
 
rac-Dibenzyl 2-(3-oxo-1-phenylbutyl)malonate (55 mg, 0.13 mmol, 1.0 eq.) and p-
toluenesulfonic acid monohydrate (3 mg, 0.013 mmol, 0.1 eq.) were dissolved in 
benzene. To the clear solution was then added (R)-(–)-2,3-butanediol (24 µL, 0.26 
mmol, 2.0 eq.). The reaction mixture was heated to reflux for 1 h (TLC indicated 
complete consumption of starting material). The solvent was removed in vacuo and 
the residue was redissolved in DCM. It was then washed sequentially with water and 
brine then dried (MgSO4), filtered and concentrated in vacuo to give the title 
compound as a pale yellow oil (65 mg, 0.13 mmol, quant.); δH (500 MHz; CDCl3, 
mixture of two diastereoisomers) 1.01 (d, 3H, J = 6.0 Hz), 1.04 (d, 3H, J = 6.2 Hz), 
1.06 (d, 3H, J = 6.2 Hz), 1.10 (app t, 6H, J = 3.0 Hz), 1.14 (s, 3H), 2.03 – 2.23 (m, 
4H), 3.27 – 3.33 (m, 2H), 3.47 – 3.55 (m, 2H), 3.70 – 3.81 (m, 4H), 4.87 (app q, 4H, 
J = 11.0 Hz), 5.15 (app d, 4H, J = 5.6 Hz), 7.03 – 7.05 (m, 4H), 7.16 – 7.34 (m, 26H); 
δC (125 MHz; CDCl3, mixture of two diastereoisomers) 16.2, 16.4, 16.9, 17.0, 26.2, 
26.3, 41.4, 41.5, 43.0, 43.1, 59.05, 59.09, 67.0, 67.18, 67.19, 78.09, 78.14, 78.2, 
78.3, 108.2, 108.3, 126.76, 126.84, 128.1, 128.2, 128.28, 128.33, 128.34, 128.4, 
128.6, 128.7, 135.17, 135.18, 135.35, 135.37, 141.4, 141.6, 167.58, 167.63, 168.0, 
168.1 
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rac-Dimethyl 2-(3-oxo-1-phenylbutyl)malonate 
 
 
 
To a stirred solution of dimethyl malonate (297 µL, 2.6 mmol, 1.0 eq.) and potassium 
tert-butoxide (29 mg, 0.26 mmol, 0.1 eq.) in dry THF (5 mL) was added 
benzylideneacetone (379 mg, 2.6 mmol, 1.0 eq.) as a solution in dry THF (5 mL). 
The orange reaction mixture was stirred at room temperature overnight then 
quenched with water. The organic phase was separated and washed sequentially 
with water and brine before being dried (MgSO4), filtered and concentrated in vacuo 
to give the crude product as an orange oil. Column chromatography of the residue 
(4:1 petrol:EtOAc) yielded the title compound as a colourless oil (372 mg, 1.35 mmol, 
52%); δH (500 MHz; CDCl3) 2.03 (s, 3H), 2.88 – 2.99 (m, 2H), 3.50 (s, 3H), 3.72 (s, 
3H), 3.73 (d, 1H, J = 9.6 Hz), 3.95 – 4.00 (m, 1H), 7.18 – 7.23 (m, 3H), 7.26 – 7.29 
(m, 2H); δC (125 MHz; CDCl3) 30.3, 40.5, 47.2, 52.4, 52.7, 57.1, 127.3, 128.0, 128.6, 
140.37, 168.1, 168.6, 206.1. 
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Dimethyl 2-(1-phenyl-2-((4R,5R)-2,4,5-trimethyl-1,3-dioxolan-2-
yl)ethyl)malonate 
 
 
 
rac-Dimethyl 2-(3-oxo-1-phenylbutyl)malonate (100 mg, 0.359 mmol, 1.0 eq.) and p-
toluenesulfonic acid monohydrate (8 mg,  0.035 mmol, 0.1 eq.) were dissolved in 
benzene. To the clear solution was then added (R)-(–)-2,3-butanediol (65 µL, 0.7 
mmol, 2.0 eq.). The reaction mixture was heated to reflux for 1 h (TLC indicated 
complete consumption of starting material). The solvent was removed in vacuo and 
the residue was redissolved in DCM. It was then washed sequentially with water and 
brine then dried (MgSO4), filtered and concentrated in vacuo to give the title 
compound as a pale yellow oil (125 mg, 0.359 mmol, quant.); δH (500 MHz; CDCl3, 
mixture of two diastereoisomers) 1.04 – 1.09 (m, 9H), 1.14 – 1.19 (m, 9H), 2.02 – 
2.24 (m, 4H), 3.36 – 3.41 (m, 2H), 3.43 (d, 6H, J = 2.4 Hz), 3.50 – 3.56 (m, 2H), 3.64 
– 3.70 (m, 4H), 3.72 (d, 6H, J = 5.8 Hz)7.16 – 7.19 (m, 2H), 7.23 – 7.26 (m, 8H); δC 
(125 MHz; CDCl3, mixture of two diastereoisomers) 16.3, 16.4, 16.8, 17.0, 26.2, 
26.3, 41.4, 41.5, 43.0, 43.1, 52.18, 52.20, 52.5, 52.6, 58.85, 58.93, 7.81, 78.16, 
78.23, 78.4, 108.3, 108.4, 126.75, 126.83, 128.11, 128.14, 128.5, 128.6, 141.5, 
141.6, 168.2, 168.3, 168.7, 168.8. 
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rac-Diisopropyl 2-(3-oxo-1-phenylbutyl)malonate 
 
 
 
To a stirred solution of diisopropyl malonate (493 µL, 2.6 mmol, 1.0 eq.) and 
potassium tert-butoxide (29 mg, 0.26 mmol, 0.1 eq.) in dry THF (5 mL) was added 
benzylideneacetone (379 mg, 2.6 mmol, 1.0 eq.) as a solution in dry THF (5 mL). 
The orange reaction mixture was stirred at room temperature overnight then 
quenched with water. The organic phase was separated and washed sequentially 
with water and brine before being dried (MgSO4), filtered and concentrated in vacuo 
to give the crude product as a yellow oil. Column chromatography of the residue 
(10:1 petrol:EtOAc) yielded the title compound as a colourless oil (666 mg, 1.77 
mmol, 68%); δH (500 MHz; CDCl3) 0.98 (d, 3H, J = 6.3 Hz), 1.05 (d, 3H, J = 6.3 Hz), 
1.24 (d, 3H, J = 6.3 Hz), 1.25, d, 3H, J = 6.3 Hz), 2.03 (s, 3H), 2.87 – 2.93 (m, 2H), 
3.65 (d, 1H, J = 10.1 Hz), 3.95 (td, 1H, J = 14.5, 5.6 Hz), 4.79 (septet, 1H, J = 6.3 
Hz), 5.07 (septet, 1H, J = 6.3 Hz), 7.18 – 7.21 (m, 1H), 7.25 – 7.29 (m, 4H); δC (125 
MHz; CDCl3) 21.28, 21.32, 21.5, 21.7, 30.3, 40.4, 47.8, 57.7, 68.8, 69.3, 127.2, 
128.3, 128.4, 140.5, 167.2, 167.8, 206.2. 
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Diisopropyl 2-(1-phenyl-2-((4R,5R)-2,4,5-trimethyl-1,3-dioxolan-2-
yl)ethyl)malonate 
 
 
 
rac-Diisopropyl 2-(3-oxo-1-phenylbutyl)malonate (130 mg, 0.39 mmol, 1.0 eq.) and 
p-toluenesulfonic acid monohydrate (7 mg, 0.04 mmol, 0.1 eq.) were dissolved in 
benzene. To the clear solution was then added (R)-(–)-2,3-butanediol (79 µL, 0.78 
mmol, 2.0 eq.). The reaction mixture was heated to reflux for 1 h (TLC indicated 
complete consumption of starting material). The solvent was removed in vacuo and 
the residue was redissolved in DCM. It was then washed sequentially with water and 
brine then dried (MgSO4), filtered and concentrated in vacuo to give the title 
compound as a pale yellow oil (158 mg, 0.39 mmol, quant.); δH (500 MHz; CDCl3, 
mixture of two diastereoisomers) 0.85 – 0.87 (m, 6H), 1.01 – 1.05 (m, 15H), 1.11 – 
1.13 (m, 6H), 1.17 – 1.24 (m, 15H), 2.01 – 2.19 (m, 4H), 3.30 – 3.43 (m, 2H), 3.45 – 
3.64 (m, 6H), 4.66 – 4.73 (m, 2H), 5.00 – 5.09 (m, 2H), 7.12 – 7.15 (m, 2H), 7.20 – 
7.26 (m, 8H); δC (125 MHz; CDCl3, mixture of two diastereoisomers) 16.3, 16.4, 16.7, 
16.9, 21.20, 21.22, 21.4, 21.5, 21.6, 21.7, 26.2, 26.3, 41.2, 41.4, 43.4, 43.6, 59.37, 
59.39, 68.5, 68.90, 69.92, 78.1, 78.15, 78.17, 108.3, 108.4, 126.56, 126.64, 127.9, 
128.0, 128.85, 128.91, 141.6, 141.7, 167.3, 167.4, 167.9, 168.0. 
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